Back to GetFilings.com
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the fiscal year ended December 31, 2004 |
|
or |
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the transition period
from to |
Commission File Number 000-50132
Sterling Chemicals, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
76-0502785 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
|
333 Clay Street, Suite 3600 |
|
(713) 650-3700 |
Houston, Texas 77002-4109
(Address of principal executive offices)
|
|
(Registrants telephone number,
including area code) |
Securities registered pursuant to Section 12(b) of the
Act: None
Securities registered pursuant to Section 12(g) of the
Act:
Common Stock, par value $.01 per share
(Title of class)
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports) and (2) has been subject
to such filing requirements for the past
90 days. Yes þ No o.
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K is not
contained herein and will not be contained, to the best of the
registrants knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this
Form 10-K or any amendment to this
Form 10-K. o.
Indicate by check mark whether the registrant is an accelerated
filer (as defined in Rule 12b-2 of the
Act). Yes o No þ.
The aggregate market value of the registrants common
stock, par value $.01 per share, held by non-affiliates at
June 30, 2004 (the last business day of the
registrants most recently completed second fiscal
quarter), based upon the value of the last sales price of these
shares as reported on the OTC Electronic Bulletin Board
maintained by the National Association of Securities Dealers,
Inc., was $30,923,325.
APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Section 12,
13 or 15(d) of the Securities Exchange Act of 1934 subsequent to
the distribution of securities under a plan confirmed by a
court. Yes þ No o.
As of January 31, 2005, Sterling Chemicals, Inc. had
2,825,000 shares of common stock outstanding.
Portions of the definitive Proxy Statement relating to the 2005
Annual Meeting of Stockholders of Sterling Chemicals, Inc. are
incorporated by reference in Part III of this
Form 10-K.
IMPORTANT INFORMATION REGARDING THIS FORM 10-K
Unless otherwise indicated, references to we,
us, our and ours in this
Form 10-K refer collectively to Sterling Chemicals, Inc.
and its wholly-owned subsidiaries.
Readers should consider the following information as they review
this Form 10-K.
Forward-Looking Statements
Certain written and oral statements made or incorporated by
reference from time to time by us or our representatives are
forward-looking statements within the meaning of
Section 27A of the United States Securities Act of 1933, as
amended, and Section 21E of the United States Securities
Exchange Act of 1934, as amended (the Exchange Act).
All statements other than statements of historical fact are, or
may be deemed to be, forward-looking statements. Forward-looking
statements include, without limitation, any statement that may
project, indicate or imply future results, events, performance
or achievements, and may contain or be identified by the words
expect, intend, plan,
predict, anticipate,
estimate, believe, should,
could, may, might,
will, will be, will
continue, will likely result,
project, forecast, budget
and similar expressions. Statements in this report that contain
forward-looking statements include, but are not limited to,
information concerning our possible or assumed future results of
operations and statements about the following subjects:
|
|
|
|
|
the cyclicality of the petrochemicals industry; |
|
|
|
current and future industry conditions; |
|
|
|
the extent and timing of expansions of production capacity of
our products, by us or by our competitors; |
|
|
|
the potential effects of market and industry conditions and
cyclicality on our business strategy, results of operations or
financial position; |
|
|
|
the level of expected savings from our cost reduction
initiatives; |
|
|
|
the adequacy of our liquidity; |
|
|
|
our environmental management programs and safety initiatives; |
|
|
|
our market sensitive financial instruments; |
|
|
|
future uses of and requirements for financial resources; |
|
|
|
future contractual obligations; |
|
|
|
future amendments or renewals of existing contractual
relationships; |
|
|
|
business strategy; |
|
|
|
growth opportunities; |
|
|
|
competitive position; |
|
|
|
expected financial position; |
|
|
|
future cash flows; |
|
|
|
future dividends; |
|
|
|
financing plans; |
|
|
|
budgets for capital and other expenditures; |
|
|
|
plans and objectives of management; |
|
|
|
outcomes of legal proceedings; |
i
|
|
|
|
|
compliance with applicable laws; and |
|
|
|
adequacy of insurance or indemnification. |
Such statements are based upon current information and
expectations and inherently are subject to a variety of risks
and uncertainties that could cause actual results to differ
materially from those expected or expressed in forward-looking
statements. Such risks and uncertainties include, among others,
the following:
|
|
|
|
|
the timing and extent of changes in commodity prices; |
|
|
|
petrochemicals industry production capacity and operating rates; |
|
|
|
market conditions in the petrochemicals industry, including the
supply-demand balance for our products; |
|
|
|
competition, including competitive products and pricing
pressures; |
|
|
|
obsolescence of product lines; |
|
|
|
the timing and extent of changes in global economic and business
conditions; |
|
|
|
increases in raw materials and energy costs, including the cost
of natural gas; |
|
|
|
our ability to obtain raw materials, energy and ocean-going
vessels at acceptable prices, in a timely manner and on
acceptable terms; |
|
|
|
regulatory initiatives and compliance with governmental
regulations; |
|
|
|
compliance with environmental laws and regulations; |
|
|
|
customer preferences; |
|
|
|
our ability to attract or retain high quality employees; |
|
|
|
operating hazards attendant to the petrochemicals industry; |
|
|
|
casualty losses; |
|
|
|
changes in foreign, political, social and economic conditions; |
|
|
|
risks of war, military operations, other armed hostilities,
terrorist acts and embargoes; |
|
|
|
changes in technology, which could require significant capital
expenditures in order to maintain competitiveness; |
|
|
|
effects of litigation; |
|
|
|
cost, availability and adequacy of insurance; |
|
|
|
adequacy of our sources of liquidity; and |
|
|
|
various other matters, many of which are beyond our control. |
The risks included here are not exhaustive. Other sections of
this report, and our other filings with the Securities and
Exchange Commission, include additional factors that could
adversely affect our business, results of operations and
financial performance. See Managements Discussion
and Analysis of Financial Condition and Results of
Operations Certain Known Events, Trends,
Uncertainties and Risk Factors contained in Item 7 of
Part II of this Form 10-K. Given these risks and
uncertainties, investors should not place undue reliance on
forward-looking statements. Forward-looking statements included
in this Form 10-K speak only as of the date of this
Form 10-K and are not guarantees of future performance.
Although we believe that the expectations reflected in these
forward-looking statements are reasonable, such expectations may
prove to have been incorrect. All subsequent written and oral
forward-looking statements attributable to us, or persons acting
on our behalf, are expressly qualified in their entirety by
these cautionary statements.
ii
Subsequent Events
All statements and information contained in this Form 10-K,
including the forward-looking statements discussed above, are
made as of February 15, 2005, unless those statements or
information are expressly made as of another date. We disclaim
any responsibility for the correctness of any statement or
information contained in this Form 10-K to the extent such
statement or information is affected or impacted by events,
circumstances or developments occurring after February 15,
2005 or by the passage of time after such date. Except to the
extent required by applicable securities laws, we expressly
disclaim any obligation or undertaking to release publicly any
updates or revisions to any statement or information contained
in this Form 10-K, including the forward-looking statements
discussed above, to reflect any change in our expectations with
regard thereto or any change in events, conditions or
circumstances on which any statement or information is based.
Document Summaries
Descriptions of documents and agreements contained in this
Form 10-K are provided in summary form only, and such
summaries are qualified in their entirety by reference to the
actual documents and agreements filed as exhibits to this
Form 10-K.
Fiscal Year
In December 2002, we changed our fiscal year-end from
September 30 to December 31. In this Form 10-K:
|
|
|
|
|
2004 and fiscal 2004 refer to the
12-month period ended December 31, 2004; |
|
|
|
2003 and fiscal 2003 refer to the
12-month period ended December 31, 2003; |
|
|
|
fiscal 2002 refers to the 12-month period ended
September 30, 2002; and |
|
|
|
the Transition Period refers to the three-month
period from October 1, 2002 through December 31, 2002. |
iii
TABLE OF CONTENTS
1
PART I
We are a leading North American producer of selected
petrochemicals used to manufacture a wide array of consumer
goods and industrial products throughout the world. Our primary
products include styrene, acetic acid and acrylonitrile. Styrene
is a commodity chemical used to produce intermediate products
such as polystyrene, expandable polystyrene resins and ABS
plastics, which are used in a wide variety of products such as
household goods, foam cups and containers, disposable food
service items, toys, packaging and other consumer and industrial
products. Approximately 50% of our styrene capacity is committed
for sales in North America under long-standing customer
relationships, and the balance of our capacity is available to
produce styrene for sales throughout the world when market
conditions warrant, including the high growth Asian markets.
Acetic acid is used primarily to produce vinyl acetate monomer,
which is used in a variety of products, including adhesives,
surface coatings and cigarette filters. All of our acetic acid
production is sold to BP Amoco Chemical Company
(BP Chemicals) pursuant to a long-term contract
that expires in 2016, which has provided us with a stable,
steadily increasing source of income since the inception of this
relationship in 1986. Acrylonitrile is used primarily in
apparel, textiles, ABS plastics, upholstery and automotive
parts, and is also used in a wide variety of other applications.
Most of our acrylonitrile sales are made under several long-term
agreements with BP Chemicals.
We manufacture all of our petrochemicals products at our world
scale facility in Texas City, Texas. This facility is
strategically located on a deepwater port, and also has truck
and railcar loading and unloading facilities, giving us the
ability to accept shipment of our major raw materials in the
most efficient manner and load shipments of our petrochemicals
products for delivery throughout the world. As set forth below,
our rated annual production capacity is among the highest in
North America for styrene, acetic acid and acrylonitrile.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of | |
|
|
|
|
|
|
|
|
Total North | |
|
|
|
|
|
|
Rated Annual | |
|
American | |
|
North American | |
|
Global | |
Product |
|
Production Capacity | |
|
Capacity | |
|
Market Position | |
|
Production Capacity | |
|
|
| |
|
| |
|
| |
|
| |
Styrene
|
|
|
1.7 billion pounds |
|
|
|
11% |
|
|
|
4 |
|
|
|
58 billion pounds |
|
Acetic Acid
|
|
|
1 billion pounds |
|
|
|
17% |
|
|
|
3 |
|
|
|
20 billion pounds |
|
Acrylonitrile
|
|
|
740 million pounds |
|
|
|
19% |
|
|
|
3 |
|
|
|
14 billion pounds |
|
We also produce plasticizers and sodium cyanide at our Texas
City facility, and Monsanto Company (Monsanto) has
constructed a facility to produce disodium iminodiacetic acid
(DSIDA) at our site. All of our plasticizers, which
are used to make flexible plastics such as shower curtains,
floor coverings, automotive parts and construction materials,
are sold to BASF Corporation (BASF) pursuant to a
long-term contract that expires in 2007. Sodium cyanide and
DSIDA are both produced from hydrogen cyanide, a by-product of
our acrylonitrile production. All of our sodium cyanide, which
is used extensively in gold mining operations, is sold to
E.I. du Pont de Nemours and Company
(DuPont) pursuant to a long-standing relationship.
DSIDA is an essential intermediate in the production of
Roundup®, a glyphosate-based herbicide. Monsanto has
contractually committed to start up their DSIDA facility by
mid-2007 and has the option of starting up the facility earlier
than that time. After start-up, we will produce DSIDA for
Monsanto under a long-term contract that will extend for at
least 15 years.
We own the styrene, acetic acid, acrylonitrile and plasticizers
manufacturing units located at our Texas City facility and
operate the sodium cyanide unit on behalf of DuPont, which owns
the sodium cyanide unit. After start-up, we will operate the
DSIDA unit on behalf of Monsanto, which owns the DSIDA unit. The
sodium cyanide and DSIDA units use hydrogen cyanide created as a
by-product from our acrylonitrile operations, and we sell all of
the hydrogen cyanide used at the sodium cyanide and DSIDA units
to DuPont and Monsanto, respectively. We have also leased
portions of our Texas City site to Praxair Hydrogen Supply, Inc.
(Praxair) and S&L Cogeneration Company, a
50/50 joint venture between us and Praxair Energy Resources,
Inc., which constructed a partial oxidation unit and a
2
cogeneration facility, respectively, on that land. We lease the
space for our principal offices, which are in Houston, Texas.
Business Strategy
Our objectives are to be a premier producer of petrochemicals,
to maintain a strong market position, to achieve first quartile
cost performance in all of our major products and to provide
superior customer service. Our management team has adopted the
following strategies in pursuit of these objectives.
Optimize Capacity Utilization Rates Through Long-Term Supply
Contracts. We attempt to improve our profitability by
arranging a constant base production volume for each of our
production units under long-term supply agreements. Currently,
we sell all of our acetic acid production to BP Chemicals
and all of our plasticizers production to BASF under this type
of contract. We also dedicate a significant portion of our
acrylonitrile and styrene production under long-term
arrangements. By optimizing capacity utilization rates, we can
lower our selling, general and administrative expenses, reduce
our working capital requirements and insulate our operations, to
some extent, from the effects of declining markets and changes
in raw material prices. We also market a significant portion of
our products and generate a significant portion of our revenues
under conversion agreements. Under our conversion agreements,
the customer furnishes raw materials that we process into
finished products. In exchange, we receive a fee typically
designed to cover our fixed and variable costs of production and
to generally provide an element of profit depending on the
existing market conditions for the product. Our conversion
agreements are designed to insulate us, to some extent, from the
effects of declining markets and changes in raw materials
prices, while allowing us to share in the benefits of favorable
market conditions for most of the products sold under these
arrangements.
Capitalize on Cyclical Peaks in Markets. While we seek to
improve our profitability by entering into long-term agreements
which provide a reasonable base level of cash flow and
production rates, we have also positioned ourselves to take
advantage of strong cash flow opportunities during positive
cyclical periods in the markets for our products, particularly
for styrene. We have significant capacity for styrene, 50% of
which is not committed under long-term arrangements and can be
sold at higher market prices during positive cyclical periods.
We may, however, also take advantage of favorable market
conditions by entering into additional long-term agreements with
respect to some of our existing uncommitted capacity.
Improve Organization Efficiency and Cost Structure. We
continually seek to improve our cost competitiveness through
organizational efficiencies, productivity enhancements,
operating controls and general cost reductions. During the last
half of 2004, we developed and adopted an organizational
efficiency project involving the design, development and
implementation of uniform and standardized systems and processes
to improve our production, maintenance, logistics and materials
management and procurement functions. Starting in 2005, we
expect the combined annual cost savings of our organizational
efficiency project and our other cost savings initiatives
implemented in 2004, and continuing to be implemented, to be
approximately $20 million (representing a 15% reduction in
our annual fixed costs), with approximately 20% to 40% of these
savings accruing to the benefit of some of our customers under
the cost reimbursement provisions of our production agreements.
However, the actual level of savings that will be achieved as a
result of our cost savings initiatives can be impacted by a
variety of factors, including operating rates of our production
units and sales volumes of our products, and may, consequently,
be lower than our expectations. In implementing our cost savings
initiatives during 2004, we incurred approximately
$5.9 million in costs related to these projects, including
$3.9 million for employee severance and benefit costs, of
which $2.4 million was incurred during the fourth quarter
of 2004.
Industry Overview
Styrene. Current global production capacity of styrene is
approximately 58 billion pounds per year, with current
total North American production capacity at approximately
15 billion pounds per year. As is the case with most
petrochemicals, markets for styrene from time to time experience
periods of strong demand, resulting in tight supply and higher
prices and profit margins. Inevitably, favorable market
3
conditions will prompt increases in supply. In most cases,
increases in supply are achieved through the construction of new
facilities or major expansions of existing facilities.
Typically, these types of projects result in large increases in
production capacity and supply and cause available supply to
greatly exceed demand for an extended period.
From 1994 through 1996, strong demand growth and high
utilization rates for styrene prevailed, which prompted several
major producers to announce new capacity increases in 1997 and
1998, particularly in the Far East. At the time this new
capacity was announced, there was also a general slowdown in the
economic growth rate in the Far East which significantly reduced
demand growth for styrene. During 2000, styrene prices and
margins increased significantly from levels experienced in 1999.
These improvements were driven by a combination of stronger
market demand, operating problems experienced at several of our
competitors and generally low inventory levels worldwide.
Styrene prices and margins hit their highest level in April 2000
and then decreased over the second half of 2000. During 2001,
U.S. and world economies experienced a general slowdown
that negatively impacted demand for most petrochemicals,
including styrene. Raw material and energy costs spiked upward
during the first half of 2001, increasing significantly from the
prior year, primarily due to the sharp increase in natural gas
prices. As a result, U.S. Gulf Coast petrochemicals
producers experienced significant margin erosion for most of
their products. Demand for styrene, relative to supply,
increased late in the second quarter of fiscal 2002 due to a
variety of factors, including economic improvements in the
United States manufacturing sector, global restocking of low
inventory levels and styrene plant shutdowns attributable to
scheduled maintenance and operating problems at several of our
competitors. During the first half of 2003, styrene demand and
margins were depressed due to high energy and raw materials
costs and uncertainties associated with the war with Iraq.
Energy and raw materials costs declined during the second half
of 2003 and, coupled with improved economic conditions in the
United States and the rest of the world, resulted in improved
margins for styrene sales.
Styrene prices were fairly high, from a historical perspective,
during 2004. However, in April 2004, prices for benzene, one of
the primary raw materials in the production of styrene,
escalated to historical highs for both spot and contract
volumes, and prices continued to rise over the course of the
second and third quarters of 2004. As the combined cost of raw
materials and energy resources is far greater than the total of
all other costs of styrene production, with the cost of benzene
having the greatest impact on overall styrene manufacturing
costs, this historically high benzene cost in 2004 made it
difficult for United States styrene producers to realize
meaningful margin improvements on their 2004 styrene sales.
Prices for benzene peaked in July 2004, with spot prices
exceeding $4 per gallon. In late 2004, however, benzene
prices fell dramatically, with spot prices for benzene falling
to approximately $2.60 per gallon as of the end of December
2004, though this was still very high from a historical
perspective.
Many industry experts are forecasting that the balance of supply
and demand for styrene will favor producers over the next two
years, especially in the Asian markets. Although it is
impossible to know whether or not market conditions will be
favorable during that time frame, we expect to have higher
operating rates and sales over the next two years, with most of
our incremental production being sold in Asia on the spot
markets. Several of our competitors have announced their
intention to build new styrene production units outside the
United States during the late 2006 to 2008 time frame, although
it is not uncommon for announced construction to be delayed or
abandoned. In addition, most of this new capacity is being
constructed in politically unstable regions of the world, such
as the Middle East, which may impact the start-up of this new
capacity. If and when these new units are completed, we would
anticipate more difficult market conditions until the additional
supply is absorbed by growth in market demand.
Acetic Acid. Current global production capacity of acetic
acid is approximately 20 billion pounds per year, with
current North American production capacity at approximately
6 billion pounds per year. The North American acetic acid
market is mature and well developed, with demand being linked to
the demand for vinyl acetate monomer, a key intermediate in the
production of a wide array of polymers. Vinyl acetate monomer is
the largest derivative of acetic acid, representing about 50% of
total demand. The acetic acid industry tends to sell most of its
products through long-term sales agreements having cost
plus pricing mechanisms, which eliminates much of the
volatility seen in other petrochemicals products and results in
more stable and predictable earnings and profit margins.
4
Several acetic acid capacity additions occurred in 1998 and
1999, including an expansion of our acetic acid unit from
800 million pounds of rated annual production capacity to
one billion pounds. In late 2000, BP Chemicals and
Celanese AG (the two largest producers of acetic acid in
the world) began operating 880 million-pound and
1.1 billion-pound acetic acid production units in Malaysia
and Singapore, respectively. These capacity additions were
somewhat offset by reductions of approximately 1.6 billion
pounds in global capacity from the shutdown of various outdated
acetic acid plants from 1999 through 2001. Recently,
BP Chemicals announced its intention to close two outdated,
higher-cost technology acetic acid production units at its Hull,
England facilities. The production units at the Hull facility
that are being closed currently have an annual production
capacity of approximately 500 million pounds of acetic
acid, some of which is sold in the European and South American
markets.
Acrylonitrile. Current global production capacity of
acrylonitrile is approximately 14 billion pounds per year,
with current total North American production capacity at
approximately 4 billion pounds per year. Markets for
acrylonitrile exhibit similar characteristics to those of
styrene in terms of capacity utilization, selling prices and
profit margins. In addition, as more than 50% of domestic
acrylonitrile production is sold in the export market, demand is
significantly impacted by customers in China, which, in 2004,
purchased 700 million pounds of acrylonitrile,
4.3 billion pounds of ABS/ SAN resin and 1 billion
pounds of acrylic fiber, equivalent to approximately
2.8 billion pounds of acrylonitrile in the form of product
or derivatives, from producers outside of China, greatly
surpassing the aggregate amount of acrylonitrile exported
globally from the United States.
Acrylonitrile demand growth worldwide has generally averaged
2.2% per year over the last decade, most of which has been
concentrated in the Asia/ Far East region, particularly in
China. During 1995 and 1996, concerns about availability of
acrylonitrile and the costs of raw materials resulted in high
prices and profit margins, which in turn prompted many producers
to add incremental acrylonitrile capacity, and two Asian
acrylonitrile consumers to build acrylonitrile plants to meet
their captive demand. The economic crisis in Asia in the late
1990s resulted in significantly weaker demand for
acrylonitrile and its derivatives, and this weaker demand,
together with the increased production capacity, resulted in
significantly depressed acrylonitrile prices and profit margins.
Beginning in late 1999, acrylonitrile prices increased
significantly due to improved market demand, operating problems
experienced at several producers and generally low inventory
levels. In 2001, acrylonitrile prices and profit margins again
weakened significantly due to the start-up of new acrylonitrile
plants in the United States and Taiwan, a general slowdown of
the United States and world economies and higher raw materials
and energy costs.
United States producers of acrylonitrile have historically
enjoyed a significant cost advantage over producers located in
other parts of the world, primarily due to low regional
propylene and energy costs. Since 2001, however, natural gas
prices in the United States have escalated sharply, eliminating
much of the domestic advantage in energy costs, and prices for
propylene (one of the major raw materials used in the production
of acrylonitrile) have become more or less equivalent with
propylene prices in other parts of the world. These developments
have made it difficult for United States producers to achieve
favorable margins on export sales of acrylonitrile.
Acrylonitrile demand, capacity utilization and profit margins
showed improvement through 2002, although still at low levels,
then fell back slightly in the second quarter of 2003 before
recovering somewhat in the second half of 2003. Demand for
acrylonitrile in 2004 was favorable to producers but profit
margins continued to be weak, primarily due to high propylene
prices in the United States and Asia resulting from limited
propylene supply. Acrylonitrile sales in China are expected to
become even more competitive in the short-term, with new
acrylonitrile capacity scheduled to come on-stream in Asia
during the first quarter of 2005 to service local markets.
Plasticizers. Plasticizers are produced from either
ethylene-based linear alpha-olefins feedstocks or
propylene-based technology. Linear plasticizers typically
receive a premium over competing propylene-based products for
customers that require enhanced performance properties. However,
the markets for competing plasticizers can be affected by the
cost of the underlying raw materials, especially when the cost
of one olefin rises faster than the other, or by the
introduction of new products.
5
Product Summary
The following table summarizes our principal products, including
our capacity, primary end uses, raw materials and major
competitors for each product. Capacity represents
rated annual production capacity at December 31, 2004,
which is calculated by estimating the number of days in a
typical year a production facility is capable of operating after
allowing for downtime for regular maintenance, and multiplying
that number by an amount equal to the facilitys optimal
daily output based on the design feedstock mix. As the capacity
of a facility is an estimated amount, actual production may be
more or less than capacity, and the following table does not
reflect actual operating rates of any of our production
facilities for any given period of time.
|
|
|
|
|
|
|
|
|
Sterling Product |
|
|
|
|
|
|
|
|
(Capacity) |
|
Intermediate Products |
|
Primary End Products |
|
Raw Materials |
|
Major Competitors |
|
|
|
|
|
|
|
|
|
Styrene
(1.7 billion pounds per year) |
|
Polystyrene, ABS/ SAN resins, styrene butadiene latex and
unsaturated polyester resins |
|
Building products, boat and automotive components, disposable
cups and trays, packaging and containers, housewares, tires,
audio and video cassettes, luggage, childrens toys, paper
coating, appliance parts and carpet backing |
|
Benzene and Ethylene |
|
Lyondell Chemical Company, BP Amoco Chemical Company, Chevron
Phillips Chemical Company, Shell Chemical Company, Cos-Mar (a
joint venture of General Electric Company and FINA Inc.), Nova
Corporation, SABIC, Samsung and Mitsubishi |
Acetic Acid
(1 billion pounds per year) |
|
Vinyl acetate, terephthalic acid, and acetate solvents |
|
Adhesives, PET bottles, fibers and surface coatings |
|
Methanol and Carbon Monoxide |
|
Celanese AG, Eastman Chemical Company and Lyondell Chemical
Company |
Acrylonitrile
(740 million pounds per year) |
|
Acrylic fibers, ABS/SAN resins, NB copolymers, adiponitrile and
acrylamide |
|
Apparel, furnishings, upholstery, household appliances, carpets
and plastics for automotive parts using ABS and SAN polymers |
|
Propylene and Ammonia |
|
BP Amoco Chemical Company, Cytec Industries Inc., E.I. du Pont
de Nemours and Company, Asahi Chemical Industry Company, Ltd.,
Solutia Inc., Tae Kwang, Formosa Plastics, CPDC and DSM |
Plasticizers
(280 million pounds per year) |
|
Flexible polyvinyl chloride (PVC) |
|
Flexible plastics, such as shower curtains and liners, floor
coverings, cable insulation, upholstery and plastic molding |
|
Alpha-olefins, Carbon Monoxide, Hydrogen and Orthoxylene |
|
ExxonMobil Corporation, Eastman Chemical Company and BASF
Corporation |
Sodium Cyanide
(85 million pounds per year) |
|
N/A |
|
Electroplating and precious metals recovery |
|
Hydrogen Cyanide and Caustic Soda |
|
E.I. du Pont de Nemours and Company, Degussa- Huls, FMC
Corporation, Tong Soh Petrochemical, Tae Kwang and DSM |
DSIDA
(80 million pounds per year) |
|
N/A |
|
Herbicides |
|
Hydrogen Cyanide and Caustic Soda |
|
Solutia Inc. |
Products
Styrene. Styrene is a commodity chemical used to produce
intermediate products such as polystyrene, expandable
polystyrene resins and ABS plastics, which are used in a wide
variety of products such as household goods, foam cups and
containers, disposable food service items, toys, packaging and
other consumer and industrial products. We have the fourth
largest production capacity for styrene in North America. Our
styrene unit is one of the largest in the world and has a rated
annual production
6
capacity of approximately 1.7 billion pounds, which
represents approximately 11% of total North American capacity.
Approximately 50% of our styrene capacity is committed for sales
in North America under long-standing customer relationships, and
the balance of our capacity is available to produce styrene for
sales throughout the world when market conditions warrant,
including the high growth Asian markets.
Acetic Acid. Acetic acid is used primarily to produce
vinyl acetate monomer, which is used in a variety of products,
including adhesives, surface coatings and cigarette filters. We
have the third largest production capacity for acetic acid in
North America. Our acetic acid unit has a rated annual
production capacity of approximately one billion pounds, which
represents approximately 17% of total North American capacity.
All of our acetic acid production is sold to BP Chemicals
pursuant to a long-term production agreement that expires in
2016, which has provided us with a stable, steadily increasing
source of income since the inception of this relationship in
1986. For a further explanation of this agreement, please refer
to Acetic Acid-BP Chemicals under
Contracts in Item 1 of Part 1. We are the
sole supplier of acetic acid in the Americas to BP Chemicals,
which is widely recognized as a technological leader in the
manufacture of acetic acid and is the second largest producer of
acetic acid in the world. In 2003, we and BP Chemicals installed
a new larger reactor at our acetic acid unit, which is designed
to permit additional low cost expansions of the acetic acid unit
in the future.
Acrylonitrile. Acrylonitrile is used primarily in
apparel, textiles, ABS plastics, upholstery and automotive
parts, and is also used in a wide variety of other applications.
We have the third largest production capacity for acrylonitrile
in North America. Our acrylonitrile unit has a rated annual
production capacity of approximately 740 million pounds,
which represents approximately 19% of total North American
capacity. Most of our acrylonitrile sales are made under several
long-term agreements with BP Chemicals. For a further
explanation of these agreements, please refer to
Acrylonitrile-BP Chemicals under
Contracts in Item 1 of Part 1. In 2001,
the combination of the start-up of new acrylonitrile plants in
the U.S. and Taiwan, a general slowdown of U.S. and world
economies and a dramatic increase in raw material and energy
costs caused acrylonitrile prices and margins to significantly
weaken. As a result, we rescheduled maintenance turnaround work
on our acrylonitrile facility, performing this work during the
second quarter of fiscal 2001 rather than later in the year. The
adverse economic conditions that led to rescheduling of the
maintenance work persisted beyond the completion of the work,
and we elected to postpone restarting our acrylonitrile
facilities and the sodium cyanide and DSIDA production units,
which are dependent on our acrylonitrile facility for
feedstocks. In June 2003, we began the process of restarting our
acrylonitrile facility, which we completed in August 2003.
In February 2005, we declared force majeure for our
acrylonitrile and derivatives operations in Texas City, Texas
due to unavailability of propylene and have shut down our
acrylonitrile facilities and sodium cyanide unit (which uses a
by-product of our acrylonitrile operations as a raw material)
until adequate supplies become available. During the temporary
shutdown, we may make major process changes to our acrylonitrile
facilities to improve our acrylonitrile manufacturing cost
position. As a part of these process changes, we may permanently
shut down our least cost efficient acrylonitrile reactor, which
would result in a reduction in our overall capacity for
acrylonitrile from 740 million pounds per year to
530 million pounds per year. If we pursue these process
changes, the total capital cost is expected to be between
$2 million and $3 million, and the modified
acrylonitrile plant and the sodium cyanide unit would likely
resume operations by the end of the second quarter of 2005,
assuming adequate supplies of propylene are then available.
Plasticizers. All of our plasticizers, which are used to
make flexible plastics such as shower curtains, floor coverings,
automotive parts and construction materials, are sold to BASF
pursuant to a long-term contract that expires in 2007. For a
further explanation of this agreement, please refer to
Plasticizers-BASF under
Contracts, in Item 1 of Part 1. Our rated
annual production capacity of plasticizers is approximately
280 million pounds.
Sodium Cyanide. Sodium cyanide, which is used extensively
in gold mining operations, is produced from hydrogen cyanide, a
by-product of our acrylonitrile production. Pursuant to a
long-term arrangement, we operate a sodium cyanide unit owned by
DuPont at our Texas City facility. The rated annual
7
production capacity of this unit is approximately
85 million pounds. We sell DuPont all of the hydrogen
cyanide used in the production of sodium cyanide at our site. As
noted above, this unit was shut down from the second quarter of
fiscal 2001 through August 2003 in connection with the
acrylonitrile shutdown and is currently shut down as a result of
the February 2005 acrylonitrile shutdown as a result of a force
majeure event.
DSIDA. Monsanto has constructed a facility to produce
DSIDA at our site. DSIDA is an essential intermediate in the
production of Monsantos Roundup®, a glyphosate-based
herbicide. The rated annual production capacity of the DSIDA
plant is approximately 80 million pounds. DSIDA is produced
from hydrogen cyanide, a by-product of our acrylonitrile
production. Monsanto has contractually committed to start up
their DSIDA facility by mid-2007 and has the option of starting
up the facility earlier than that time. After start-up, we will
produce DSIDA for Monsanto, and will sell Monsanto all of the
hydrogen cyanide needed to produce DSIDA at our site under
long-term contracts that will extend for at least 15 years.
Sales and Marketing
We generally sell our petrochemicals products to customers for
use in the manufacture of other chemicals and products, which in
turn are used in the production of a wide array of consumer
goods and industrial products throughout the world. We compete
on the basis of product price, quality and deliverability. We
sell our petrochemicals products pursuant to:
|
|
|
|
|
multi-year contracts; |
|
|
|
conversion agreements; and |
|
|
|
spot transactions in both the domestic and export markets. |
Prices for our styrene and acrylonitrile products are determined
by global market factors that are largely beyond our control
and, except with respect to products sold under a number of our
multi-year contracts, we generally sell these products at
prevailing market prices. From time to time, we may resell raw
materials we purchased from others, purchase styrene or
acrylonitrile for resale or sell ethylbenzene that we have
produced from our own purchased benzene and ethylene or from
customer supplied materials.
We have long-term agreements that provide for the dedication of
100% of our production of acetic acid, plasticizers, sodium
cyanide and DSIDA, each to one customer. Some of these
agreements provide for cost recovery plus an agreed profit
margin based upon market prices. These agreements are intended
to:
|
|
|
|
|
optimize capacity utilization rates; |
|
|
|
lower our selling, general and administrative expenses; |
|
|
|
reduce our working capital requirements; |
|
|
|
insulate our operations, to some extent, from the effects of
declining markets and changes in raw materials prices; and |
|
|
|
in some cases, gain access to certain improvements in
manufacturing process technology. |
We also market a significant portion of our volumes of
petrochemicals and generate a significant portion of our
revenues under our conversion agreements. Under our conversion
agreements, the customer furnishes raw materials that we process
into finished products. In exchange, we receive a fee typically
designed to cover our fixed and variable costs of production and
to generally provide an element of profit depending on the
existing market conditions for the product. These conversion
agreements are intended to help us maintain lower levels of
working capital and, in some cases, gain access to certain
improvements in manufacturing process technology. Our conversion
agreements are designed to insulate us, to some extent, from the
effects of declining markets and changes in raw materials
prices, while allowing us to share in the benefits of favorable
market conditions for most of the products sold under these
arrangements. The
8
balance of our petrochemicals products are sold by our direct
sales force, sales agents or through ANEXCO, LLC, our marketing
joint venture with BP Chemicals.
For information regarding our export sales, see Note 10 of
the Notes to Consolidated Financial Statements included in
Item 8 of Part II of this Form 10-K.
Contracts
Our key multi-year contracts, which collectively accounted for
19% of our revenues for fiscal 2004, are described below. BP
Chemicals accounted for 14%, 16% and 10% of our revenues during
2004, 2003 and fiscal 2002, respectively. In 2004 and 2003, an
additional customer accounted for 15% and 12% of our total
revenue, respectively. Additionally in 2004, another customer
accounted for 14% of our total revenue. No other single
customers accounted for more than 10% of our revenues in any of
the last 3 fiscal years.
Acetic Acid-BP
Chemicals
In 1986, we entered into a long-term acetic acid Production
Agreement with BP Chemicals, which has since been amended
several times. Under this Production Agreement,
BP Chemicals has the exclusive right to purchase all of our
acetic acid production until at least August 2016.
BP Chemicals markets all of the acetic acid we produce and
pays us, among other amounts, a portion of the profits earned
from their sales of our acetic acid. In addition,
BP Chemicals reimburses us for our operating costs and,
until August 2006, makes certain monthly payments to us.
Acrylonitrile-BP
Chemicals
Our acrylonitrile relationship with BP Chemicals is governed by
a variety of documents, including a Production Agreement and a
Joint Venture Agreement. In 1988, we entered into a long-term
Production Agreement with BP Chemicals and BP Chemicals
contributed the majority of the capital expenditures required
for starting the third acrylonitrile reactor train at our
acrylonitrile facility. Under this Production Agreement,
BP Chemicals has the right, but not the obligation, to
purchase acrylonitrile from us up to a specified percentage of
our annual rated production capacity. BP Chemicals
furnishes the necessary raw materials and pays us a conversion
fee for any acrylonitrile it elects to purchase, and reimburses
us for a specified portion of our fixed and variable costs
related to our acrylonitrile production, irrespective of whether
BP Chemicals purchases any acrylonitrile under the
Production Agreement. To protect BP Chemicals in the event we
default under the Production Agreement, BP Chemicals has a
first priority security interest in the third reactor and
related equipment and in the first acrylonitrile produced in our
three reactor units to the extent BP Chemicals is entitled to
purchase acrylonitrile under the Production Agreement. In April
1998, we amended and restated the Production Agreement to, among
other things, encourage increased manufacturing and technical
cooperation, and we entered into a Joint Venture Agreement with
BP Chemicals, pursuant to which we formed ANEXCO, LLC, a 50/50
joint venture that markets all of the parties respective
sales of acrylonitrile everywhere in the world other than the
United States, Canada, Mexico, Turkey and the European Union. In
June 2003, we entered into an acrylonitrile expanded
relationship agreement with BP Chemicals, significantly
increasing BP Chemicals right to purchase acrylonitrile
from us under the Production Agreement and modifying the Joint
Venture Agreement in a manner that, together with the
modifications to the Production Agreement, was intended to
enhance our ability to operate our acrylonitrile facility at
optimal rates throughout the acrylonitrile market cycles. We
have incorporated certain technological improvements into two of
our acrylonitrile reactors under a separate license agreement
with an affiliate of BP Chemicals, and we have the right to
incorporate these and any future improvements into our remaining
acrylonitrile reactor.
Plasticizers-BASF
Since 1986, we have sold all of our plasticizers production to
BASF pursuant to a product sales agreement that expires at the
end of 2007. Under the product sales agreement, BASF provides us
with some of the required raw materials and markets the
plasticizers we produce. BASF is obligated to make
9
certain quarterly payments to us and to reimburse us monthly for
our actual production costs. In addition, we share in the
profits and losses realized by BASF in connection with the
plasticizers we produce. In January 2004, BASF purchased
Sunocos plasticizers business with manufacturing
facilities in Pasadena, Texas. We are currently evaluating the
impact that this acquisition will have on our plasticizers
relationship with BASF and are exploring various alternatives
that may be available to us related to our plasticizers
operations. Under certain circumstances, the BASF-Sunoco
transaction could have negative effects under our product sales
agreement with BASF. However, we do not believe that any such
negative effects would have a material impact on our business,
financial position, results of operations or cash flows. We are
currently in discussions with BASF regarding a restructuring and
extension of our plasticizers product sales agreement, but we do
not know whether these discussions will ultimately be successful.
Raw Materials for Products and Energy Resources
For most of our products, the combined cost of raw materials and
energy resources is far greater than the total of all other
costs of production combined. As a result, an adequate supply of
raw materials and utilities at reasonable prices and on
acceptable terms is critical to the success of our business.
Most of the raw materials we use are global commodities, which
are made by a large number of producers. Prices for many of
these raw materials are subject to wide fluctuations for a
variety of reasons beyond our control. Although we believe that
we will continue to be able to secure adequate supplies of our
raw materials and energy, we may be unable to do so at
acceptable prices or payment terms. See Certain Known
Events, Trends, Uncertainties and Risk Factors included in
Item 7 of Part II of this Form 10-K.
Styrene. We manufacture styrene by converting ethylene
and benzene into ethylbenzene, which we then process into
styrene. Ethylene and benzene are both commodity petrochemicals
and prices for each can fluctuate widely due to significant
changes in the availability of these products. We have
multi-year arrangements with several major ethylene and benzene
suppliers that provide a significant percentage of our estimated
requirements for purchased ethylene and benzene at generally
prevailing and competitive market prices. Our conversion
agreements require that the other parties to these agreements
furnish us with the ethylene or benzene necessary to fulfill our
conversion obligations. If various customers for whom we
manufacture styrene under conversion agreements were to cease
furnishing their own raw materials, our requirements for
purchased benzene and ethylene could significantly increase.
Acetic Acid. Acetic acid is manufactured primarily from
carbon monoxide and methanol. Praxair supplies us with all of
the carbon monoxide we require for the production of acetic acid
from a partial oxidation unit constructed by Praxair on land
leased from us at our Texas City facility. Currently, our
methanol requirements are supplied by BP Chemicals.
Acrylonitrile. We produce acrylonitrile by reacting
propylene and ammonia. Propylene and ammonia are both commodity
chemicals and prices for each can fluctuate widely due to
significant changes in the availability of these products. Under
our Production Agreement with BP Chemicals,
BP Chemicals furnishes us with the propylene or ammonia
necessary to produce any acrylonitrile it elects to purchase. We
purchase the rest of the propylene and ammonia we need for
acrylonitrile production. If BP Chemicals were to cease
furnishing its own raw materials, our requirements for purchased
propylene and ammonia could significantly increase. During
portions of 2004, acrylonitrile operating rates were restricted
due to lack of propylene supply at acceptable prices.
Plasticizers. The primary raw materials for plasticizers
are alpha-olefins and orthoxylene, which are supplied by BASF
under our long-term product sales agreement, and carbon monoxide
and hydrogen, which are supplied by Praxair.
Sodium Cyanide. Sodium cyanide is manufactured using
hydrogen cyanide produced as a by-product of our acrylonitrile
manufacturing process.
DSIDA. DSIDA is manufactured using hydrogen cyanide
produced as a by-product of our acrylonitrile manufacturing
process.
10
Technology and Licensing
In 1986, Monsanto granted us a non-exclusive, irrevocable and
perpetual right and license to use Monsantos technology
and other technology Monsanto acquired through third-party
licenses in effect at the time of the acquisition of our Texas
City facility from Monsanto. We use these licenses in the
production of styrene, acetic acid, acrylonitrile and
plasticizers.
During 1991, BP Chemicals Ltd. (BPCL) purchased the
acetic acid technology from Monsanto, subject to existing
licenses. Under an Acetic Acid Technology Agreement with BP
Chemicals and BPCL, BPCL granted us a non-exclusive, irrevocable
and perpetual right and license to use acetic acid technology
owned by BPCL and some of its affiliates at our Texas City
facility, including any new acetic acid technology developed by
BPCL at its acetic acid facilities in England during the term of
such agreement or pursuant to the research and development
program provided by BPCL under the terms of such agreement.
In connection with the long-term acrylonitrile Production
Agreement entered into with BP Chemicals in 1988, BPCL
granted us a non-exclusive, irrevocable and perpetual
royalty-free license to use its acrylonitrile technology at our
Texas City facility. This license automatically terminates upon
the termination of our acrylonitrile Production Agreement with
BP Chemicals. However, such termination would not prevent
our continued use of BP Chemicals catalyst or
BPCLs technology, or prevent our continued production of
acrylonitrile at our Texas City facility. We have agreed with
BPCL to cross-license any technology or improvements relating to
the manufacture of acrylonitrile at our Texas City facility.
Although we do not engage in alternative process research with
respect to our Texas City facility, we do monitor new technology
developments and, when we believe it is necessary, we typically
seek to obtain licenses for process improvements.
Competition
The petrochemical industry is highly competitive. Many of our
competitors are larger and have substantially greater financial
resources than we have. Among our competitors are some of the
worlds largest chemical companies that, in contrast to us,
have their own raw materials resources. In addition, a
significant portion of our business is based upon widely
available technology. The entrance of new competitors into the
industry and the addition by existing competitors of new
capacity could have a negative impact on our ability to maintain
existing market share or maintain or increase profit margins,
even during periods of increased demand for our products. You
can find a list of our principal competitors in the
Product Summary table above.
Historically, profitability of the petrochemicals industry has
been affected by vigorous price competition, which may intensify
due to, among other things, new domestic and foreign industry
capacity. Our businesses are impacted by changes in the world
economy, including changes in currency exchange rates. In
general, weak economic conditions, either in the United States
or worldwide, tend to reduce demand and profit margins for our
products.
Foreign markets for our products can be affected by import laws
and regulations. A significant portion of our products are sold
in North America, but we also make significant sales in Asia
when market conditions are favorable. In 2004, our export sales
accounted for approximately 37% of our total revenues, with 26%
of our total sales being made in Asian markets, 6% in Mexican
markets, 3% in European markets and 2% in South American markets.
Environmental Matters
Our operations involve the handling, production, transportation,
treatment and disposal of materials that are classified as
hazardous or toxic waste and that are extensively regulated by
environmental and health and safety laws, regulations and permit
requirements. Environmental permits required for our operations
are subject to periodic renewal and can be revoked or modified
for cause or when new or
11
revised environmental requirements are implemented. Changing and
increasingly strict environmental requirements can affect the
manufacture, handling, processing, distribution and use of our
chemical products and, if so affected, our business and
operations may be materially and adversely affected. In
addition, changes in environmental requirements can cause us to
incur substantial costs in upgrading or redesigning our
facilities and processes, including our waste treatment,
storage, disposal and other waste handling practices and
equipment.
We conduct environmental management programs designed to
maintain compliance with applicable environmental requirements
at all of our facilities. We routinely conduct inspection and
surveillance programs designed to detect and respond to leaks or
spills of regulated hazardous substances and to correct
identified regulatory deficiencies. We believe that our
procedures for waste handling are consistent with industry
standards and applicable requirements. In addition, we believe
that our operations are consistent with good industry practice.
We continue to participate in the Responsible Care®
initiatives as a part of our membership in several trade groups,
which are partner associations in the American Chemistry Council
in the United States. Notwithstanding our efforts and beliefs, a
business risk inherent in chemical operations is the potential
for personal injury and property damage claims from employees,
contractors and their employees and nearby landowners and
occupants. While we believe our business operations and
facilities generally are operated in compliance with all
applicable environmental and health and safety requirements in
all material respects, we cannot be sure that past practices or
future operations will not result in material claims or
regulatory action, require material environmental expenditures
or result in exposure or injury claims by employees, contractors
and their employees and the public. Some risk of environmental
costs and liabilities is inherent in our operations and
products, as it is with other companies engaged in similar
businesses.
Our operating expenditures for environmental matters, mostly
waste management and compliance of our continuing operations,
were $26 million in both 2004 and in 2003. We also spent
$8 million for environmentally related capital projects in
2004 and $3 million for these types of capital projects in
2003. In 2005, we anticipate spending approximately
$4 million for capital projects related to waste
management, incident prevention and environmental compliance. We
do not expect to make any capital expenditures in 2005 related
to remediation of environmental conditions.
In light of our historical expenditures and expected future
results of operations and sources of liquidity, we believe we
will have adequate resources to conduct our operations in
compliance with applicable environmental and health and safety
requirements. Nevertheless, we may be required to make
significant site and operational modifications that are not
currently contemplated in order to comply with changing facility
permitting requirements and regulatory standards. Additionally,
we have incurred, and may continue to incur, liability for
investigation and cleanup of waste or contamination at our own
facilities or at facilities operated by third parties where we
have disposed of waste. We continually review all estimates of
potential environmental liabilities, but we may not have
identified or fully assessed all potential liabilities arising
out of our past or present operations or the amount necessary to
investigate and remediate any conditions that may be significant
to us. It is our policy to make safety, environmental and
replacement capital expenditures a priority in order to ensure
adequate safety and compliance at all times. In the event we
should not have available to us, at any time, liquidity sources
sufficient to fund any of these expenditures, prudent business
practice might require that we cease operations at the affected
facility to avoid exposing our employees and contract workers,
the surrounding community or the environment to potential harm.
Air emissions from our Texas City facility are subject to
certain permit requirements and self-implementing emission
limitations and standards under state and federal laws. Our
Texas City facility is located in an area that the Environmental
Protection Agency (EPA) has classified as not having
attained the ambient air quality standards for ozone, which is
controlled by direct regulation of volatile organic compounds
and nitrogen oxide. Our Texas City facility is also subject to
the federal governments June 1997 National Ambient Air
Quality Standards, which lower the ozone and particulate matter
threshold for attainment. The Texas Commission for Environmental
Quality (TCEQ) has imposed strict requirements on
regulated facilities, including our Texas City facility, to
ensure that the air quality control
12
region will achieve the ambient air quality standards for ozone.
Local authorities also may impose new ozone and particulate
matter standards. Compliance with these stricter standards may
substantially increase our future nitrogen oxide, volatile
organic compounds and particulate matter control costs, the
amount and full impact of which cannot be determined at this
time.
On December 13, 2002, the TCEQ adopted a revised State
Implementation Plan (SIP) for compliance with the
ozone provisions of the Clean Air Act. The SIP is currently
being reviewed by the EPA, which is expected to make further
revisions to these rules. Under the current SIP, we would be
required to reduce emissions of nitrogen oxide at our Texas City
facility by approximately 80% by the end of 2007. The current
SIP rules also require monitoring of emissions of highly
reactive volatile organic carbons (HRVOCs), such as
ethylene and propylene, by the end of 2005, and may impose a
site-wide cap on emissions of HRVOCs in 2006. At the conclusion
of its review of the SIP, the EPA may require further control
measures, including possibly increasing the total amount of
reductions of nitrogen oxide emissions required from 80% to 90%.
Based on the SIP as adopted by the TCEQ, we believe that the
total cost of the capital improvements required to comply with
all of these new regulations will be between $22 million
and $24 million, of which $6.0 million,
$0.8 million and zero were expended in 2004, 2003 and
fiscal 2002, respectively. We anticipate that the balance of
these capital expenditures and other expenses will need to be
incurred between 2005 and 2008. Under some of our production
agreements, we will be able to recover a small portion of these
costs from the other parties to these agreements. We are
currently evaluating several alternative methods of reducing
nitrogen oxide emissions at our Texas City facility that would
either require less capital expenditures or result in energy
savings that would, over a period of years, more than offset the
initial capital expenditures. However, alternative methods may
not be available to us or, even if available, such alternative
methods may not reduce the net amount of our required capital
expenditures by a meaningful amount.
To reduce the risk of offsite consequences from unanticipated
events, we acquired a greenbelt buffer zone adjacent to our
Texas City facility in 1991. We also participate in a regional
air monitoring network to monitor ambient air quality in the
Texas City community.
Employees
As of December 31, 2004, we had 336 employees. All of our
hourly employees at our Texas City facility, a total of 134
people, are covered by a collective bargaining agreement with
the Texas City, Texas Metal Trades Council, AFL-CIO, of
Galveston County, Texas (the Union). Our current
collective bargaining agreement with the Union expires on
May 1, 2007. Although we believe our relationship with our
hourly employees is generally good, we did lock out our
employees for 16 weeks in 2002, and our hourly employees
engaged in a strike for one week in 2004, in both cases in
connection with efforts to reach new collective bargaining
agreements.
Insurance
We maintain insurance at levels that we believe are reasonable
and that are typical for our industrys insurance
coverages, a portion of which are provided by a captive
insurance company maintained by us and a few other chemical
companies. However, we are not fully insured against all
potential hazards incident to our business. Additionally, we may
incur losses beyond the limits of, or outside the coverage of,
our insurance. We maintain full replacement value insurance
coverage for property damage to our facilities and business
interruption insurance. Nevertheless, a significant interruption
in the operation of one or more of our facilities could have a
material adverse effect on our business. As a result of market
conditions, premiums and deductibles for certain insurance
policies can increase substantially and, in some instances,
certain insurance may become unavailable or available only for
reduced amounts of coverage. We may not in the future be able to
maintain our existing coverage or our premiums may increase
substantially. As a result of the terrorist attacks of
September 11, 2001 and other events, our insurance carriers
have created exclusions for losses from terrorism from our
all risk property insurance policies. While separate
terrorism insurance coverage is available, premiums for such
coverage are very expensive, especially for chemical facilities,
and the policies are subject to very high deductibles. Available
terrorism coverage
13
typically excludes coverage for losses from acts of foreign
governments as well as nuclear, biological and chemical attacks.
We have determined that it is not economically prudent to obtain
terrorism insurance, especially given the significant risks that
are not covered by such insurance, and we do not carry terrorism
insurance on our property at this time.
Access to Filings
Access to our annual reports on Form 10-K, quarterly
reports on Form 10-Q and current reports on Form 8-K
and amendments to those reports filed with or furnished to the
Securities and Exchange Commission pursuant to
Section 13(a) of the Exchange Act, as well as reports filed
electronically pursuant to Section 16(a) of the Exchange
Act, may be obtained through our website
(http://www.sterlingchemicals.com). Our website provides a
hyperlink to a third-party website where these reports may be
viewed and printed at no cost as soon as reasonably practicable
after we have electronically filed such material with the
Securities and Exchange Commission. The contents of our website
are not, and shall not be deemed to be, incorporated into this
report.
Our petrochemicals facility is located in Texas City, Texas,
approximately 45 miles south of Houston, on a 290-acre site
on Galveston Bay near many other chemical manufacturing
complexes and refineries. Currently, there are facilities to
produce six petrochemicals products at the Texas City, Texas
site: styrene, acetic acid, acrylonitrile, plasticizers, sodium
cyanide and DSIDA. We own all of the real property which
comprises our Texas City facility and we own the styrene,
acrylonitrile, acetic acid and plasticizers manufacturing units
located at the site. DuPont and Monsanto built the sodium
cyanide and DSIDA units, respectively, on land leased from us at
our Texas City facility. DuPont owns the sodium cyanide unit,
which we operate on behalf of DuPont. Monsanto owns the DSIDA
unit. Monsanto has contractually committed to start-up the DSIDA
unit by mid-2007 and has the option of restarting the unit prior
to that time. After start-up, we will operate the DSIDA unit on
behalf of Monsanto under a long-term contract that will extend
for at least 15 years. We have also leased portions of the
site to Praxair and S&L Cogeneration Company, a 50/50 joint
venture between us and Praxair Energy Resources, Inc., which
constructed a partial oxidation unit and a cogeneration
facility, respectively, on that land. Our Texas City site offers
approximately 135 acres for future expansion by us or by
other companies that can benefit from our existing
infrastructure and facilities, and includes a greenbelt around
the northern edge of the plant site. We continuously explore
opportunities for further construction of facilities at our
site. The construction of a new facility at our site by another
company typically lowers our overall fixed costs for each of our
operating units and provides us with additional revenue. We own
148 railcars and, at our Texas City site, we have facilities to
load our products in ocean-going vessels, barges, trucks and
railcars for shipment to customers throughout the world.
We lease our principal executive offices, located at 333 Clay
Street, Suite 3600 in Houston, Texas.
We believe our properties and equipment are sufficient to
conduct our business.
|
|
Item 3. |
Legal Proceedings |
On July 16, 2001, Sterling Chemicals Holdings, Inc.
(Holdings) and most of its U.S. subsidiaries,
including us (collectively referred to as the
Debtors), filed voluntary petitions for
reorganization under Chapter 11 of the United States
Bankruptcy Code (the Bankruptcy Code) in the
U.S. Bankruptcy Court for the Southern District of Texas
(the Bankruptcy Court). The plan of reorganization
was confirmed on November 20, 2002 (as confirmed, our
Plan of Reorganization) and, on December 19,
2002 (the Effective Date), our Plan of
Reorganization became effective and we and the other Debtors
emerged from bankruptcy pursuant to the terms of our Plan of
Reorganization. As a result of the commencement of the
Chapter 11 cases, an automatic stay was imposed against the
commencement or continuation of legal proceedings against the
Debtors outside of the Bankruptcy Court. Claimants with alleged
claims against the Debtors were required to assert their claims
in the Chapter 11 cases by timely
14
filing a proof of claim, to which the Debtors were allowed to
file an objection and seek a determination from the Bankruptcy
Court as to whether such claims were allowable. Claimants who
desired to liquidate their claims in legal proceedings outside
of the Bankruptcy Court were required to obtain relief from the
automatic stay by order of the Bankruptcy Court before doing so.
If such relief was granted, the automatic stay remained in
effect with respect to the collection of liquidated claim
amounts. As a general rule, all claims against the Debtors that
sought a recovery from assets of the Debtors estates have
been addressed in the Chapter 11 cases and have been or
will be paid only pursuant to the terms of the Plan of
Reorganization or negotiated settlements.
A few issues remain outstanding before the Bankruptcy Court
related to the allowability and classification of certain
claims. We do not believe that the outcome of any of these
issues will have a material adverse effect on our business,
financial position, results of operations or cash flows, but we
cannot guarantee that result.
We are subject to various other claims and legal actions that
arise in the ordinary course of our business. Claims and legal
actions against the Debtors that existed as of the
Chapter 11 filing date are subject to the discharge
injunction provided for in the Plan of Reorganization, and
recoveries sought thereon from assets of the Debtors are subject
to the terms of the Plan of Reorganization.
|
|
Item 4. |
Submission of Matters to a Vote of Security Holders |
No matters were submitted to a vote of security holders during
the fourth quarter of 2004.
15
PART II
|
|
Item 5. |
Market for Registrants Common Equity and Related
Stockholder Matters |
Our common stock, par value $.01 per share, is currently
quoted on the Over-the-Counter (OTC) Electronic
Bulletin Board maintained by the National Association of
Securities Dealers, Inc. under the symbol SCHI. The
following table contains information about the high and low
sales prices per share of our common stock since January 1,
2003, when our common stock was first quoted on the OTC
Electronic Bulletin Board. Price information reflects
quotes from the OTC Electronic Bulletin Board. Information
about OTC Electronic Bulletin Board bid quotations
represents prices between dealers, does not include retail
mark-ups, mark-downs or commissions, and may not necessarily
represent actual transactions. Quotations on the OTC Electronic
Bulletin Board are sporadic, and currently there is no
established public trading market for our common stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First | |
|
Second | |
|
Third | |
|
Fourth | |
|
|
Quarter | |
|
Quarter | |
|
Quarter | |
|
Quarter | |
|
|
| |
|
| |
|
| |
|
| |
2004 High
|
|
$ |
29.00 |
|
|
$ |
26.00 |
|
|
$ |
25.00 |
|
|
$ |
37.00 |
|
Low
|
|
$ |
25.00 |
|
|
$ |
21.00 |
|
|
$ |
23.00 |
|
|
$ |
23.50 |
|
2003 High
|
|
$ |
40.01 |
|
|
$ |
23.00 |
|
|
$ |
17.00 |
|
|
$ |
25.50 |
|
Low
|
|
$ |
22.00 |
|
|
$ |
15.00 |
|
|
$ |
14.00 |
|
|
$ |
15.25 |
|
The last reported sale price per share of our common stock as
reported on the OTC Electronic Bulletin Board on
February 2, 2005 was $39.50. As of February 2, 2005,
there were 342 holders of record of our common stock. This
number does not include stockholders for whom shares are held in
a nominee or street name.
Dividend Policy
We have not declared or paid any cash dividends with respect to
our common stock since we emerged from bankruptcy in December
2002. We do not presently intend to pay cash dividends with
respect to our common stock for the foreseeable future. In
addition, we cannot pay dividends on our shares of common stock
under the indenture for our 10% Senior Secured Notes due
2007, (our Secured Notes) or our revolving credit
agreement. The payment of cash dividends, if any, will be made
only from assets legally available for that purpose, and will
depend on our financial condition, results of operations,
current and anticipated capital requirements, general business
conditions, restrictions under the existing debt instruments and
other factors deemed relevant by our Board of Directors.
16
|
|
Item 6. |
Selected Financial Data |
The following table sets forth selected financial data with
respect to our consolidated financial condition and consolidated
results of operations and should be read in conjunction with
Item 7. Managements Discussion and Analysis of
Financial Condition and Results of Operations and our
Consolidated Financial Statements and related notes included in
Item 8 of this Form 10-K.
On July 16, 2001, Sterling Chemicals Holdings, Inc.
(Holdings), Sterling Chemicals, Inc. and most of
their U.S. subsidiaries (collectively, the
Debtors) filed voluntary petitions for
reorganization under Chapter 11 of the United States
Bankruptcy Code (the Bankruptcy Code) in the
U.S. Bankruptcy Court for the Southern District of Texas
(the Bankruptcy Court). The Debtors filed a plan of
reorganization with the Bankruptcy Court on May 14, 2002
which, after several amendments, was confirmed on
November 20, 2002 (as confirmed, our Plan of
Reorganization). On December 19, 2002 (the
Effective Date), our Plan of Reorganization became
effective and the Debtors emerged from bankruptcy pursuant to
the terms of our Plan of Reorganization. During the period from
July 16, 2001 through December 19, 2002, the Debtors
operated their respective businesses as debtors-in-possession
pursuant to the Bankruptcy Code. Due to the Debtors
emergence from bankruptcy and the implementation of fresh-start
accounting, we refer to ourselves as Predecessor
Sterling for periods on or before December 19, 2002
and Reorganized Sterling for periods after
December 19, 2002. Prior to December 6, 2002,
all issued and outstanding shares of Predecessor Sterlings
capital stock were held by Holdings and, accordingly, per share
data prior to December 19, 2002 is not presented.
The consolidated statements of operations information for the
years ended December 31, 2004, December 31, 2003 and
the transition period from December 20, 2002 to
December 31, 2002, and the consolidated balance sheet
information at December 31, 2004, 2003 and 2002, reflect
the financial position and operating results after giving effect
to our Plan of Reorganization and the application of the
principles of fresh-start accounting in accordance with the
provisions of Statement of Position 90-7, Financial
Reporting by Entities in Reorganization under the Bankruptcy
Code (SOP 90-7). Accordingly, such
financial information is not comparable to the historical
financial information before December 20, 2002. During
2002, we changed our year end from September 30 to
December 31.
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
Predecessor Sterling | |
|
|
| |
|
| |
|
|
Year ended | |
|
Year ended | |
|
December 20 to | |
|
October 1 to | |
|
Fiscal Year Ended September 30, | |
|
|
December 31, | |
|
December 31 | |
|
December 31, | |
|
December 19, | |
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In Thousands, Except Per Share Data) | |
Operating Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$ |
851,662 |
|
|
$ |
592,791 |
|
|
$ |
12,572 |
|
|
$ |
99,888 |
|
|
$ |
381,801 |
|
|
$ |
468,738 |
|
|
$ |
797,756 |
|
Gross profit (loss)
|
|
|
2,568 |
|
|
|
3,051 |
|
|
|
(29 |
) |
|
|
300 |
|
|
|
27,646 |
|
|
|
(52,639 |
) |
|
|
97,504 |
|
Income (loss) from continuing
operations(1)
|
|
|
(62,444 |
) |
|
|
(13,223 |
) |
|
|
(1,544 |
) |
|
|
223,974 |
|
|
|
(52,616 |
) |
|
|
(135,640 |
) |
|
|
14,891 |
|
Income (loss) from discontinued
operations(2)
|
|
|
|
|
|
|
(976 |
) |
|
|
|
|
|
|
194,637 |
|
|
|
16,630 |
|
|
|
(46,070 |
) |
|
|
(78,738 |
) |
Per Share Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to common stockholders
|
|
|
(24.30 |
) |
|
|
(6.84 |
) |
|
|
(0.61 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) from continuing operations attributable to
common stockholders.
|
|
|
(24.30 |
) |
|
|
(6.49 |
) |
|
|
(0.61 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working
capital(3)
|
|
$ |
102,530 |
|
|
$ |
118,165 |
|
|
$ |
129,413 |
|
|
$ |
132,058 |
|
|
$ |
122,178 |
|
|
$ |
179,082 |
|
|
$ |
(96,760 |
) |
Total assets
|
|
|
473,553 |
|
|
|
550,503 |
|
|
|
547,170 |
|
|
|
546,014 |
|
|
|
489,648 |
|
|
|
511,850 |
|
|
|
677,143 |
|
Long-term debt (excluding current portion of long-term
debt)(4)
|
|
|
100,579 |
|
|
|
100,579 |
|
|
|
94,275 |
|
|
|
94,275 |
|
|
|
|
|
|
|
42,270 |
|
|
|
438,910 |
|
Stockholders equity (deficiency in assets)
|
|
|
120,083 |
|
|
|
189,436 |
|
|
|
209,011 |
|
|
|
210,725 |
|
|
|
(611,477 |
) |
|
|
(563,582 |
) |
|
|
(377,790 |
) |
|
|
(1) |
During 2004, we recorded a $48.5 million goodwill
impairment charge and a $22 million impairment charge
related to our acrylonitrile long-lived assets. Also during
2004, we recorded a pension curtailment gain of
$13 million. The period from October 1, 2002 through
December 19, 2002 includes a net loss on fresh-start
adjustments of $203 million along with a net gain on debt
restructuring of $458 million. During fiscal 2002, we
recorded $56.8 million of deferred tax expense to reflect a
full valuation allowance on our U.S. deferred tax assets. |
|
(2) |
Pursuant to the Plan of Reorganization, on December 19,
2002, the Debtors pulp chemicals business was sold to
Superior Propane, Inc. for approximately $373 million and
the Debtors acrylic fibers business was sold to local
management of that business for nominal consideration. In
accordance with Statement of Financial Accounting Standards
(SFAS) No. 144, Accounting for the
Impairment and Disposal of Long Lived Assets, we have
reported the operating results of these businesses as
discontinued operations in the consolidated statement of
operations and cash flows for Predecessor Sterling, and the
assets and liabilities of these businesses have been presented
separately as assets held for sale and liabilities related to
discontinued operations in Predecessor Sterlings
consolidated balance sheet. During fiscal 2000, we recorded a
$60 million non-cash charge related to the write down of
our acrylic fibers production assets. |
|
(3) |
Working capital at September 30, 2002 and 2001 excludes
pre-petition liabilities. Working capital at September 30,
2002, 2001 and 2000 includes net assets (liabilities) of
discontinued operations held for sale of $125 million,
$130 million and ($137) million, respectively. See
Note 1 of the Notes to Consolidated Financial Statements
included in Item 8 of this Form 10-K. |
|
(4) |
Excludes long-term debt of $418.4 million and
$295.0 million, classified as pre-petition
liabilities subject to compromise and pre-petition
liabilities not subject to compromise, respectively
for September 30, 2002 and 2001. Long-term debt at
September 30, 2000 excludes $355 million of debt |
18
|
|
|
allocated to discontinued operations and treated as current
liabilities. See Note 1 to Consolidated Financial
Statements included in Item 8 of this Form 10-K. |
|
|
Item 7. |
Managements Discussion and Analysis of Financial
Condition and Results of Operations |
In December 2002, we changed our fiscal year-end from
September 30 to December 31, effective with the
calendar year beginning January 1, 2003. In this
Form 10-K, fiscal 2002 refers to the fiscal
year ended September 30, 2002, and the Transition
Period refers to the three-month period from
October 1, 2002 through December 31, 2002, which
includes the results of Predecessor Sterling from
October 1, 2002 through December 19, 2002 and the
results of Reorganized Sterling from December 20, 2002
through December 31, 2002. Also in this Form 10-K,
2004 and fiscal 2004 refer to the
12-month period ended December 31, 2004 and
2003 and fiscal 2003 refer to the
12-month period ended December 31, 2003. The following
discussion is intended to aid in understanding our historical
financial position and results of operations for 2004, 2003, the
Transition Period and fiscal 2002, and should be read in
conjunction with our financial statements appearing elsewhere in
this report.
Overview
We are a leading North American producer of selected
petrochemicals used to manufacture a wide array of consumer
goods and industrial products throughout the world. Our primary
products include styrene, acetic acid and acrylonitrile. Styrene
is a commodity chemical used to produce intermediate products
such as polystyrene, expandable polystyrene resins and ABS
plastics, which are used in a wide variety of products such as
household goods, foam cups and containers, disposable food
service items, toys, packaging and other consumer and industrial
products. Approximately 50% of our styrene capacity is committed
for sales in North America under long-standing customer
relationships, and the balance of our capacity is available to
produce styrene for sales throughout the world when market
conditions warrant, including the high growth Asian markets.
Acetic acid is used primarily to produce vinyl acetate monomer,
which is used in a variety of products, including adhesives,
surface coatings and cigarette filters. All of our acetic acid
production is sold to BP Amoco Chemical Company (BP
Chemicals) pursuant to a long-term contract that expires
in 2016, which has provided us with a stable, steadily
increasing source of income since the inception of this
relationship in 1986. Acrylonitrile is used primarily in
apparel, textiles, ABS plastics, upholstery and automotive
parts, and is also used in a wide variety of other applications.
Most of our acrylonitrile sales are made under several long-term
agreements with BP Chemicals.
We manufacture all of our petrochemicals products at our world
scale facility in Texas City, Texas. This facility is
strategically located on a deepwater port and also has truck and
railcar loading and unloading facilities, giving us the ability
to accept shipment of our major raw materials in the most
efficient manner and load shipments of our petrochemicals
products for delivery throughout the world. As set forth below,
our rated annual production capacity is among the highest in
North America for styrene, acetic acid and acrylonitrile.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of | |
|
|
|
|
|
|
|
|
Total North | |
|
|
|
|
|
|
Rated Annual | |
|
American | |
|
North American | |
|
Global |
Product |
|
Production Capacity | |
|
Capacity | |
|
Market Position | |
|
Production Capacity |
|
|
| |
|
| |
|
| |
|
|
Styrene
|
|
|
1.7 billion pounds |
|
|
|
11% |
|
|
|
4 |
|
|
58 billion pounds |
Acetic Acid
|
|
|
1 billion pounds |
|
|
|
17% |
|
|
|
3 |
|
|
20 billion pounds |
Acrylonitrile
|
|
|
740 million pounds |
|
|
|
19% |
|
|
|
3 |
|
|
14 billion pounds |
We also produce plasticizers and sodium cyanide at our Texas
City facility, and Monsanto Company (Monsanto) has
constructed a facility to produce disodium iminodiacetic acid
(DSIDA) at our site. All of our plasticizers, which
are used to make flexible plastics such as shower curtains,
floor coverings, automotive parts and construction materials,
are sold to BASF Corporation (BASF) pursuant to a
long-term contract that expires in 2007. Sodium cyanide and
DSIDA are both produced from hydrogen
19
cyanide, a by-product of our acrylonitrile production. All of
our sodium cyanide, which is used extensively in gold mining
operations, is sold to E.I. du Pont de Nemours and Company
(DuPont) pursuant to a long standing relationship.
DSIDA is an essential intermediate in the production of
Roundup®, a glyphosate-based herbicide. Monsanto has
contractually committed to start up their DSIDA facility by
mid-2007 and has the option of starting up the facility earlier
than that time. After start-up, we will produce DSIDA for
Monsanto under a long-term contract that will extend for at
least 15 years.
We own the styrene, acetic acid, acrylonitrile and plasticizers
manufacturing units located at our Texas City site and operate
the sodium cyanide unit on behalf of DuPont, which owns the
sodium cyanide unit. After start-up, we will operate the DSIDA
unit on behalf of Monsanto, which owns the DSIDA unit. The
sodium cyanide and DSIDA units use hydrogen cyanide created as a
by-product from our acrylonitrile operations, and we sell all of
the hydrogen cyanide used at the sodium cyanide and DSIDA units
to DuPont and Monsanto, respectively. We have also leased
portions of the Texas City site to Praxair Hydrogen Supply, Inc.
(Praxair) and S&L Cogeneration Company, a 50/50
joint venture between us and Praxair Energy Resources, Inc.,
which constructed a partial oxidation unit and a cogeneration
facility, respectively, on that land.
We generally sell our petrochemicals products to customers for
use in the manufacture of other chemicals and products, which in
turn are used in the production of a wide array of consumer
goods and industrial products throughout the world. Two of our
products, styrene and acrylonitrile, are commodities and exhibit
wide swings in prices and profit margins based upon current and
anticipated levels of supply and demand. The acetic acid
industry tends to sell most of its products through long-term
sales agreements having cost plus pricing
mechanisms, which eliminates much of the volatility seen in
other petrochemicals products and results in more stable and
predictable earnings and profit margins. Although exceptions
occasionally occur, as a general rule, if styrene profit margins
are favorable, our overall financial performance is good, but
our overall financial performance suffers when styrene margins
are unfavorable. The markets for styrene and acrylonitrile
roughly follow repetitive cycles, and general trends in the
supply and demand balance for these products may be observed
over time. However, it is difficult, if not impossible, to
definitively predict when market conditions will be favorable or
unfavorable.
The financial performance of each of our products is primarily a
function of sales prices, the cost of raw materials and energy
and sales volumes. While changes in the prices for our products
may be tracked through a variety of sources, a change in price
does not necessarily result in a corresponding change in our
financial performance. When the prices of our products increase
or decrease, our overall financial performance may improve,
decline or stay roughly the same depending upon the extent and
direction of changes in our costs for raw materials and energy
and our production rates. For most of our products, the combined
cost of raw materials and energy resources is far greater than
all other costs of production combined. We use significant
amounts of natural gas as fuel in the production of our
products, and the producers of most of our raw materials use
significant amounts of natural gas in their production. As a
result, our production and raw materials costs increase or
decrease based upon changes in the price for natural gas.
Natural gas and most of our raw materials are commodities and,
consequently, are subject to wide fluctuations in prices, which
can, and often do, move independently of changes in the prices
for our products. Prices for, and the availability of, natural
gas and many of our raw materials are largely based on regional
factors, which can result in wide disparities in prices in
different parts of the world or shortages or unavailability in
some regions at the same time when these products are plentiful
in other parts of the world. Prices for styrene and
acrylonitrile, on the other hand, tend to be more consistent
throughout the world, after taking into account transportation
costs. Consequently, changes in prices for natural gas and raw
materials tend to impact the margin on our sales rather than the
price of our products, with margins increasing when natural gas
and raw materials costs decline and vice versa. In
addition, many producers in other parts of the world use
oil-based processes rather than natural gas-based processes.
Consequently, the relationship between the price of crude oil
and the price of natural gas can either increase or decrease our
competitiveness depending on their relative values at any
particular point in time. Sales volumes influence our overall
financial performance in a variety of ways. As a general rule,
increases in sales volumes will result in an increase in overall
revenues and vice versa, although this is not necessarily
the case since the
20
prices for some of our products can change dramatically from
month-to-month. More importantly, changes in production rates
impact the average cost per pound of the products produced. If
more pounds are produced, our fixed costs are spread over a
greater number of pounds resulting in a lower average cost to
produce each pound. In addition, our production rates influence
the overall efficiency of our manufacturing unit and the yields
we receive from our raw materials.
Styrene. Styrene prices were fairly high, from a
historical perspective, during 2004. However, in April 2004,
prices for benzene, one of the primary raw materials in the
production of styrene, escalated to historical highs for both
spot and contract volumes, and prices continued to rise over the
course of the second and third quarters of 2004. As the combined
cost of raw materials and energy resources is far greater than
the total of all other costs of styrene production, with the
cost of benzene having the greatest impact on overall styrene
manufacturing costs, this historically high benzene cost in 2004
made it difficult for United States styrene producers to
realize meaningful margin improvements on their 2004 styrene
sales. Prices for benzene peaked in July 2004, with spot prices
exceeding $4 per gallon. In late 2004, however, benzene
prices fell dramatically, with spot prices for benzene falling
to approximately $2.60 per gallon as of the end of December
2004, though this was still very high from a historical
perspective.
Many industry experts are forecasting that the balance of supply
and demand for styrene will favor producers over the next two
years, especially in the Asian markets. Although it is
impossible to know whether or not market conditions will be
favorable during that time frame, we expect to have higher
operating rates and sales over the next two years, with most of
our incremental production being sold in Asia on the spot
markets. Inevitably, favorable market conditions will prompt
increases in supply, in most cases through construction of new
facilities or expansion of existing facilities. Several of our
competitors have announced their intention to build new styrene
production units outside the United States during the late 2006
to 2008 time frame, although it is not uncommon for announced
construction to be delayed or abandoned. In addition, most of
this new capacity is being constructed in politically unstable
regions of the world, such as the Middle East, which may impact
the start-up of this new capacity. If and when these new units
are completed, we would anticipate more difficult market
conditions until the additional supply is absorbed by growth in
market demand.
Acetic Acid. Margins for acetic acid have grown steadily
over the past several years, with our profitability for acetic
acid reaching record levels in 2004. The North American acetic
acid market is mature and well developed, with demand being
linked to the demand for vinyl acetate monomer, a key
intermediate in the production of a wide array of polymers.
Vinyl acetate monomer is the largest derivative of acetic acid,
representing about 50% of total demand. The acetic acid industry
tends to sell most of its products through long term sales
agreements having cost plus pricing mechanisms,
which eliminates much of the volatility seen in other
petrochemicals products and results in more stable and
predictable earnings and profit margins. All of our acetic acid
production is sold to BP Chemicals under a long-term
production agreement that expires in 2016. Under the production
agreement, BP Chemicals markets all of the acetic acid we
produce and pays us, among other amounts, a portion of the
profits earned from their sales of our acetic acid.
Several acetic acid capacity additions occurred in 1998 and
1999, including an expansion of our acetic acid unit from
800 million pounds of rated annual production capacity to
one billion pounds. In late 2000, BP Chemicals and Celanese
AG (the two largest producers of acetic acid in the world) began
operating 880 million-pound and 1.1 billion-pound
acetic acid production units in Malaysia and Singapore,
respectively. These capacity additions were somewhat offset by
reductions of approximately 1.6 billion pounds in global
capacity from the shutdown of various outdated acetic acid
plants from 1999 through 2001. Recently, BP Chemicals announced
its intention to close two outdated higher-cost technology
acetic acid production units at its Hull, England facilities.
The production units at the Hull facility that are being closed
currently have an annual production capacity of approximately
500 million pounds of acetic acid, some of which is sold in
the European and South American markets.
Acrylonitrile. As we export most of our acrylonitrile
production to Asia, export margins are the principal economic
driver for our acrylonitrile business. United States producers
of acrylonitrile have
21
historically enjoyed a significant cost advantage over producers
located in other parts of the world, primarily due to low
regional propylene and energy costs. Since 2001, however,
natural gas prices in the United States have escalated sharply,
eliminating much of the domestic advantage in energy costs, and
prices for propylene (one of the major raw materials used in the
production of acrylonitrile) have become more or less equivalent
with propylene prices in other parts of the world. These
developments, along with higher than historical shipping costs,
have made it difficult for us and other United States producers
to achieve favorable margins on export sales of acrylonitrile.
Acrylonitrile sales in China are expected to become even more
competitive in the short-term, with new acrylonitrile capacity
scheduled to come on-stream in Asia during the first quarter of
2005 to service local markets. We continue to review our options
with respect to our acrylonitrile business as a result of losses
in 2003 and 2004.
In February 2005, we declared force majeure for our
acrylonitrile and derivatives operations in Texas City, Texas
due to unavailability of propylene and have shut down our
acrylonitrile facilities and sodium cyanide unit (which uses a
by-product of our acrylonitrile operations as a raw material)
until adequate supplies become available. During the temporary
shutdown, we may make major process changes to our acrylonitrile
facilities to improve our acrylonitrile manufacturing cost
position. As a part of these process changes, we may permanently
shut down our least cost efficient acrylonitrile reactor, which
would result in a reduction in our overall capacity for
acrylonitrile from 740 million pounds per year to
530 million pounds per year. If we pursue these process
changes, the total capital cost is expected to be between
$2 million and $3 million, and the modified
acrylonitrile plant and the sodium cyanide unit would likely
resume operations by the end of the second quarter of 2005,
assuming adequate supplies of propylene are then available.
|
|
|
Reorganization and Fresh-Start Accounting |
On July 16, 2001, the Debtors filed voluntary petitions for
reorganization under the Bankruptcy Code in the Bankruptcy
Court. Our Plan of Reorganization was confirmed on
November 20, 2002, and on December 19, 2002, our Plan
of Reorganization became effective and we and the other Debtors
emerged from bankruptcy pursuant to the terms of our Plan of
Reorganization. The reorganization permitted the Debtors to
retain core assets, improve liquidity through the restructuring
of their debt and eliminate unfavorable contracts. All of the
senior secured creditors of the Debtors were fully paid all
principal and interest owing to them, and the indebtedness of
the Debtors was reduced from approximately $1.0 billion to
$94.3 million in principal amount of our Secured Notes.
Pursuant to our Plan of Reorganization, on December 19,
2002 the Debtors pulp chemicals business was sold to
Superior Propane, Inc. for approximately $373 million and
the Debtors acrylic fibers business was sold to local
management of that business for nominal consideration.
Upon our emergence from bankruptcy on December 19, 2002, we
implemented fresh-start accounting under the provisions of
Statement of Position 90-7, Financial Reporting by
Entities in Reorganization under the Bankruptcy Code
(SOP 90-7) and became a new reporting entity.
Under SOP 90-7, our reorganization value was allocated to
our assets and liabilities, our accumulated deficit was
eliminated and new preferred and common equity was issued
pursuant to our Plan of Reorganization. In connection with our
Plan of Reorganization, our financial advisor,
Greenhill & Co., LLC (Greenhill) prepared a
valuation of our business. In preparing its valuation, Greenhill
considered a number of factors, including valuations by other
parties and the application of various valuation methods,
including discounted cash flow analysis, comparable company
analysis and precedent transaction analysis. Based on
Greenhills valuation, the estimated reorganization value
was allocated as follows (Dollars in Thousands):
|
|
|
|
|
Long-term debt
|
|
$ |
94,275 |
|
Redeemable preferred stock
|
|
|
30,000 |
|
Stockholders equity
|
|
|
210,725 |
|
|
|
|
|
Total
|
|
$ |
335,000 |
|
|
|
|
|
22
Results of Operations
The following table sets forth revenues, gross profit (loss),
operating income (loss) from continuing operations and net
income (loss) from continuing operations for 2004, 2003, the
Transition Period and fiscal 2002. Information for the three
months ended December 31, 2001 is also presented for
comparative purposes to the Transition Period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
Predecessor Sterling | |
|
|
| |
|
| |
|
|
|
|
December 20 | |
|
|
|
Fiscal Year | |
|
Three Months | |
|
|
Year Ended | |
|
Year Ended | |
|
to | |
|
October 1 to | |
|
Ended | |
|
Ended | |
|
|
December 31, | |
|
December 31, | |
|
December 31, | |
|
December 19, | |
|
September 30, | |
|
December 31, | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
2002 | |
|
2001 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Revenues:
|
|
$ |
851,662 |
|
|
$ |
592,791 |
|
|
$ |
12,572 |
|
|
$ |
99,888 |
|
|
$ |
381,801 |
|
|
$ |
63,355 |
|
Gross profit (loss):
|
|
|
2,568 |
|
|
|
3,051 |
|
|
|
(29 |
) |
|
|
300 |
|
|
|
27,646 |
|
|
|
(4,210 |
) |
Income (loss) from continuing operations:
|
|
|
(62,644 |
) |
|
|
(13,223 |
) |
|
|
(1,544 |
) |
|
|
223,974 |
|
|
|
(52,616 |
) |
|
|
(23,090 |
) |
|
|
|
Comparison of Fiscal 2004 to Fiscal 2003 |
|
|
|
Revenues, Gross Profit (Loss) and Net Income (Loss) from
continuing operations |
Our revenues were $852 million in 2004, an increase of 44%
from $593 million in revenues in 2003. This increase in
revenues resulted primarily from higher sales prices during 2004
and increased revenues realized from the full year production of
acrylonitrile in 2004. We recorded a net loss from continuing
operations of $63 million for 2004, compared to a net loss
of $13 million recorded in 2003. This increase in net loss
was primarily due to impairments of $48 million for
goodwill and $22 million for our acrylonitrile assets in
2004.
Revenues from our styrene operations were $530 million in
2004, an increase of 30% from $409 million in revenues in
2003. Direct sales prices for styrene in 2004 increased 49% from
those realized during 2003. Spot prices for styrene, a component
of our direct sales prices, ranged from $0.37 to $0.63 per
pound during 2004, compared to $0.26 to $0.37 per pound
during 2003. However, our total sales volumes for styrene in
2004 were 11% lower than 2003. The decrease in sales volumes
during 2004 was primarily attributable to the one-month
scheduled maintenance turnaround that we completed during the
first quarter of 2004. During 2004, prices for benzene, one of
the primary raw materials required for styrene production, were
92% higher than the prices we paid for benzene in 2003, and
prices for ethylene, the other primary raw material required for
styrene production, were 35% higher than the prices we paid for
ethylene in 2003. Average costs for natural gas, another major
component in the cost of manufacturing styrene, increased 11%
during 2004 compared to average natural gas costs during 2003.
Margins on our styrene sales in 2004 decreased from those
realized in 2003, as the increases in our raw materials and
energy costs more than offset the increases in our styrene sales
prices. Towards the end of 2004, spot prices for benzene sharply
declined from the historically high levels seen during the third
quarter of 2004. At the end of December 2004, spot prices for
benzene dropped to approximately $2.60 per gallon from
their historical high in the third quarter of 2004 of around
$4.00 per gallon. As benzene prices have the greatest
impact on the variable manufacturing costs of styrene, the
decrease in benzene prices resulted in downward pressure on
styrene sales prices, which in turn resulted in a reduction of
the carrying values of our December 31, 2004 ending
inventories of styrene and its raw materials by approximately
$14 million.
Revenues from our acrylonitrile operations were
$196 million in 2004, an increase of 221% from the
$61 million in revenues in 2003, primarily due to the
increased revenues realized from production of acrylonitrile and
sodium cyanide in 2004 over the entire period. As previously
discussed in Item 1 of Part I of this Form 10-K,
during most of the first half of 2003, our acrylonitrile
facility and related derivative production facilities were shut
down. During 2004, the prices we paid for propylene and ammonia,
the two primary raw materials required for acrylonitrile
production, increased 60% and decreased 4%, respectively, from
the prices we paid for these raw materials during 2003.
Operating losses on our acrylonitrile sales in
23
2004 were lower than those realized in 2003, primarily because
our 2003 results included significant start-up costs.
Revenues from our other petrochemicals operations, primarily
acetic acid, plasticizers and methanol, were $126 million
in 2004, a slight increase from $123 million in revenues in
2003. This slight increase in revenues primarily consisted of an
18% increase in acetic acid revenues and a 12% increase in
plasticizers revenues, which were mostly offset by the absence
of revenues derived from our prior methanol contract with
Methanex Corporation, which expired on December 31, 2003.
We achieved record profitability in our acetic acid business
in 2004.
|
|
|
Organizational efficiency project |
During the last half of 2004, we developed an organizational
efficiency project involving the design, development and
implementation of uniform and standardized systems, processes
and policies to improve our production, maintenance, process
efficiency, logistics and materials management and procurement
functions. Over the course of developing this project, we
analyzed our organizational structure, selected an optimum
workforce design and staffing model and identified various
production and process efficiency measures. On November 5,
2004, our Board of Directors authorized us to implement the
project. Starting in 2005, we expect the combined annual cost
savings of our organizational efficiency project and our other
cost savings initiatives implemented in 2004, and continuing to
be implemented, to be approximately $20 million
(representing a 15% reduction in our annual fixed costs), with
approximately 20% to 40% of these savings accruing to the
benefit of some of our customers under the cost reimbursement
provisions of our production agreements. However, the actual
level of savings that will be achieved as a result of our cost
savings initiatives can be impacted by a variety of factors,
including operating rates of our production units and sales
volumes of our products, and may, consequently, be lower than
our expectations. In implementing our cost savings initiatives
during 2004, we incurred approximately $5.9 million in
costs related to these projects, including $3.9 million for
employee severance and benefit costs, of which $2.4 million
was incurred during the fourth quarter of 2004.
|
|
|
Impairment of long-lived assets |
During the second quarter of 2004, we performed an assessment of
the carrying value of our long-lived assets to be held and used,
including goodwill. This assessment was performed because of
negative industry and economic trends affecting both our
existing operations and expected future margins, primarily
driven by high raw materials and energy prices. At the
conclusion of this assessment, we recorded an impairment of our
goodwill of $48.5 million.
During the fourth quarter of 2004, we performed an assessment of
the carrying value of our acrylonitrile long-lived assets to be
held and used. This assessment was performed because negative
industry and economic trends have impacted our acrylonitrile
business, recent forecasts by industry experts project these
negative conditions to continue over the next two years as a
result of new acrylonitrile capacity coming on stream in Asia
and our continued review of strategic options with respect to
our acrylonitrile business as a result of a recent history of
operating losses. At the conclusion of this assessment, we
recorded an impairment of our long-lived acrylonitrile assets of
approximately $22 million.
For these impairment analyses, recoverability was determined by
comparing the estimated fair value of these assets, utilizing
the present value of expected net cash flows, to the carrying
value of these assets. In determining the present value of
expected net cash flows, we estimated future net cash flows from
these assets and the timing of those cash flows and then applied
a discount rate to reflect the time value of money and the
inherent uncertainty of those future cash flows. The discount
rate we used was based on independently calculated risks for a
composite group of commodity chemical companies, our target
capital mix and an estimated market risk premium. The
assumptions we used in estimating future cash flows were
consistent with our internal planning.
24
|
|
|
Gain on pension curtailment |
Effective as of January 1, 2005, we froze all accruals
under our defined benefit pension plan for our salaried
employees, which resulted in a plan curtailment under
SFAS No. 88 Employers Accounting for
Settlements and Curtailments of Defined Benefit Pension Plans
and for Termination Benefits. As a result, we recorded a
pretax curtailment gain of $13 million in the fourth
quarter of 2004. At the time we froze accruals under our defined
benefit pension plan, we also increased the company match for
employee contributions under our 401(k) plan.
|
|
|
Gain on sale of methanol plant |
On December 29, 2004, we completed the sale of our idled
methanol plant to Sigma Investment Holdings, L.L.C.
(Sigma). Sigma is required to dismantle the methanol
plant before March 1, 2006, and they have indicated that
they intend to reassemble the methanol plant in Asia. Under our
Methanol Production Agreement with BP Chemicals, BP Chemicals is
entitled to a portion of the net proceeds from the sale of our
methanol plant. After taking into account sales commissions and
various costs and estimated expenses we will be required to
incur in connection with dismantling the methanol plant, as well
as the distribution to BP Chemicals, we generated a pre-tax gain
of $2.4 million during the fourth quarter of 2004 from the
sale of our methanol plant.
We recorded no other income in 2004 compared to the
$4 million in other income we recorded in 2003, which
primarily consisted of a $3.7 million sales tax refund we
received from the State of Texas.
|
|
|
Provision (benefit) for income taxes |
During 2004, our effective tax rate was 16% compared to 37% in
2003. The difference from the statutory rate in 2004 was a
result of the impairment of our goodwill of $48.5 million
that we recorded during 2004, as the impairment charge was a
non-tax deductible charge.
|
|
|
Comparison of Fiscal 2003 to Fiscal 2002 |
|
|
|
Revenues, Gross Profit (Loss) and Net Income (Loss) from
continuing operations |
Our revenues were $593 million in 2003, an increase of 55%
from $382 million in revenues in fiscal 2002. This increase
in revenues resulted primarily from an increase in styrene sales
prices and a significant increase in the amount of acrylonitrile
sales following the resumption of the production of
acrylonitrile in 2003. We recorded a net loss from continuing
operations of $13 million for 2003, compared to a net loss
of $53 million recorded by Predecessor Sterling for fiscal
2002. This decrease in net loss from continuing operations was
primarily due to lower interest costs and the absence of
reorganization costs following our emergence from bankruptcy in
December 2002, partially offset by lower gross profit during
2003 compared to fiscal 2002.
Revenues from our styrene operations were $409 million in
2003, an increase of 49% from $274 million in revenues in
fiscal 2002. Direct sales prices for styrene in 2003 increased
26% from those realized during fiscal 2002. Spot prices for
styrene, a component of our direct sales prices, ranged from
$0.26 to $0.37 per pound during 2003, compared to $0.17 to
$0.35 per pound during fiscal 2002. Our total sales volumes
for styrene in 2003 were roughly equivalent to Predecessor
Sterlings total sales volumes for styrene during fiscal
2002. During 2003, prices for benzene, one of the primary raw
materials for styrene, were 38% higher than the prices paid by
Predecessor Sterling for benzene in fiscal 2002, and prices for
ethylene, the other primary raw material for styrene, were 24%
higher than the prices paid by Predecessor Sterling for ethylene
in fiscal 2002. Average costs for natural gas, another major
component in the cost of manufacturing styrene, increased 79%
during 2003 compared to average natural gas costs during fiscal
2002. These factors contributed to a reduction in gross profit
from our styrene operations in 2003 compared to fiscal 2002.
25
We restarted our acrylonitrile unit during 2003. Revenues from
our acrylonitrile operations were $61 million in 2003,
compared to $7 million in revenues from acrylonitrile
operations recorded by Predecessor Sterling during fiscal 2002.
Direct sales prices for acrylonitrile in 2003 increased 21% from
those realized in fiscal 2002.
Revenues from our other petrochemicals operations, including
acetic acid, plasticizers and methanol, were $123 million
in 2003, an increase of 22% from the $101 million in
revenues recorded by Predecessor Sterling from these operations
during fiscal 2002. This increase was largely due to an increase
in our acetic acid and methanol revenues in 2003 compared to
fiscal 2002.
We recorded other income of $4 million in 2003 compared to
$2 million of other income generated by Predecessor
Sterling in fiscal 2002. This increase was primarily due to a
$3.7 million sales tax refund we received from the State of
Texas in 2003.
As we emerged from bankruptcy in December 2002, we did not incur
any reorganization items during 2003. Items that we previously
recorded as reorganization items were included as Selling,
General and Administrative Expenses during 2003. Reorganization
items incurred by Predecessor Sterling during fiscal 2002 were
$17 million. These costs were primarily for professional
fees incurred after our filing for reorganization under
Chapter 11.
|
|
|
Interest and Debt Related Expenses, Net of Interest Income |
We recorded total interest and debt related expense, net of
interest income, of $10 million in 2003, which was
substantially lower than the $50 million in total interest
and debt related expense recorded by Predecessor Sterling in
fiscal 2002. This decrease was primarily due to the cancellation
of Predecessor Sterlings senior secured debt of
$295 million, which carried an interest rate of
123/8%.
The senior secured debt, along with our other pre-existing debt,
was cancelled upon our emergence from bankruptcy in December
2002. In 2003, our interest expense was primarily generated by
the Secured Notes, which had an initial principal amount of
$94 million.
|
|
|
Provision (Benefit) for Income Taxes |
Our benefit for income taxes was $8 million in 2003,
compared to a provision for income taxes of $0.1 million
recorded by Predecessor Sterling in fiscal 2002. In 2003, we
recorded a benefit for the net operating losses we generated
during 2003, whereas Predecessor Sterling recorded a full
valuation allowance for net operating losses generated in
fiscal 2002.
|
|
|
Comparison of the Three Months Ended December 31,
2002 to the Three Months Ended
December 31, 2001 |
For the three months ended December 31, 2002, the financial
data presented below combines the period from December 20,
2002 to December 31, 2002, representing Reorganized
Sterling, with the period October 1, 2002 to
December 19, 2002, representing Predecessor Sterling.
|
|
|
Revenues, Operating Income (Loss) and Net Income (Loss) from
continuing operations |
Our revenues were $112 million for the three months ended
December 31, 2002 (the 2002 Quarter), compared
to $63 million in revenues during the three months ended
December 31, 2001 (the 2001 Quarter). This
increase in revenues resulted primarily from an increase in
styrene sales prices and volumes due to improved market
conditions. We recorded net income attributable to common
stockholders of $417 million for the 2002 Quarter, compared
to a net loss attributable to common stockholders of
$15 million that Predecessor Sterling recorded for the 2001
Quarter. This increase in net income was
26
primarily due to transactions related to our Plan of
Reorganization, which included a gain on debt restructuring of
$458 million, offset by fresh-start adjustments of
$203 million.
Revenues from our styrene operations were $83 million for
the 2002 Quarter, an increase of 118% from $38 million in
revenues from those operations in the 2001 Quarter. Our total
sales volumes for styrene for the 2002 Quarter increased 34%
from those realized by Predecessor Sterling during the 2001
Quarter. Direct sales prices for styrene in the 2002 Quarter
increased 37% from those realized during the 2001 Quarter. Spot
prices for styrene, a component of our direct sales prices,
ranged from $0.25 to $0.35 per pound during the 2002
Quarter, compared to $0.17 to $0.19 per pound during the
2001 Quarter. During the 2002 Quarter, prices for benzene and
ethylene, the two primary raw materials for styrene, increased
50% and 13%, respectively, from the prices paid for these
products in the 2001 Quarter. The average price for natural gas
increased 63% during the 2002 Quarter compared to the average
price for natural gas during the 2001 Quarter. Due to the
factors discussed above, margins on our styrene sales for the
2002 Quarter increased somewhat from those realized by
Predecessor Sterling during the 2001 Quarter.
Revenues for acrylonitrile remained essentially the same during
the 2002 Quarter compared to the 2001 Quarter. Our acrylonitrile
unit was shut down during both periods.
Revenues from our other petrochemicals operations, including
acetic acid, plasticizers and methanol, were $29 million
for the 2002 Quarter, an increase of 21% from the
$24 million in revenues received by Predecessor Sterling
from these operations during the 2001 Quarter. Our other
petrochemicals operations reported an increase of
$3 million in operating earnings for the 2002 Quarter,
compared to that realized by Predecessor Sterling during the
2001 Quarter. These increases in revenues and operating earnings
were largely due to improved sales margins.
Reorganization items incurred during the 2002 Quarter were
$15 million compared to $4 million for the 2001
Quarter, primarily due to an increase in professional fees
incurred in connection with the Debtors emergence from
Chapter 11.
Liquidity and Capital Resources
Pursuant to the Plan of Reorganization, on December 19,
2002, we issued $94.3 million in original principal amount
of our Secured Notes to the holders of Predecessor
Sterlings
123/8% Senior
Secured Notes due 2006. Our Secured Notes are senior secured
obligations and rank equally in right of payment with all of our
other existing and future senior indebtedness, and senior in
right of payment to all of our existing and future subordinated
indebtedness. Our Secured Notes are guaranteed by Sterling
Chemicals Energy, Inc. (Sterling Energy), one of our
wholly owned subsidiaries. Sterling Energys guaranty ranks
equally in right of payment with all of its existing and future
senior indebtedness, and senior in right of payment to all of
its existing and future subordinated indebtedness. Our Secured
Notes and Sterling Energys guaranty are secured by a first
priority lien on all of our production facilities and related
assets.
Our Secured Notes bear interest at an annual rate of 10%,
payable semi-annually on June 15 and December 15 of
each year. Under certain circumstances, for any interest period
ending on or before December 19, 2004, we could elect to
pay interest on our Secured Notes through the issuance of
additional Secured Notes rather than the payment of cash.
However, if we paid interest through the issuance of additional
Secured Notes rather than the payment of cash, the interest rate
for the relevant period was increased to
133/8%.
In December 2003, we made an interest payment on our Secured
Notes at the higher rate through the issuance of
$6.3 million in original principal amount of additional
Secured Notes, increasing the aggregate principal amount of
outstanding Secured Notes to $100.6 million. We have made
all other interest payments on our Secured Notes in cash.
Subject to compliance with the terms of our Revolving Credit
Agreement, dated December 19, 2002, with The CIT Group/
Business Credit, Inc., as administrative agent and a lender, and
certain other lenders (our Revolver), we may redeem
our Secured Notes at any time at a redemption price of 100% of
the outstanding principal amount thereof plus
27
accrued and unpaid interest. In addition, in the event of a
specified change of control or the sale of our facility in Texas
City, Texas, we are required to offer to repurchase our Secured
Notes at 101% of the outstanding principal amount thereof plus
accrued and unpaid interest. Under certain circumstances, we are
also required to use the proceeds of other asset sales to
repurchase any of our Secured Notes tendered by the holders of
our Secured Notes at a price equal to 100% of the outstanding
principal amount thereof plus accrued and unpaid interest.
The indenture governing our Secured Notes contains numerous
covenants and conditions, including, but not limited to,
restrictions on our ability to incur indebtedness, create liens,
sell assets, make investments, make capital expenditures, engage
in mergers and acquisitions and pay dividends. The indenture
also includes various circumstances and conditions that would,
upon their occurrence and subject in certain cases to notice and
grace periods, create an event of default thereunder. However,
the indenture does not require us to satisfy any financial
ratios or maintenance tests.
On December 19, 2002, we established the Revolver, which
provides up to $100 million in revolving credit loans. The
Revolver has an initial term ending on September 19, 2007.
Under the Revolver, we and Sterling Energy are co-borrowers and
are jointly and severally liable for any indebtedness
thereunder. The Revolver is secured by first priority liens on
all of our accounts receivable, inventory and other specified
assets, as well as all of the issued and outstanding capital
stock of Sterling Energy.
Borrowings under the Revolver bear interest, at our option, at
an annual rate of either the Alternate Base Rate plus 0.75% or
the LIBO Rate (as defined in the Revolver) plus
2.75%. The Alternate Base Rate is equal to the
greater of the Base Rate as announced from time to
time by JPMorgan Chase Bank in New York, New York or
0.50% per annum above the latest Federal Funds
Rate (as defined in the Revolver). The average borrowing
rate under the Revolver for the year ended December 31,
2004 was 5.8%. Under the Revolver, we are also required to pay
an aggregate commitment fee of 0.50% per year (payable
monthly) on any unused portion of the Revolver. Available credit
under the Revolver is subject to a monthly borrowing base of 85%
of eligible accounts receivable plus the lesser of
$50 million and 65% of eligible inventory. In addition, the
borrowing base for the Revolver must exceed outstanding
borrowings thereunder by $8 million at all times. As of
December 31, 2004, total credit available under the
Revolver was limited to $74 million due to these borrowing
base limitations. As of December 31, 2004, there was
$18 million of loans outstanding under the Revolver, and we
had an additional $2 million in outstanding letters of
credit issued pursuant to the Revolver.
The Revolver contains numerous covenants and conditions,
including, but not limited to, restrictions on our ability to
incur indebtedness, create liens, sell assets, make investments,
make capital expenditures, engage in mergers and acquisitions
and pay dividends. The Revolver also contains a covenant that
requires us to earn a specified amount of earnings before
interest, income taxes, depreciation and amortization (as
defined in the Revolver) on a monthly basis if, for 15
consecutive days, unused availability under the Revolver plus
cash on hand is less than $20 million. The Revolver
includes various circumstances and conditions that would, upon
their occurrence and subject in certain cases to notice and
grace periods, create an event of default thereunder.
Our liquidity (i.e., cash and cash equivalents plus total
credit available under the Revolver, subject to the conditions
to borrowings under the Revolver) was $56 million at
December 31, 2004, a decrease of $60 million compared
to our liquidity at December 31, 2003. This decrease was
caused to a large extent by negative cash flows from our
operations, partially due to maintenance turnarounds of our
styrene and acrylonitrile units performed during the first
quarter of 2004. The total cost of the turnarounds of our
styrene and acrylonitrile units, including maintenance expense,
catalyst installation and capital projects, was
$21 million. In addition, our liquidity decreased due to an
increase in inventory in the fourth quarter of 2004 as a result
of shipments of 46 million pounds of styrene to Asia for
expected sale in the first quarter of 2005. This inventory,
valued at approximately $22 million, is not included in our
borrowing base under the Revolver until it is sold. We believe
that our cash on hand, together with credit available under the
Revolver, will be sufficient to meet our short-term and
long-term liquidity needs for the reasonably foreseeable future,
although we cannot give any assurances to that effect.
28
Working capital at December 31, 2004 was $103 million,
a decrease of $15 million from our working capital at
December 31, 2003. This decrease in working capital was
primarily due to reductions in cash as a result of negative cash
flows from operations during 2004, which were influenced by
costs related to the maintenance turnarounds described above and
an increase in the current portion of long-term debt.
Net cash used in our operations was $47 million in 2004,
whereas net cash used in our operations in 2003 was
$41 million. During the three-month period ended
December 31, 2002, $3 million in net cash was provided
by operations.
The primary factors impacting our cash flow from operations are
production and sales volumes and the prices of our raw materials
and finished products. See discussion of these factors in
Results of Operations above. Net cash flow used in
our investing activities was $11 million in 2004 and
$16 million in 2003. For the three months ended
December 31, 2002, $357 million in net cash flow was
provided by investing activities, primarily from the sale of our
pulp chemicals business.
Net cash flows provided by financing activities were
$18 million in 2004 due to borrowings under the Revolver,
and zero in 2003. For the three months ended December 31,
2002, $260 million was used by financing activities, which
was primarily for the partial repayment of Predecessor
Sterlings
123/8% Senior
Secured Notes and the repayment of the outstanding balance under
our debtor-in-possession credit facility at the time we emerged
from bankruptcy.
Our capital expenditures were $15 million in 2004,
$16 million in 2003 and $7 million in fiscal 2002.
Capital expenditures are expected to be approximately between
$20 and $25 million in 2005. These capital expenditures
will primarily be for routine safety, environmental and
replacement capital and the continuation of capital projects
related to the reduction of emissions of nitrogen oxide and
highly volatile organic compounds required under the State
Implementation Plan adopted by the Texas Commission for
Environmental Quality related to compliance with the ozone
provisions of the Clean Air Act.
Our capital expenditures for environmentally related prevention,
containment and process improvements were $8 million in
2004 and $3 million in 2003. We anticipate spending
approximately $4 million on these types of expenditures
during 2005.
Contractual Cash Obligations
The following table summarizes our significant contractual
obligations at December 31, 2004, and the effect such
obligations are expected to have on our liquidity and cash flows
in future periods.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than | |
|
|
|
|
|
More than | |
|
|
|
|
1 year | |
|
1-3 years | |
|
4-5 years | |
|
5 years | |
|
Total | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Long-term debt
|
|
$ |
|
|
|
$ |
100,579 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
100,579 |
|
Interest payments on long-term debt
|
|
|
10,058 |
|
|
|
20,200 |
|
|
|
|
|
|
|
|
|
|
|
30,258 |
|
Current portion of long-term
debt(1)
|
|
|
|
|
|
|
17,684 |
|
|
|
|
|
|
|
|
|
|
|
17,684 |
|
Capital leases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating leases
|
|
|
293 |
|
|
|
879 |
|
|
|
586 |
|
|
|
805 |
|
|
|
2,563 |
|
Purchase
obligations(2)
|
|
|
135,000 |
|
|
|
112,000 |
|
|
|
55,000 |
|
|
|
166,000 |
|
|
|
468,000 |
|
Pension and other postretirement benefits
|
|
|
9,181 |
|
|
|
22,746 |
|
|
|
6,503 |
|
|
|
33,690 |
|
|
|
72,120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
154,532 |
|
|
$ |
274,088 |
|
|
$ |
62,089 |
|
|
$ |
200,495 |
|
|
$ |
691,204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29
|
|
(1) |
The interest payment obligations on our Revolver are not
presented because the interest payments fluctuate depending on
the interest rate and balance of our Revolver. |
|
(2) |
For the purposes of this table, we have considered contractual
obligations for the purchase of goods or services as agreements
involving more than $1 million that are enforceable and
legally binding and that specify all significant terms,
including: fixed or minimum quantities to be purchased, fixed,
minimum or variable price provisions and the approximate timing
of the transaction. Most of the purchase obligations identified
include variable pricing provisions. We have estimated the
future prices of these items, utilizing forward curves where
available. The pricing estimated for use in this table is
subject to market risk. |
Critical Accounting Policies, Use of Estimates and
Assumptions
A summary of our significant accounting policies is included in
Note 1 of the Notes to Consolidated Financial Statements
included in Item 8 of this Form 10-K. We believe
that the consistent application of these policies enables us to
provide readers of our financial statements with useful and
reliable information about our operating results and financial
condition. The following accounting policies are the ones we
believe are the most important to the portrayal of our financial
condition and results and require our most difficult, subjective
or complex judgments.
We generally recognize revenue from sales in the open market,
raw material conversion agreements and long-term supply
contracts at the time the products are shipped. Some of our
contractual arrangements include a profit sharing component, and
we estimate and accrue our expected revenues from these profit
sharing arrangements on a monthly basis. Shipping and handling
costs associated with the delivery of our products to customers
are included in cost of goods sold.
Inventories are carried at the lower-of-cost-or-market value.
Cost is primarily determined on the first-in, first-out basis,
except for stores and supplies, which are valued at average
cost. The comparison of cost to market value involves estimation
of the market value of our products. We enter into agreements
with other companies to exchange chemical inventories in order
to minimize working capital requirements and to facilitate
distribution logistics. Balances related to quantities due to or
payable by us in connection with these exchange agreements are
included in inventory.
We assess our long-lived assets other than goodwill for
impairment whenever facts and circumstances indicate that the
carrying amount may not be fully recoverable. To analyze
recoverability, we project undiscounted net future cash flows
over the remaining life of these assets. If these projected cash
flows from these assets are less than the carrying amount of
these assets, an impairment would be recognized. Any impairment
loss would be measured based upon the difference between the
carrying amount and the fair value of the relevant assets. For
these impairment analyses, recoverability is determined by
comparing the estimated fair value of these assets, utilizing
the present value of expected net cash flows, to the carrying
value of these assets. In determining the present value of
expected net cash flows, we estimate future net cash flows from
these assets and the timing of those cash flows and then apply a
discount rate to reflect the time value of money and the
inherent uncertainty of those future cash flows. The discount
rate we use is based on independently calculated risks for a
composite group of commodity chemical companies, our target
capital mix and an estimated market risk premium. The
assumptions we use in estimating future cash flows are
consistent with our internal planning.
30
We assess goodwill for impairment on an annual basis, or sooner
if events indicate such a review is necessary. Recoverability is
determined by comparing the estimated fair value of these
assets, utilizing the present value of expected net cash flows,
to the carrying value of these assets. In determining the
present value of expected net cash flows, we estimate our future
net cash flows from these assets and the timing of those cash
flows and then apply a discount rate to reflect the time value
of money and the inherent uncertainty of those future cash
flows. The discount rate we use, is based on independently
calculated risks for a composite group of commodity chemical
companies, our target capital mix and an estimated market risk
premium. The assumptions we use in estimating future cash flows
are consistent with our internal planning.
Deferred income taxes are provided for revenue and expenses
which are recognized in different periods for income tax and
financial statement purposes. Deferred tax assets are regularly
assessed for recoverability based on both historical and
anticipated earnings levels, and a valuation allowance is
recorded when it is more likely than not that these amounts will
not be recovered.
We sponsor domestic defined benefit pension and other
postretirement plans. Major assumptions used in the accounting
for these employee benefit plans include the discount rate,
expected return on plan assets and health care cost increase
projections. Assumptions are determined based on our historical
data and appropriate market indicators, and are evaluated each
year as of the plans measurement date. A change in any of
these assumptions would have an effect on net periodic pension
and postretirement benefit costs reported in our financial
statements.
As a part of normal recurring operations, each of our
manufacturing units is completely shut down from time to time,
for a period typically lasting two to four weeks, to replace
catalysts and perform major maintenance work required to sustain
long-term production. These periods are commonly referred to as
turnarounds or shutdowns. While actual
timing is subject to a number of variables, turnarounds of our
styrene unit typically occur every two to three years and
turnarounds of our acrylonitrile unit typically occur every 18
to 21 months. We currently expense the costs of turnarounds
as the associated expenses are incurred. Prior to our adoption
of fresh-start accounting, we had accrued these costs over the
expected period between turnarounds. As expenses for
turnarounds, especially for our styrene and acrylonitrile units,
can be significant, the impact of expensing turnaround costs as
they are incurred can be material for financial reporting
periods during which the turnarounds actually occur.
New Accounting Standards
On December 8, 2003, the Medicare Prescription Drug
Improvement and Modernization Act of 2003 (the Act)
was passed. The Act introduces a prescription drug benefit under
Medicare (Medicare Part D), as well as a federal subsidy to
sponsors of retiree health care benefit plans that provide a
benefit that is at least actuarially equivalent to Medicare
Part D. In January 2004, the Financial Accounting Standards
Board (the FASB) issued FASB Staff Position
No. FAS 106-1, Accounting and Disclosure
Requirements Related to the Medicare Prescription Drug
Improvement and Modernization Act of 2003
(FAS 106-1), which is effective for interim or
annual financial statements of fiscal years ending after
December 7, 2003 and permits a one-time election to defer
accounting for the effects of the Act. In May 2004, the FASB
issued FASB Staff Position No. 106-2, Accounting and
Disclosure Requirements Related to the Medicare Prescription
Drug, Improvement and Modernization Act of 2003
(FAS 106-2), which supercedes FAS 106-1.
FAS 106-2 provides guidance on the accounting for the
effects of the Act for employers that sponsor postretirement
heath care plans that provide prescription drug
31
benefits, and requires those employers to provide certain
disclosures regarding the effect of the federal subsidy provided
under the Act. FAS 106-2 applies to us effective
July 1, 2004. We measured the effects of the Act on our
accumulated postretirement benefit obligation and determined
that, based on the regulatory guidance currently available,
benefits provided by our postretirement plan are at least
actuarially equivalent to Medicare Part D, and accordingly,
we expect to be entitled to the federal subsidy in the years
2006 through 2009. We estimate that this subsidy will be
approximately 20% of the net benefits under our plan, or
$0.2 million annually.
In November 2004, the FASB issued SFAS No. 151,
Inventory Costs an amendment of ARB
No. 43, Chapter 4, (SFAS 151)
in an effort to conform U.S. accounting standards for
inventories to International Accounting Standards. SFAS 151
requires idle facility expenses, freight, handling costs and
wasted material (spoilage) costs to be recognized as
current-period charges. It also requires that the allocation of
fixed production overheads to the costs of conversion be based
on the normal capacity of the relevant production facilities.
SFAS 151 will be effective for inventory costs incurred
during fiscal years beginning after June 15, 2005. We are
currently evaluating the impact of this standard on our
consolidated financial statements.
In December 2004, the FASB issued SFAS No. 123-Revised
2004 (SFAS 123(R)), Share-Based
Payment. This is a revision of SFAS No. 123,
Accounting for Stock-Based Compensation, and supersedes APB
No. 25, Accounting for Stock Issued to Employees. As noted
in the notes to financial statements, we do not record
compensation expense for stock-based compensation. Under
SFAS 123(R), we will be required to measure the cost of
employee services received in exchange for stock based on the
grant-date fair value (with limited exceptions). That cost will
be recognized over the period during which an employee is
required to provide service in exchange for the award (usually
the vesting period). The fair value will be estimated using an
option-pricing model. Excess tax benefits, as defined in
SFAS 123(R), will be recognized as an addition to paid-in
capital. This is effective as of the beginning of the first
interim or annual reporting period that begins after
June 15, 2005. We are currently in the process of
evaluating the impact of SFAS 123(R) on our financial
statements, including different option-pricing models. The pro
forma table in Note 2 of the Notes to the Consolidated
Financial Statements illustrates the effect on net income and
earnings per share if we had applied the fair value recognition
provisions of SFAS 123.
In December 2003, the FASB issued FASB Statement
No. 132-Revised 2003 (SFAS 132R),
Employers Disclosures about Pensions and Other
Postretirement Benefits. This standard increases the
existing disclosure requirements by requiring more details about
pension plan assets, benefit obligations, cash flows, benefit
costs and related information. Companies are required to
segregate plan assets by category, such as debt, equity and real
estate, and to provide certain expected rates of return and
other informational disclosures. SFAS 132R also requires
companies to disclose various elements of pension and
postretirement benefit costs in interim-period financial
statements for quarters beginning after December 15, 2003
(see Note 8 of the Notes to the Consolidated Financial
Statements). We have complied with the disclosure requirements
of SFAS 132R.
Certain Known Events, Trends, Uncertainties and Risk
Factors
|
|
|
Cyclicality in the petrochemicals industry has in the past
and may in the future result in reduced operating margins or
operating losses. |
Two of our products, styrene and acrylonitrile, are commodities
that exhibit wide swings in demand, prices and margins based
upon current and anticipated levels of supply and demand. Demand
for our products is largely influenced by the rate of growth in
the worlds economy, with the growth rate of the economy in
Asia becoming increasingly more important. Our historical
operating results reflect the cyclical and volatile nature of
the petrochemicals industry. These cycles are characterized by
periods of tight supply, leading to higher operating rates and
margins, followed by periods of oversupply leading to reduced
operating rates and lower margins. In most cases, increases in
supply are achieved through the construction of new capacity or
major expansions of existing facilities. Typically, these types
of projects result in large increases in production capacity and
supply, and cause available supply to greatly exceed demand for
an
32
extended period. In addition, profitability in the
petrochemicals industry is affected by the worldwide level of
demand growth, along with vigorous price competition, which may
intensify due to, among other things, new domestic and foreign
industry capacity. In general, weak economic conditions, either
in the United States or in the world, tend to reduce the rate of
demand growth and margins.
While the markets for styrene and acrylonitrile roughly follow a
repetitive cycle, and general trends in the supply and demand
balance for these products may be observed over time, it is
difficult, if not impossible, to definitively predict when
market conditions will be favorable or unfavorable.
Historically, the peaks in the market cycles for
styrene and acrylonitrile tend to occur every seven to ten
years, with prolonged periods of depressed market conditions
between the peaks. Since our inception, a part of our business
strategy has been to take advantage of the high margins that can
be realized during periods when the balance of supply and demand
for styrene and acrylonitrile favors producers. Consequently, a
large portion of our capacity for these products is uncommitted
and available for sale in the spot markets. While having
available uncommitted capacity can lead to dramatically improved
financial performance during periods when the balance of supply
and demand favors producers, it also causes negative market
conditions to affect us more severely than most of our
competitors in terms of sales volumes and margins. Future growth
in demand for these products may not be sufficient to alleviate
any existing or future conditions of excess industry capacity,
and such conditions may not be sustained or may be further
aggravated by anticipated or unanticipated capacity additions or
other events.
|
|
|
Our level of indebtedness could adversely affect our
ability to react to changes in our business, and we may be
limited in our ability to use debt to fund future capital
needs. |
As of December 31, 2004, our total debt was
$118 million. Our substantial indebtedness could adversely
affect our financial condition and make it more difficult for us
to satisfy our obligations. Our substantial indebtedness could:
|
|
|
|
|
require us to dedicate a substantial portion of our cash flow
from operations to payments with respect to our indebtedness,
thereby reducing the availability of our cash flow to fund
working capital, capital expenditures and other general
corporate expenditures; |
|
|
|
increase our vulnerability to adverse general economic or
industry conditions; |
|
|
|
limit our flexibility in planning for, or reacting to,
competition or changes in our business or our industry: |
|
|
|
limit our ability to borrow additional funds; |
|
|
|
restrict us from making strategic acquisitions, introducing new
products or services or exploiting business opportunities; |
|
|
|
make it more difficult for us to satisfy our obligations with
respect to our indebtedness, including our Secured
Notes; and |
|
|
|
place us at a competitive disadvantage relative to competitors
that have less debt or greater financial resources. |
The covenants in the indenture for our Secured Notes and in the
Revolver also limit our flexibility by restricting our ability
to incur indebtedness, pay dividends and make other restricted
payments or investments, sell assets, make capital expenditures,
engage in certain mergers and acquisitions and refinance
existing indebtedness.
Our ability to make payments on and refinance our indebtedness,
including our Secured Notes, will depend on our ability to
generate cash from our future operations. Our ability to
generate cash from future operations is subject, in large part,
to general economic, competitive, legislative and regulatory
factors and other factors that are beyond our control. We may
not be able to generate enough cash flow from operations or be
able to obtain enough capital to service our debt or fund our
planned capital expenditures. In addition, we may need to
refinance some or all of our indebtedness on or before maturity.
We may not
33
be able to refinance our indebtedness on commercially reasonable
terms or at all. If we cannot service or refinance our
indebtedness, we may have to take actions such as selling
assets, seeking additional equity or reducing or delaying
capital expenditures, strategic acquisitions, investments or
alliances. We may not be able to take such actions, if
necessary, on commercially reasonable terms or at all. If we are
unable to make scheduled debt payments or comply with the other
provisions of our debt instruments, our various lenders will be
permitted under certain circumstances to accelerate the maturity
of the indebtedness owing to them and exercise other remedies
provided for in those instruments and under applicable law.
|
|
|
Despite our level of indebtedness, we and our subsidiaries
may be able to incur substantially more debt; which may impact
our ability to meet our debt service requirements. |
We and our subsidiaries may be able to incur substantial
additional indebtedness in the future. Although the indenture
governing our Secured Notes and our other debt instruments and
financing arrangements contain restrictions on the incurrence of
additional indebtedness, these restrictions are subject to a
number of qualifications and exceptions, and the indebtedness
incurred in compliance with these restrictions could be
substantial. To the extent new debt is added to our currently
anticipated debt levels, the substantial risks described in this
Form 10-K would increase. Also, these restrictions do not
prevent us from incurring obligations that do not constitute
indebtedness.
|
|
|
Natural gas prices have a significant impact on our
competitiveness. High natural gas prices can have the effect of
closing markets to our products where we are not
competitive. |
Our production costs are impacted by the price of natural gas in
a variety of ways. We use significant amounts of natural gas as
fuel in the production of our products, so any increase in the
price for natural gas leads to a direct increase in our
production costs. In addition, most of our suppliers use
significant amounts of natural gas in the production of the raw
materials we need to produce our products, which causes our raw
materials costs to also increase when the price for natural gas
increases. Prices for natural gas are largely based on regional
factors, which can result in wide disparities in natural gas
prices in different parts of the world. Prices for styrene and
acrylonitrile, on the other hand, tend to be more consistent
throughout the world, after taking into account transportation
costs. Consequently, when prices for natural gas rise in the
United States but not in other parts of the world, we may not be
able to recover these increased costs through higher sales
prices, and our ability to compete with producers elsewhere in
the world is diminished. In addition, many producers in other
parts of the world use oil-based processes rather than natural
gas based processes. Consequently, the relationship between the
price of crude oil and the price of natural gas can also affect
our competitiveness and our ability to recover increases in the
price of natural gas through higher sales prices. Over the last
few years, we have experienced periods when our cost for natural
gas was at levels that resulted in our being unable to sell
styrene and acrylonitrile in Europe or Asia at prices above our
variable costs of production, essentially closing those markets
to sales of our styrene and acrylonitrile. In the future, we may
not be able to obtain natural gas at prices that do not
adversely impact our competitiveness.
|
|
|
Our financial performance may be adversely affected if we
are unable to obtain raw materials at reasonable prices or on
acceptable terms. |
For most of our products, the combined cost of raw materials and
energy resources is far greater than the total of all other
costs of production combined. As a result, an adequate supply of
raw materials at reasonable prices and on acceptable terms is
critical to the success of our business. We may not be able to
secure adequate supplies of any of our raw materials or energy
resources at reasonable prices or on acceptable terms. If we are
unable to obtain raw materials at reasonable prices and on
acceptable terms, our results of operations are negatively
affected. Most of the raw materials necessary for our production
of petrochemicals are commodities and, consequently, are subject
to wide fluctuations in prices for a variety of reasons beyond
our control. Several factors may impact the cost or supply of
our raw materials and energy resources, including regional and
global balances of supply and demand, the availability and
pricing for crude oil and the occurrence of plant outages and
other supply disruptions. While the markets for our
34
products are generally global, prices and availability for most
of our raw materials are influenced by regional factors. As a
result, we may pay higher prices for raw materials than our
competitors in other parts of the world or be unable to obtain
raw materials at times when they are available to our
competitors, both of which may negatively impact our
competitiveness and our financial performance.
All of our primary raw materials are supplied by others pursuant
to long-term contracts or spot market purchases. While we
frequently enter into supply agreements, as is the general
practice in our industry, these agreements typically provide for
market-based pricing. Consequently, our supply agreements
provide only limited protection against price volatility. In
addition, the commodity markets for our raw materials may be
subject to disruptions. If our suppliers are unable to meet
their obligations under applicable supply agreements or we are
otherwise unable to obtain reasonably priced raw materials, our
business may be disrupted. For example, we rely on Praxair as
our sole supplier of carbon monoxide, which is a necessary raw
material for our production of acetic acid, and any disruption
in the supply of carbon monoxide from Praxair will disrupt our
production of acetic acid. In the case of either raw material
price increases or supply disruptions, we could incur
significant additional costs. While we attempt to match cost
increases with corresponding product price increases, we are not
always able to immediately raise product prices and, ultimately,
our ability to pass on underlying cost increases to our
customers is greatly dependent upon market conditions. Any
underlying cost increase that we are not able to pass on to our
customers could have a material adverse effect on our business,
financial condition, results of operations or cash flows.
|
|
|
Our financial performance may be adversely affected by our
inability to secure ocean-going vessels. |
A large portion of styrene and acrylonitrile sales are made to
customers in foreign countries, particularly in Asia. As a
result, securing adequate shipping space at acceptable prices is
critical to the success of our business. We may not be able to
secure adequate shipping space at reasonable prices or on
acceptable terms. If we are unable to obtain adequate shipping
space at reasonable prices and on acceptable terms, our results
of operations are negatively affected. Recently, there has been
a severe shortage of cargo space on chemical tankers serving
foreign markets, which has caused shipping rates to escalate
dramatically and, at times, resulted in our inability to secure
shipping space at all. Higher shipping rates increase our costs
relative to producers located in close proximity to foreign
customers and reduce our overall competitiveness in those
markets. If we are unable to secure adequate shipping space at
acceptable prices, we may be unable to make sales in foreign
countries, even during periods of increased demand for our
products.
|
|
|
We may be unable to compete successfully with integrated
and larger competitors. |
We compete with some of the worlds largest chemical
companies, most of whom are engaged in much broader businesses
and either supply significant portions of the raw materials they
need to produce styrene or acrylonitrile, or internally use
significant amounts of the styrene or acrylonitrile they produce
to make derivative products. We do not make any of the primary
raw materials required for styrene or acrylonitrile production
or convert any of our styrene or acrylonitrile into other
products. Consequently, our production costs can be higher than
those of our competitors during periods when demand for these
raw materials exceeds supply and, in more extreme cases, we may
not be able to obtain these raw materials in the market at times
when our competitors are supplying their own raw materials. In
addition, as production costs are highly influenced by
production rates, the absence of internal uses for our styrene
and acrylonitrile typically results in lower production rates,
and consequently higher production costs, at our facilities
during periods when the balance of supply and demand for styrene
or acrylonitrile favors consumers, while production rates and
costs at our competitors, who internally consume significant
amounts of styrene or acrylonitrile, are less volatile.
|
|
|
Our industry is highly competitive and our results are
significantly impacted by manufacturing costs. |
We compete with some of the worlds largest chemical
companies on the basis of product price, quality and
deliverability. However, prices for our petrochemicals products
are determined by global
35
market factors that are largely beyond our control. Except with
respect to a number of our long-term contracts, we generally
sell our products at prevailing market prices. As a result, our
financial performance relative to our competitors, most of whom
are larger than us, is greatly influenced by our manufacturing
costs. Currently, our acrylonitrile production costs are higher
than the industry average due to our inability to obtain
chemical value for a large portion of our by-product hydrogen
cyanide. Monsanto has contractually committed to start up its
DSIDA facility at our Texas City site by mid-2007, which will
improve our hydrogen cyanide utilization. However, even after
restarting the DSIDA plant, we will still have substantial
quantities of under-utilized hydrogen cyanide. While we continue
to explore alternatives for upgrading our hydrogen cyanide
utilization, we cannot predict whether our efforts will be
successful.
|
|
|
The loss of a long-term contract or a significant customer
could adversely affect us. |
We sell significant portions of our acrylonitrile and styrene
production, and all of our acetic acid, plasticizers and DSIDA
production, under long-term contracts. In 2005, one customer is
expected to account for up to 33% of our acrylonitrile sales,
three customers are expected to account for over 50% of our
styrene sales, one customer will account for 100% of our acetic
acid sales and one customer will account for 100% of our
plasticizers sales. The loss of one or more of these contracts
or customers, or a material reduction in the amount of product
purchased under one or more of these contracts or by one or more
of these customers, could have a material adverse effect on us.
Our acetic acid and acrylonitrile businesses are largely
dependent on our contractual relationships with BP Chemicals. A
termination of our relationship with BP Chemicals for either of
these products would have severe negative implications for that
business, which could have a material adverse effect on our
overall business, results of operations, cash flows and
financial condition. We enter into long-term styrene contracts
to secure purchase commitments over extended periods at levels
that will enable us to produce styrene at adequate operating
rates throughout the styrene market cycle. At the same time, we
also leave a large portion of our styrene production capacity
uncommitted for sales in the spot market. We may not be able to
secure or maintain adequate commitments to purchase styrene over
any period and we may not be able to maintain a balance between
our contract sales and spot sales at any particular level or at
a level that will result in favorable financial performance for
any period.
|
|
|
The petrochemicals industry has experienced several years
of depressed conditions and many of our customers are in
troubled financial condition. |
The petrochemicals industry is highly volatile and has
experienced several years of depressed conditions. As a result,
many of our customers have suffered prolonged losses and seen
their liquidity diminish. While we attempt to manage our credit
exposure to our customers on a case-by-case basis through a
variety of methods, including requiring letters of credit,
establishing credit limits or, in extreme cases, requiring
cash-on-delivery for our products, we cannot be sure that our
customers will not default on their obligations to us. A default
by one or more of our customers on their payment obligations to
us would have a negative effect on our financial condition, cash
flows and results of operations, which effect could be material.
|
|
|
Our technology is widely available and could become
obsolete. |
Most of our competitors have significantly greater financial
resources than us and engage in substantial research and
development activities. If any of our current or future
competitors develop proprietary technology that enables them to
produce products at a significantly lower cost or produce
products with enhanced performance characteristics, our
technology could be rendered uneconomical or obsolete.
Currently, a competing technology exists to produce styrene
monomer in conjunction with the production of propylene oxide,
which allows for the production of styrene monomer with lower
overall production economics than the technology we utilize
based on historical market prices for propylene oxide and other
feedstock costs utilized in that technology. If this technology
becomes a more predominant method for producing styrene monomer,
our financial condition, cash flows and results of operations
could be negatively impacted, which effect could be material. In
addition, a significant portion of our business is
36
based upon widely available technology. Accordingly, barriers to
entry, apart from capital availability, are low in certain
product segments of our business, and the entrance of new
competitors into the industry may reduce our ability to capture
improving profit margins in circumstances where capacity
utilization in the industry is increasing.
|
|
|
We face risks related to our export sales of products that
may negatively affect our business. |
A significant portion of our sales of styrene and acrylonitrile
are to international customers. Our international operations are
subject to risks of doing business abroad, including
fluctuations in current exchange rates, transportation delays
and interruptions, political and economic instability and
disruptions, restrictions on the transfer of funds, the
imposition of duties and tariffs, import and export controls,
changes in governmental policies, labor unrest and current and
changing regulatory environments. These events could have an
adverse effect on our international operations in the future by
reducing the demand for our products, decreasing the prices at
which we can sell our products or otherwise having an adverse
effect on our business, financial condition or results of
operations. We cannot guarantee that we will not be found to be
operating in noncompliance with applicable customs, currency
exchange control regulations, transfer pricing regulations or
other laws or regulations to which we may be subject.
Further, the markets for our products, and the prices we receive
for our products, are based on international supply and demand.
In recent years, demand for supply, and capacity expansion in
Asia, particularly China, have driven price trends. China has
pursued an aggressive economic expansion in recent years. If
such expansion were to cease, or significantly slow, the markets
for our products could be materially adversely affected.
Countries in Asia and in the Middle East have also completed or
announced significant capacity increases for most of the
products we produce, and may expand production in the future.
Most of this capacity has been or is being built in areas that
are in close proximity to the markets where we sell a
significant part of our production of petrochemicals. These
developments could have a significant negative impact on our
ability to maintain existing market share or may adversely
impact our profit margins.
|
|
|
Our business activities in the Peoples Republic of
China subject us to certain risks. |
A significant portion of our acrylonitrile is exported to China
and, when market conditions are favorable, we export significant
quantities of our styrene to China. Consequently, our business
may be adversely affected by the political, social and economic
environment in China, including changes in such environment.
Under its current leadership, China has been pursuing economic
reform policies, including the encouragement of private economic
activity and greater economic decentralization. However, the
Chinese government may not continue to pursue such policies,
such policies may not be successful even if continued to be
pursued and such policies may be significantly altered from time
to time. Moreover, economic reforms and growth in China have
been more successful in certain provinces than others, and the
continuation or increase of such disparities could affect the
political or social stability of China.
China does not have a well developed, consolidated body of law
governing foreign investment enterprises. As a result, the
administration of laws and regulations by governmental agencies
may be subject to considerable discretion and variation. In
addition, the legal system of China relating to foreign
investments is both new and continually evolving, and currently
there can be no certainty as to the application of its laws and
regulations in particular instances. If for any reason we were
required to discontinue exporting to China, our competitiveness
and market position could be materially jeopardized, and we may
not be able to secure alternative commitments to purchase our
products. Furthermore, our activities in China are by law
subject, in some circumstances, to administrative review and
approval by various national and local agencies of the Chinese
government. The inability to obtain such approvals could have a
material adverse effect on our business, financial condition and
results of operations.
37
|
|
|
We depend upon the continued operation of our Texas City
facility and any significant downtime at our facility would
affect our operations. |
All of the petrochemicals we manufacture are produced at our
Texas City facility. Significant unscheduled downtime at our
Texas City facility could have a material adverse effect on our
results. Unanticipated downtime can occur for a variety of
reasons, including equipment breakdowns, interruptions in the
supply of raw materials, power failures, sabotage, natural
forces or other hazards associated with the production of
petrochemicals. Although we maintain business interruption
insurance, this insurance does not provide coverage for business
interruptions of less than 45 days and is limited in
overall coverage.
|
|
|
Our operations involve risks that may not be covered by
our insurance or may increase our operating costs. |
A business risk inherent in all chemical operations is the
potential for personal injury and property damage claims from
employees, contractors and their employees and nearby landowners
and occupants. In addition, some risk of environmental costs and
liabilities is inherent in our operations and products. Risks of
this nature that we may face include:
|
|
|
|
|
pipeline leaks and ruptures, explosions and fires; |
|
|
|
severe weather and natural disasters; |
|
|
|
mechanical failures, unscheduled downtimes, labor difficulties
and transportation interruptions; |
|
|
|
remediation complications; |
|
|
|
chemical spills and discharges or releases of toxic or hazardous
substances or gases; and |
|
|
|
storage tank leaks. |
Some of these events can cause bodily injury and loss of life,
severe damage to or destruction of property and equipment and
environmental damage, and may result in suspension of operations
and the imposition of civil or criminal penalties and
liabilities. We may also face expenses and liabilities as a
result of past or future operations relating to these risks.
Furthermore, we are subject to present and future claims with
respect to workplace exposure, workers compensation and
other matters.
We maintain insurance at levels that we believe are reasonable
and that are typical for our industrys insurance
coverages, a portion of which are provided by a captive
insurance company maintained by us and a few other chemical
companies, but we are not fully insured against all potential
hazards incident to our business. Accordingly, our insurance
coverages may be inadequate for any given risk or liability,
such as a loss of the supply of electricity or carbon monoxide.
In addition, our insurance companies may be incapable of
honoring their commitments if an unusually high number of claims
were made against their policies. As a result of market
conditions, premiums and deductibles for certain insurance
policies can increase substantially and, in some instances,
certain insurance may become unavailable or available only for
reduced amounts of coverage. If we were to incur a significant
liability for which we were not fully insured, it could have a
material adverse effect on our business, financial condition and
results of operations.
|
|
|
Terrorist attacks, the current military action in Iraq,
general instability in various OPEC member nations and other
attacks or acts of war in the United States and abroad may
adversely affect the markets in which we operate, our operations
and our profitability. |
The attacks of September 11, 2001 and subsequent events,
including the current military action in Iraq, have caused
instability in the United States and other financial markets and
have led, and may continue to lead, to further armed
hostilities, prolonged military action in Iraq or further acts
of terrorism in the United States or abroad, which could cause
further instability in financial markets. Current regional
tensions and conflicts in various OPEC member nations, including
the current military action in Iraq, have caused, and may
continue to cause, increased raw material costs, specifically
raising the prices of oil and
38
gas, which are used in our operations or affect the price of our
raw materials. Furthermore, the terrorist attacks, subsequent
events or future developments in any of these areas may result
in reduced demand from our customers for our products. These
developments could subject our operations to increased risks
and, depending on their magnitude, could have a material adverse
effect on our business, financial condition, results of
operations or cash flows.
|
|
|
Our property insurance does not cover acts of terrorism
and, in the event of a terrorist attack, we could lose net sales
and our facilities. |
As a result of the terrorist attacks of September 11, 2001
and other events, our insurance carriers have created exclusions
for losses from terrorism from our all risk property
insurance policies. While separate terrorism insurance coverage
is available, premiums for such coverage are very expensive,
especially for chemical facilities, and the policies are subject
to very high deductibles. Available terrorism coverage typically
excludes coverage for losses from acts of foreign governments,
as well as from nuclear, biological and chemical attacks. We
have determined that it is not economically prudent to obtain
terrorism insurance, especially given the significant risks that
are not covered by such insurance, and we do not carry terrorism
insurance on our property at this time. In the event of a
terrorist attack impacting one or more of our facilities, we
could lose the net sales from the facilities, and the facilities
themselves, and could become liable for contamination or
personal or property damage from exposure to hazardous materials
caused by a terrorist attack.
|
|
|
New regulations concerning the transportation of hazardous
chemicals and the security of chemical manufacturing facilities
could result in higher operating costs. |
Targets such as chemical manufacturing facilities may be at
greater risk of future terrorist attacks than other targets in
the United States. As a result, the chemical industry has
responded to the issues surrounding the terrorist attacks of
September 11, 2001 by starting new initiatives relating to
the security of chemicals industry facilities and the
transportation of hazardous chemicals in the United States.
Simultaneously, local, state and federal governments have begun
a regulatory process that could lead to new regulations
impacting the security of chemical plant locations and the
transportation of hazardous chemicals. Our business or our
customers businesses could be adversely affected because
of the cost of complying with new regulations.
|
|
|
We are subject to many environmental and safety
regulations that may result in significant unanticipated costs
or liabilities or cause interruptions in our operations. |
Our operations involve the handling, production, transportation,
treatment and disposal of materials that are classified as
hazardous or toxic and that are extensively regulated by
environmental and health and safety laws, regulations and permit
requirements. We may incur substantial costs, including fines,
damages and criminal or civil sanctions, or experience
interruptions in our operations for actual or alleged violations
or compliance requirements arising under environmental laws, any
of which could have a material adverse effect on our business,
financial condition, results of operations or cash flows. Our
operations could result in violations of environmental laws,
including spills or other releases of hazardous substances to
the environment. In the event of a catastrophic incident, we
could incur material costs. Furthermore, we may be liable for
the costs of investigating and cleaning up environmental
contamination on or from our properties or at off-site locations
where we disposed of or arranged for the disposal or treatment
of hazardous materials or from disposal activities that
pre-dated the purchase of our businesses. Based on available
information, we believe that the costs to investigate and
remediate known contamination will not have a material adverse
effect on our business, financial condition, results of
operations or cash flows. However, if significant previously
unknown contamination is discovered, or if existing laws or
their enforcement change, then the resulting expenditures could
have a material adverse effect on our business, financial
condition, results of operations or cash flows.
Environmental, health and safety laws, regulations and permit
requirements, and the potential for further expanded laws,
regulations and permit requirements may increase our costs or
reduce demand for
39
our products and thereby negatively affect our business.
Environmental permits required for our operations are subject to
periodic renewal and can be revoked or modified for cause or
when new or revised environmental requirements are implemented.
Changing and increasingly strict environmental requirements and
the potential for further expanded regulation may increase our
costs and can affect the manufacturing, handling, processing,
distribution and use of our products. If so affected, our
business and operations may be materially and adversely
affected. In addition, changes in these requirements may cause
us to incur substantial costs in upgrading or redesigning our
facilities and processes, including our waste treatment,
storage, disposal and other waste handling practices and
equipment. For these reasons, we may need to make capital
expenditures beyond those currently anticipated to comply with
existing or future environmental or safety laws. The Texas
Commission for Environmental Quality (TCEQ) has
enacted regulations requiring significant reductions of nitrogen
oxide, which apply to our Texas City facility. The TCEQ also
proposed similar regulations requiring the reduction of
particulate matter, which apply to our Texas City facility.
Under these regulations, we are required to reduce emissions of
nitrogen oxide at our Texas City facility by up to 80% by the
end of 2007. During 2004, we incurred approximately
$6 million of capital costs in order to comply with these
regulations, and we expect to incur an additional
$16 million to $18 million in capital improvements for
this purpose over the next three years. The nitrogen oxide
regulations covering the Houston/ Galveston Area State
Implementation Plan have not yet been approved by the
Environmental Protection Agency (EPA). At the
conclusion of its review of these regulations, the EPA may
require further control measures, including possibly increasing
the total amount of reductions of nitrogen oxide emissions
required from 80% to 90% which would increase the amount of
capital required to achieve compliance with these regulations.
|
|
|
Current and future legal proceedings may have unfavorable
outcomes. |
We are currently a party to several legal proceedings and
additional legal proceedings could be filed against us in the
future. The ultimate resolution of current or future proceedings
may have a material adverse effect on us.
|
|
|
Future problems with labor relations may negatively affect
our business. |
As of December 31, 2004, we had 336 employees, 40% of whom
are covered by a collective bargaining agreement with the Texas
City, Texas Metal Trades Council, AFL-CIO, of Galveston County,
Texas (the Union), which covers all of our hourly
employees at our Texas City facility. Our current collective
bargaining agreement with the Union expires on May 1, 2007.
Although we believe our relationship with our hourly employees
is generally good, we did lock out our employees for
16 weeks in 2002, and our hourly employees engaged in a
strike for one week in 2004, in both cases in connection with
efforts to reach a new collective bargaining agreement. A strike
in the future by the Union representing our hourly employees
could have a material adverse effect on our financial condition,
results of operations or cash flows.
|
|
|
Transactions consummated pursuant to our plan of
reorganization could result in the imposition of material tax
liabilities. |
Prior to our emergence from bankruptcy, we eliminated our
holding company structure by merging Holdings with and into
Predecessor Sterling. We believe that this merger qualifies as a
tax-free reorganization pursuant to Section 368(a)(1)(G) of
the Internal Revenue Code (commonly referred to as a G
Reorganization) for United States federal income tax
purposes. However, if the Internal Revenue Service determines
that the merger does not so qualify, we could incur additional
federal income taxes of a material amount, either as a result of
the merger or the consummation of the plan of reorganization. If
the Internal Revenue Service successfully challenged our
position, the additional tax liability would have a material
adverse effect on our business, cash flows and financial
condition. The Internal Revenue Service may not agree with our
position and may challenge it.
40
|
|
|
Our securities are thinly traded and control of our equity
is concentrated in a few holders. |
Our preferred stock and warrants are not registered under the
Exchange Act and our common stock is not listed on any national
or regional securities exchange. Quotations for shares of our
common stock are listed by certain members of the National
Association of Securities Dealers, Inc. on the OTC Electronic
Bulletin Board. However, our common stock has been traded
infrequently, in transactions arranged through brokers or
otherwise, and reliable market quotations for shares of our
common stock may or may not be available. As a result, we cannot
give any assurances that an active trading market will exist for
any of our equity securities, and a holder of any of these
securities may find it difficult to dispose of, or to obtain
accurate quotations as to the market value of, such securities.
Ownership of our equity is significantly concentrated.
Resurgence Asset Management, L.L.C. and its affiliates
managed funds and accounts own in excess of 98% of our preferred
stock and over 63% of our common stock, representing ownership
of over 80% of the total voting power of our equity. Each share
of our preferred stock is convertible at the option of the
holder thereof at any time into 1,000 shares of our common
stock, subject to adjustments. The holders of our preferred
stock are entitled to designate a number of our Directors
roughly proportionate to their overall equity ownership, but in
any event not less than a majority of our Directors as long as
they hold in the aggregate at least 35% of the total voting
power of our equity. As a result, these holders have the ability
to control our management, policies and financing decisions,
elect a majority of our Board and control the vote on most
matters presented to a vote of our stockholders. In addition,
our shares of preferred stock carry a cumulative dividend rate
of 4% per quarter, payable in additional shares of
preferred stock. Consequently, each dividend paid in additional
shares of our preferred stock has a dilutive effect on our
shares of common stock and increases the percentage of the total
voting power of our equity owned by Resurgence Asset Management,
L.L.C. and its affiliates managed funds and accounts. In
2004, we issued an additional 417.921 shares of our
preferred stock (convertible into 417.921 shares of our
common stock) in dividends, which represents approximately 7.3%
of the current total voting power of our equity securities. The
concentration of ownership of our equity may depress the market
value of our equity securities and the dilutive effect of
dividends on our shares of preferred stock may further depress
the market value of our shares of common stock.
Our Secured Notes are not registered under the Exchange Act and
are not listed on any national or regional securities exchange.
Our Secured Notes are traded infrequently, in transactions
arranged through brokers or otherwise, and reliable market
quotations for our Secured Notes may or may not be available. A
debt security with a small outstanding principal amount
available for trading (commonly referred to as a small
float), such as our Secured Notes, may command a
lower price than would a comparable debt security with a greater
float. We cannot give any assurances that an active trading
market in our Secured Notes will exist or as to the prices at
which our Secured Notes may trade.
41
|
|
Item 7A. |
Quantitative and Qualitative Disclosures about Market
Risk |
The table below provides information about our market sensitive
financial instruments and constitutes a forward-looking
statement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, | |
Expected Maturity Dates |
|
2005 |
|
2006 |
|
2007 | |
|
2008 |
|
2009 |
|
Thereafter |
|
Total | |
|
2004 | |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
| |
|
|
(Dollars in Thousands) | |
DEBT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revolver
|
|
$ |
|
|
|
$ |
|
|
|
$ |
17,684 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
17,684 |
|
|
$ |
17,684 |
|
Secured Notes
|
|
|
|
|
|
|
|
|
|
|
100,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,579 |
|
|
|
99,699 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals
|
|
$ |
|
|
|
$ |
|
|
|
$ |
118,263 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
118,263 |
|
|
$ |
117,383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings under the Revolver bear interest, at our option, at
an annual rate of either the Alternate Base Rate plus 0.75% or
the LIBO Rate (as defined in the Revolver) plus
2.75%. The Alternate Base Rate is equal to the
greater of the Base Rate as announced from time to
time by JPMorgan Chase Bank in New York, New York or
0.50% per annum above the latest Federal Funds
Rate (as defined in the Revolver). The average borrowing
rate under the Revolver for 2004 was 5.8%. A 1% change in the
borrowing rate under the Revolver would result in an approximate
$0.2 million charge in our annual interest expense. Our
Secured Notes bear interest at an annual rate of 10%, payable
semi-annually on June 15 and December 15 of each year. The fair
value of our Revolver is the same as its carrying value due to
the short-term nature of this financial instrument. The fair
value of our Secured Notes is based on their quoted price.
42
|
|
Item 8. |
Financial Statements and Supplementary Data |
INDEX TO FINANCIAL STATEMENTS
Sterling Chemicals, Inc.
|
|
|
|
|
Consolidated Statements of Operations for the year ended
December 31, 2004, the year ended December 31, 2003,
the three months ended December 31, 2002 and the fiscal
year ended September 30, 2002
|
|
|
44 |
|
Consolidated Balance Sheets as of December 31, 2004 and 2003
|
|
|
45 |
|
Consolidated Statements of Changes in Stockholders Equity
(Deficiency in Assets) for the year ended December 31,
2004, the year ended December 31, 2003, the three months
ended December 31, 2002 and the fiscal year ended
September 30, 2002
|
|
|
46 |
|
Consolidated Statements of Cash Flows for the year ended
December 31, 2004, the year ended December 31, 2003,
the three months ended December 31, 2002 and the fiscal
year ended September 30, 2002
|
|
|
47 |
|
Notes to Consolidated Financial Statements
|
|
|
48 |
|
Report of Independent Registered Public Accounting Firm
|
|
|
76 |
|
43
STERLING CHEMICALS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
Predecessor Sterling | |
|
|
| |
|
| |
|
|
|
|
|
|
Fiscal Year | |
|
|
Year Ended | |
|
Year Ended | |
|
December 20 to | |
|
October 1 to | |
|
Ended | |
|
|
December 31, | |
|
December 31, | |
|
December 31, | |
|
December 19, | |
|
September 30, | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands, Except Share Data) | |
Revenues
|
|
$ |
851,662 |
|
|
$ |
592,791 |
|
|
$ |
12,572 |
|
|
$ |
99,888 |
|
|
$ |
381,801 |
|
Cost of goods sold
|
|
|
849,094 |
|
|
|
589,740 |
|
|
|
12,601 |
|
|
|
99,588 |
|
|
|
354,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit (loss)
|
|
|
2,568 |
|
|
|
3,051 |
|
|
|
(29 |
) |
|
|
300 |
|
|
|
27,646 |
|
Selling, general and administrative expenses
|
|
|
14,673 |
|
|
|
15,881 |
|
|
|
1,988 |
|
|
|
3,072 |
|
|
|
14,975 |
|
Impairment of long-lived assets
|
|
|
70,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on pension curtailment
|
|
|
(12,944 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on sale of methanol plant
|
|
|
(2,396 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense (income)
|
|
|
|
|
|
|
(3,520 |
) |
|
|
|
|
|
|
368 |
|
|
|
(1,925 |
) |
Equity (income) loss from joint venture
|
|
|
(3,046 |
) |
|
|
2,068 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganization items
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,214 |
|
|
|
17,022 |
|
Fresh-start adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
203,344 |
|
|
|
|
|
Gain on debt restructuring
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(457,824 |
) |
|
|
|
|
Interest and debt related expenses, net of interest
income(1)
|
|
|
10,427 |
|
|
|
9,729 |
|
|
|
355 |
|
|
|
12,144 |
|
|
|
50,065 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income tax
|
|
|
(74,644 |
) |
|
|
(21,107 |
) |
|
|
(2,372 |
) |
|
|
223,982 |
|
|
|
(52,491 |
) |
Provision (benefit) for income taxes
|
|
|
(12,000 |
) |
|
|
(7,884 |
) |
|
|
(828 |
) |
|
|
8 |
|
|
|
125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(62,644 |
) |
|
|
(13,223 |
) |
|
|
(1,544 |
) |
|
|
223,974 |
|
|
|
(52,616 |
) |
Income (loss) from discontinued
operations(2)
|
|
|
|
|
|
|
(976 |
) |
|
|
|
|
|
|
194,637 |
|
|
|
16,630 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
(62,644 |
) |
|
|
(14,199 |
) |
|
|
(1,544 |
) |
|
|
418,611 |
|
|
|
(35,986 |
) |
Preferred stock dividends
|
|
|
5,994 |
|
|
|
5,125 |
|
|
|
170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to common stockholders
|
|
$ |
(68,638 |
) |
|
$ |
(19,324 |
) |
|
$ |
(1,714 |
) |
|
$ |
418,611 |
|
|
$ |
(35,986 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share of common stock, basic and diluted
|
|
$ |
(24.30 |
) |
|
$ |
(6.84 |
) |
|
$ |
(0.61 |
) |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted
|
|
|
2,825,000 |
|
|
|
2,825,000 |
|
|
|
2,825,000 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
Contractual interest for the October 1 to December 19,
2002 period and the fiscal year ended September 30, 2002
totaled $18,003 and $76,429, respectively. |
|
(2) |
Includes a net gain on disposal of $188,891 for the period
October 1, 2002 to December 19, 2002. The tax expense
associated with discontinued operations for the listed periods
presented is zero, zero, zero, $342 and $14,743, respectively. |
The accompanying notes are an integral part of the consolidated
financial statements.
44
STERLING CHEMICALS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
|
| |
|
|
December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(Dollars in Thousands) | |
ASSETS |
Current assets:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
1,901 |
|
|
$ |
42,384 |
|
|
Accounts receivable, net of allowance of $3,092 and $6,860,
respectively
|
|
|
113,074 |
|
|
|
87,565 |
|
|
Inventories, net
|
|
|
87,980 |
|
|
|
61,583 |
|
|
Prepaid expenses and other current assets
|
|
|
4,198 |
|
|
|
6,430 |
|
|
Deferred tax asset
|
|
|
4,108 |
|
|
|
9,081 |
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
211,261 |
|
|
|
207,043 |
|
Property, plant and equipment, net
|
|
|
248,598 |
|
|
|
277,613 |
|
Goodwill
|
|
|
|
|
|
|
48,463 |
|
Other assets, net
|
|
|
13,694 |
|
|
|
17,384 |
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
473,553 |
|
|
$ |
550,503 |
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
Current liabilities:
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
67,260 |
|
|
$ |
64,833 |
|
|
Accrued liabilities
|
|
|
23,787 |
|
|
|
24,045 |
|
|
Current portion of long-term debt
|
|
|
17,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
108,731 |
|
|
|
88,878 |
|
Long-term debt
|
|
|
100,579 |
|
|
|
100,579 |
|
Deferred income tax liability
|
|
|
28,407 |
|
|
|
49,909 |
|
Deferred credits and other liabilities
|
|
|
74,464 |
|
|
|
86,407 |
|
Redeemable preferred stock
|
|
|
41,289 |
|
|
|
35,294 |
|
Commitments and contingencies (Note 9)
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
|
Common stock, $.01 par value
|
|
|
28 |
|
|
|
28 |
|
|
Additional paid-in capital
|
|
|
199,408 |
|
|
|
205,402 |
|
|
Accumulated deficit
|
|
|
(78,387 |
) |
|
|
(15,743 |
) |
|
Accumulated other comprehensive loss
|
|
|
(966 |
) |
|
|
(251 |
) |
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
120,083 |
|
|
|
189,436 |
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$ |
473,553 |
|
|
$ |
550,503 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
45
STERLING CHEMICALS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF
CHANGES IN STOCKHOLDERS EQUITY (DEFICIENCY IN
ASSETS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated | |
|
|
|
|
|
|
Common Stock | |
|
Additional | |
|
|
|
Other | |
|
|
|
|
|
|
| |
|
Paid-In | |
|
Accumulated | |
|
Comprehensive | |
|
Deferred | |
|
|
|
|
Shares | |
|
Amount | |
|
Capital | |
|
Deficit | |
|
Loss | |
|
Compensation | |
|
Total | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Amounts in Thousands) | |
Predecessor Sterling:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2001
|
|
|
1 |
|
|
$ |
|
|
|
$ |
(141,786 |
) |
|
$ |
(383,740 |
) |
|
$ |
(38,053 |
) |
|
$ |
(3 |
) |
|
$ |
(563,582 |
) |
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35,986 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Translation adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(516 |
) |
|
|
|
|
|
|
|
|
|
Pension adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,685 |
) |
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(48,187 |
) |
Revaluation of ESOP shares to independently appraised market
value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
289 |
|
|
|
|
|
|
|
|
|
|
|
289 |
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2002
|
|
|
1 |
|
|
|
|
|
|
|
(141,786 |
) |
|
|
(419,437 |
) |
|
|
(50,254 |
) |
|
|
|
|
|
|
(611,477 |
) |
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
418,611 |
|
|
|
|
|
|
|
|
|
|
|
418,611 |
|
Fresh-start adjustments
|
|
|
2,824 |
|
|
|
28 |
|
|
|
352,483 |
|
|
|
826 |
|
|
|
50,254 |
|
|
|
|
|
|
|
403,591 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 19, 2002
|
|
|
2,825 |
|
|
|
28 |
|
|
|
210,697 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
210,725 |
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,544 |
) |
|
|
|
|
|
|
|
|
|
|
(1,544 |
) |
Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
(170 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(170 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2002
|
|
|
2,825 |
|
|
|
28 |
|
|
|
210,527 |
|
|
|
(1,544 |
) |
|
|
|
|
|
|
|
|
|
|
209,011 |
|
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14,199 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(251 |
) |
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14,450 |
) |
Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
(5,125 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,125 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2003
|
|
|
2,825 |
|
|
$ |
28 |
|
|
$ |
205,402 |
|
|
$ |
(15,743 |
) |
|
$ |
(251 |
) |
|
$ |
|
|
|
$ |
189,436 |
|
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(62,644 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(715 |
) |
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(63,359 |
) |
Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
(5,994 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,994 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2004
|
|
|
2,825 |
|
|
$ |
28 |
|
|
$ |
199,408 |
|
|
$ |
(78,387 |
) |
|
$ |
(966 |
) |
|
$ |
|
|
|
$ |
120,083 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
46
STERLING CHEMICALS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Sterling | |
|
|
Reorganized Sterling | |
|
| |
|
|
| |
|
|
|
Fiscal Year | |
|
|
Year Ended | |
|
Year Ended | |
|
December 20 to | |
|
October 1 to | |
|
Ended | |
|
|
December 31, | |
|
December 31, | |
|
December 31, | |
|
December 19, | |
|
September 30, | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) from continuing operations
|
|
$ |
(62,644 |
) |
|
$ |
(13,223 |
) |
|
$ |
(1,544 |
) |
|
$ |
223,974 |
|
|
$ |
(52,616 |
) |
Adjustments to reconcile net income (loss) to net cash provided
by (used in) operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
28,693 |
|
|
|
27,656 |
|
|
|
858 |
|
|
|
4,857 |
|
|
|
22,912 |
|
|
Interest amortization
|
|
|
398 |
|
|
|
383 |
|
|
|
12 |
|
|
|
887 |
|
|
|
4,805 |
|
|
Impairment of long-lived assets
|
|
|
70,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on pension curtailment
|
|
|
(12,944 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lower-of-cost-or-market adjustment
|
|
|
16,407 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on sale of methanol plant
|
|
|
(2,396 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fresh-start adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
203,344 |
|
|
|
|
|
|
Gain on cancellation of debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(457,824 |
) |
|
|
|
|
|
Deferred tax benefit
|
|
|
(16,529 |
) |
|
|
(7,986 |
) |
|
|
(854 |
) |
|
|
|
|
|
|
|
|
|
Other
|
|
|
1 |
|
|
|
(252 |
) |
|
|
|
|
|
|
(594 |
) |
|
|
9,432 |
|
Change in assets/liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(25,509 |
) |
|
|
(45,750 |
) |
|
|
12,075 |
|
|
|
18,382 |
|
|
|
(11,552 |
) |
|
Inventories
|
|
|
(42,804 |
) |
|
|
(30,572 |
) |
|
|
(3,940 |
) |
|
|
5,856 |
|
|
|
(5,937 |
) |
|
Prepaid expenses
|
|
|
2,232 |
|
|
|
(1,869 |
) |
|
|
789 |
|
|
|
(1,592 |
) |
|
|
(1,093 |
) |
|
Other assets
|
|
|
(3,650 |
) |
|
|
2,127 |
|
|
|
11 |
|
|
|
(208 |
) |
|
|
(6,228 |
) |
|
Accounts payable
|
|
|
2,427 |
|
|
|
31,688 |
|
|
|
2,298 |
|
|
|
(1,299 |
) |
|
|
18,197 |
|
|
Accrued liabilities
|
|
|
(1,879 |
) |
|
|
3,714 |
|
|
|
2,268 |
|
|
|
(7,100 |
) |
|
|
3,472 |
|
|
Other liabilities
|
|
|
286 |
|
|
|
(6,725 |
) |
|
|
(1,866 |
) |
|
|
4,447 |
|
|
|
18,761 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
(47,413 |
) |
|
|
(40,809 |
) |
|
|
10,107 |
|
|
|
(6,870 |
) |
|
|
153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(14,771 |
) |
|
|
(15,649 |
) |
|
|
(116 |
) |
|
|
(837 |
) |
|
|
(6,700 |
) |
|
Net proceeds from the sale of methanol fixed assets
|
|
|
4,017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from the sale of the pulp chemicals business
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
357,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities
|
|
|
(10,754 |
) |
|
|
(15,649 |
) |
|
|
(116 |
) |
|
|
356,804 |
|
|
|
(6,700 |
) |
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net borrowings under the Revolver
|
|
|
17,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Secured Notes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
94,275 |
|
|
|
|
|
|
Proceeds from issuance of new common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000 |
|
|
|
|
|
|
Proceeds from issuance of new preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000 |
|
|
|
|
|
|
Net borrowings under DIP Facility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(42,200 |
) |
|
|
14,972 |
|
|
Repayment of the
133/8% Notes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(371,916 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
17,684 |
|
|
|
|
|
|
|
|
|
|
|
(259,841 |
) |
|
|
14,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash from continuing operations
|
|
|
(40,483 |
) |
|
|
(56,458 |
) |
|
|
9,991 |
|
|
|
90,093 |
|
|
|
8,425 |
|
Net increase (decrease) in cash from discontinued operations
|
|
|
|
|
|
|
(976 |
) |
|
|
|
|
|
|
(10,109 |
) |
|
|
196 |
|
Cash and cash equivalents beginning of period
|
|
|
42,384 |
|
|
|
99,818 |
|
|
|
89,827 |
|
|
|
9,843 |
|
|
|
1,222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents end of year
|
|
$ |
1,901 |
|
|
$ |
42,384 |
|
|
$ |
99,818 |
|
|
$ |
89,827 |
|
|
$ |
9,843 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplement disclosures of cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid, net of interest income received
|
|
$ |
(10,957 |
) |
|
$ |
(3,575 |
) |
|
$ |
|
|
|
$ |
(934 |
) |
|
$ |
(5,200 |
) |
|
Cash paid for reorganization items
|
|
|
|
|
|
|
(13,115 |
) |
|
|
(1,140 |
) |
|
|
(931 |
) |
|
|
(11,729 |
) |
|
Cash paid for income taxes
|
|
|
(50 |
) |
|
|
(175 |
) |
|
|
|
|
|
|
(64 |
) |
|
|
(110 |
) |
The accompanying notes are an integral part of the consolidated
financial statements.
47
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
1. |
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES |
Unless otherwise indicated, references to we,
us, our and ours refer
collectively to Sterling Chemicals, Inc. and its wholly-owned
subsidiaries. We own or operate facilities at our petrochemicals
complex located in Texas City, Texas, approximately
45 miles south of Houston, on a 290-acre site on Galveston
Bay near many other chemical manufacturing complexes and
refineries. Currently, there are facilities to produce six
petrochemical products at the Texas City site; styrene, acetic
acid, acrylonitrile, plasticizers, sodium cyanide and disodium
iminodiacetic acid (DSIDA). We own all of the real
property which comprises our Texas City facility and we own the
styrene, acrylonitrile, acetic acid and plasticizers
manufacturing units located at the site. An idled methanol unit
located at the Texas City site was recently sold and is expected
to be dismantled and removed from the site by March 1,
2006. E.I. du Pont de Nemours and Company
(DuPont) and Monsanto Company (Monsanto)
built the sodium cyanide and DSIDA units, respectively, on land
leased from us at our Texas City facility. DuPont owns the
sodium cyanide unit, which we operate on behalf of DuPont.
Monsanto owns the DSIDA unit. Monsanto has contractually
committed to start up the DSIDA unit by mid-2007 and has the
option of restarting the unit prior to that time. After
start-up, we will operate the DSIDA unit on behalf of Monsanto
under a long-term contract that will extend for at least
15 years. The sodium cyanide and DSIDA units use hydrogen
cyanide created as a by-product from our acrylonitrile
operations to make other products. Our Texas City site offers
approximately 135 acres for future expansion by us or by
other companies that can benefit from our existing
infrastructure and facilities, and includes a greenbelt around
the northern edge of the plant site. We have also leased
portions of the site to Praxair Hydrogen Supply, Inc.
(Praxair) and S&L Cogeneration Company, a 50/50
joint venture between us and Praxair Energy Resources, Inc.,
which constructed a partial oxidation unit and a cogeneration
facility, respectively, on that land. We generally sell our
petrochemicals products to customers for use in the manufacture
of other chemicals and products, which in turn are used in the
production of a wide array of consumer goods and industrial
products.
In December 2002, we changed our fiscal year-end from
September 30 to December 31. In these consolidated
financial statements:
|
|
|
|
|
2004 and fiscal 2004 refer to the
12-month period ended December 31, 2004; |
|
|
|
2003 and fiscal 2003 refer to the
12-month period ended December 31, 2003; |
|
|
|
fiscal 2002 refers to the 12-month period ended
September 30, 2002; and |
|
|
|
the Transition Period refers to the three-month
period from October 1, 2002 through December 31, 2002. |
|
|
|
Bankruptcy Reorganization |
On July 16, 2001, Sterling Chemicals Holdings, Inc.
(Holdings), and most of its U.S. subsidiaries,
including us (collectively, the Debtors), filed
voluntary petitions for reorganization under Chapter 11 of
the United States Bankruptcy Code in the U.S. Bankruptcy
Court for the Southern District of Texas. The Debtors plan
of reorganization (our Plan of Reorganization) was
confirmed on November 20, 2002 and, on December 19,
2002 (the Effective Date), the Debtors emerged from
bankruptcy pursuant to the terms of our Plan of Reorganization.
Due to the Debtors emergence from bankruptcy and the
implementation of fresh-start accounting, we refer to ourselves
as Predecessor Sterling for periods on or before
December 19, 2002 and Reorganized Sterling for
periods after December 19, 2002.
The financial results for fiscal 2002 were affected by our
filing for reorganization under Chapter 11 of the
U.S. Bankruptcy Code. Our post-emergence consolidated
financial statements reflect results after the
48
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
consummation of our Plan of Reorganization and the application
of the principles of fresh-start accounting in accordance with
the provisions of Statement of Position 90-7,
Financial Reporting by Entities in Reorganization under
the Bankruptcy Code (SOP 90-7). See
Note 3 to the consolidated financial statements.
Predecessor Sterling and Reorganized Sterling, after adopting
fresh-start accounting, are different reporting entities and the
consolidated financial statements are not comparable.
Pursuant to our Plan of Reorganization, on the Effective Date
the Debtors pulp chemicals business was sold to Superior
Propane, Inc. for approximately $373 million, and the
Debtors acrylic fibers business was sold to local
management of that business for nominal consideration. In
accordance with Statement of Financial Accounting Standards
(SFAS) No. 144, Accounting for the
Impairment and Disposal of Long Lived Assets, we have
reported activity pertaining to the Debtors prior pulp
chemicals and acrylic fibers businesses as discontinued
operations in the condensed consolidated statements of
operations.
|
|
|
Principles of Consolidation |
The consolidated financial statements include the accounts of
all of our wholly-owned and majority-owned subsidiaries, with
all significant intercompany accounts and transactions having
been eliminated. Our 50% equity investment in a cogeneration
joint venture is not material to our financial position or
results of operations. Our 50% equity investment in an
acrylonitrile marketing joint venture is accounted for under the
equity method, with our share of the operating results of the
joint venture recorded as equity (income) loss from joint
venture in the consolidated statements of operations.
|
|
|
Cash and Cash Equivalents |
We consider all investments having an initial maturity of three
months or less to be cash equivalents.
|
|
|
Allowance for Doubtful Accounts |
Accounts receivable is presented net of allowance for doubtful
accounts. We regularly review our accounts receivable balances
and, based on estimated collectibility, adjust the allowance
account accordingly. As of December 31, 2004 and 2003, the
allowance for doubtful accounts was $3.0 million and
$6.9 million, respectively. Bad debt expense for 2004,
2003, the three-months ending December 31, 2002 and fiscal
year 2002 was $0.5 million, $0.6 million,
$0.2 million and $0.3 million, respectively. The
decrease of $3.8 million in the allowance for doubtful
accounts in 2004 primarily related to the settlement of a
contract dispute with Flexsys America L.P.
(Flexsys). In fiscal 2001, we reserved
$4.3 million against the $5.0 million in receivables
owed to us by Flexsys at that time. In late 2004, we agreed to a
settlement with Flexsys and subsequently wrote-off the
$4.3 million reserve in the allowance for doubtful
accounts, along with the associated accounts receivable balance.
The net result of this settlement was a gain of
$0.6 million reflected in revenues.
Inventories are stated at the lower-of-cost-or-market. As of
December 31, 2004, a lower-of-cost-or-market adjustment of
approximately $16 million was recorded. Cost is primarily
determined on the first-in, first-out basis, except for stores
and supplies, which are valued at average cost.
We enter into agreements with other companies to exchange
chemical inventories in order to minimize working capital
requirements and to facilitate distribution logistics. Balances
related to quantities due to or payable by us are included in
inventory.
49
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
|
|
|
Property, Plant and Equipment |
Property, plant and equipment are recorded at cost. Major
renewals and improvements, which extend the useful lives of
equipment, are capitalized. Disposals are removed at carrying
cost less accumulated depreciation with any resulting gain or
loss reflected in operations. Depreciation is provided using the
straight-line method over estimated useful lives ranging from
five to 25 years, with the predominant life of plant and
equipment being 15 years. We capitalize interest costs,
which are incurred as part of the cost of constructing major
facilities and equipment. The amount of interest capitalized for
2004, 2003 and fiscal 2002 was $0.9 million,
$0.6 million and $0.3 million, respectively.
As a part of normal recurring operations, each of our
manufacturing units is completely shut down from time to time,
for a period typically lasting two to four weeks, to replace
catalysts and perform major maintenance work required to sustain
long-term production. These periods are commonly referred to as
turnarounds or shutdowns. While actual
timing is subject to a number of variables, turnarounds of our
styrene unit typically occur every two to three years and
turnarounds of our acrylonitrile unit typically occur every 18
to 21 months. Costs of turnarounds are expensed are
incurred. Prior to the application of fresh-start accounting,
such costs were accrued in advance over the expected period
between turnarounds. As expenses for turnarounds, especially for
our styrene and acrylonitrile units, can be significant, the
impact of expensing the costs of turnarounds can be material for
financial reporting periods during which the turnarounds
actually occur.
We assess our long-lived assets other than goodwill for
impairment whenever facts and circumstances indicate that the
carrying amount may not be fully recoverable. To analyze
recoverability, we project undiscounted net future cash flows
over the remaining life of these assets. If these projected cash
flows from these assets are less than the carrying amount of
these assets, an impairment would be recognized. Any impairment
loss would be measured based upon the difference between the
carrying amount and the fair value of the relevant assets. For
these impairment analyses, recoverability is determined by
comparing the estimated fair value of these assets, utilizing
the present value of expected net cash flows, to the carrying
value of these assets. In determining the present value of
expected net cash flows, we estimate future net cash flows from
these assets and the timing of those cash flows and then apply a
discount rate to reflect the time value of money and the
inherent uncertainty of those future cash flows. The discount
rate we use is based on independently calculated risks for a
composite group of commodity chemical companies, our target
capital mix and an estimated market risk premium. The
assumptions we use in estimating future cash flows are
consistent with our internal planning. During 2004, we recorded
an impairment charge of $22 million relating to our
long-lived acrylonitrile assets.
We assess goodwill for impairment on an annual basis, or sooner
if events indicate such a review is necessary. Recoverability is
determined by comparing the estimated fair value of these
assets, utilizing the present value of expected net cash flows,
to the carrying value of these assets. In determining the
present value of expected net cash flows, we estimate our future
net cash flows from these assets and the timing of those cash
flows and then apply a discount rate to reflect the time value
of money and the inherent uncertainty of those future cash
flows. The discount rate we use, is based on independently
calculated risks for a composite group of commodity chemical
companies, our target capital mix and an estimated market risk
premium. The assumptions we use in estimating future cash flows
are consistent with our internal planning. During 2004, we
recorded an impairment charge of $48 million relating to
goodwill.
50
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Debt issue costs relating to long-term debt are amortized over
the term of the related debt instrument using the straight-line
method, which is materially consistent with the effective
interest method, and are included in other assets. Debt issue
cost amortization, which is included in interest and
debt-related expenses, was $0.4 million, $0.3 million
and $4.8 million, respectively for 2004, 2003 and fiscal
2002.
Deferred income taxes are provided for revenue and expenses
which are recognized in different periods for income tax and
financial statement purposes. Deferred tax assets are regularly
assessed for recoverability based on both historical and
anticipated earnings levels, and a valuation allowance is
recorded when it is more likely than not that these amounts will
not be recovered.
Environmental costs are expensed as incurred unless the
expenditures extend the economic useful life of the relevant
assets. Costs that extend the economic life of assets are
capitalized and depreciated over the remaining life of those
assets. Liabilities are recorded when environmental assessments
or remedial efforts are probable and the cost can be reasonably
estimated.
We generate revenues through sales in the open market, raw
material conversion agreements and long-term supply contracts.
In addition, we have entered into profit sharing arrangements
with respect to some of our petrochemicals products. We
recognize revenue from sales in the open market, raw material
conversion agreements and long-term supply contracts when the
products are shipped. Revenues from profit sharing arrangements
are estimated and accrued monthly. Deferred credits are
amortized over the life of the contracts which gave rise to them.
|
|
|
Earnings (Loss) Per Share |
Basic earnings per share (EPS) is computed using the
weighted-average number of shares outstanding during the year.
Diluted EPS includes common stock equivalents, which are
dilutive to earnings per share. For the year ended
December 31, 2004, we had a $69 million net loss
attributable to common stockholders and recorded a
$24.30 net loss per share attributable to common
stockholders for both basic EPS and diluted EPS. For the periods
prior to December 20, 2002, all issued and outstanding
shares of Predecessor Sterlings capital stock were held by
Holdings and, accordingly, loss per share is not presented.
51
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
|
|
|
Accumulated Other Comprehensive Income (Loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative | |
|
|
|
|
|
|
Translation | |
|
|
|
|
|
|
Adjustment | |
|
Pension Adjustment | |
|
Total | |
|
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Predecessor Sterling:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2002
|
|
|
(35,171 |
) |
|
|
(15,083 |
) |
|
|
(50,254 |
) |
Fresh-start adjustments
|
|
|
35,171 |
|
|
|
15,083 |
|
|
|
50,254 |
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 19, 2002
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2002
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes
|
|
|
|
|
|
|
(251 |
) |
|
|
(251 |
) |
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2003
|
|
|
|
|
|
|
(251 |
) |
|
|
(251 |
) |
Changes
|
|
|
|
|
|
|
(715 |
) |
|
|
(715 |
) |
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2004
|
|
$ |
|
|
|
$ |
(966 |
) |
|
$ |
(966 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosures about Fair Value of Financial
Instruments |
In preparing disclosures about the fair value of financial
instruments, we have assumed that the carrying amount
approximates fair value for cash and cash equivalents, accounts
receivable, accounts payable and certain accrued liabilities due
to the short maturities of these instruments. The fair values of
long-term debt instruments are estimated based upon quoted
market values (if applicable) or on the current interest rates
available to us for debt with similar terms and remaining
maturities.
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues
and expenses during the reported periods. Significant estimates
include impairment considerations, allowance for doubtful
accounts, inventory valuation, revenue recognition related to
profit sharing accruals, environmental and litigation reserves
and provision for income taxes.
Certain amounts reported in the consolidated financial
statements for the prior periods have been reclassified to
conform with the current consolidated financial statement
presentation with no effect on net loss or stockholders
equity (deficiency in assets).
|
|
2. |
STOCK-BASED COMPENSATION PLAN |
On December 19, 2002, we adopted our 2002 Stock Plan and
reserved 379,747 shares of our common stock for issuance
under our 2002 Stock Plan (subject to adjustment). Under our
2002 Stock Plan, officers and key employees, as designated by
our Board of Directors, may be issued stock options, stock
awards, stock appreciation rights or stock units. On
February 11, 2003, we granted options to purchase a total
of 326,000 shares of our common stock to certain of our
officers and key employees at an exercise price of
52
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
$31.60 per share and, on November 5, 2004, we granted
options to purchase a total of 27,500 shares of our common
stock to a member of our senior management team at an exercise
price of $31.60. Currently, there are options to purchase a
total of 294,334 shares of our common stock outstanding
under our 2002 Stock Plan, all at an exercise price of $31.60.
We account for our stock-based compensation arrangements using
the intrinsic value method in accordance with the provisions of
Accounting Principles Board Opinion No. 25,
Accounting for Stock Issued to Employees
(APB 25), and related interpretations. Under
APB 25, if the exercise price of employee stock options
equals or exceeds the market price of the underlying stock on
the date of grant, no compensation expense is recognized. All
stock options issued under our 2002 Stock Plan were granted with
exercise prices at estimated fair value at the time of grant.
Therefore, no compensation expense has been recognized under
APB 25.
The fair value of each grant is estimated on the date of grant
using the Black-Scholes option pricing model with the following
weighted-average assumptions:
|
|
|
|
|
|
|
|
|
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
Expected life (years)
|
|
|
10.0 |
|
|
|
10.0 |
|
Expected volatility
|
|
|
42.0 |
% |
|
|
42.0 |
% |
Expected dividend yield
|
|
|
|
|
|
|
|
|
Risk-free interest rate
|
|
|
3.85 |
% |
|
|
3.85 |
% |
Weighted-average fair value of options granted during the year
|
|
$ |
12.95 |
|
|
$ |
18.58 |
|
The following table illustrates the effect on our net loss and
loss per share attributable to common stockholders if
compensation costs for stock options issued under our 2002 Stock
Plan had been recorded pursuant to Statement of Financial
Accounting Standards (SFAS) No. 123,
Accounting for Stock-Based Compensation, for the
years ended December 31, 2004 and 2003. There were no
options outstanding under our 2002 Stock Plan prior to
February 11, 2003.
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
|
For the Year Ended | |
|
|
December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(Dollars in Thousands, | |
|
|
Except Share Data) | |
Net loss attributable to common stockholders, as reported
|
|
$ |
(68,638 |
) |
|
$ |
(19,324 |
) |
Add: Stock-based employee compensation expense included in
reported net loss, net of related tax effects
|
|
|
|
|
|
|
|
|
Deduct: Total stock-based employee compensation expense
determined under fair value based method for all awards, net of
related tax effects
|
|
|
1,147 |
|
|
|
1,944 |
|
|
|
|
|
|
|
|
Pro forma net loss
|
|
$ |
(69,785 |
) |
|
$ |
(21,268 |
) |
|
|
|
|
|
|
|
Loss per share attributable to common stockholders:
|
|
|
|
|
|
|
|
|
As reported
|
|
$ |
(24.30 |
) |
|
$ |
(6.84 |
) |
Pro forma
|
|
|
(24.70 |
) |
|
|
(7.53 |
) |
|
|
3. |
FRESH-START ACCOUNTING |
Upon our emergence from bankruptcy on December 19, 2002, we
implemented fresh-start accounting under the provisions of
SOP 90-7 and became a new reporting entity. Under
SOP 90-7, our reorganization value was allocated to our
assets and liabilities, our accumulated deficit was eliminated
and new preferred and common equity was issued pursuant to our
Plan of Reorganization. In connection with our Plan of
53
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Reorganization, our financial advisor, Greenhill & Co.,
LLC (Greenhill) prepared a valuation of our
business. In preparing its valuation, Greenhill considered a
number of factors, including valuations by other parties and the
application of various valuation methods, including discounted
cash flow analysis, comparable company analysis and precedent
transaction analysis. Based on Greenhills valuation, the
estimated reorganization value was allocated as follows (Dollars
in Thousands):
|
|
|
|
|
Long-term debt
|
|
$ |
94,275 |
|
Redeemable preferred stock
|
|
|
30,000 |
|
Stockholders equity
|
|
|
210,725 |
|
|
|
|
|
Total
|
|
$ |
335,000 |
|
|
|
|
|
In connection with the cancellation of certain debt of Holdings
and Predecessor Sterling pursuant to the Plan of Reorganization,
on December 19, 2002 we recorded a $457.8 million gain
related to the cancellation of that debt. Also in connection
with fresh-start accounting, we changed our method of accounting
for plant turnaround costs. We previously accrued the cost of
these turnarounds in advance, but we now expense all costs for
turnarounds as incurred. A one-time credit to reverse a
$5.2 million existing accrual for turnaround expenses was
recorded as part of our fresh-start accounting transactions. A
reconciliation of the adjustments recorded in connection with
our debt restructuring, the adoption of fresh-start accounting
and the accounting for discontinued operations at
December 19, 2002 is presented below:
54
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor | |
|
|
|
|
|
|
|
Reorganized | |
|
|
Sterling | |
|
|
|
|
|
|
|
Sterling | |
|
|
December 19, | |
|
Discontinued | |
|
Reorganization | |
|
Fresh-Start | |
|
December 19, | |
|
|
2002 | |
|
Operations | |
|
Adjustments | |
|
Adjustments | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
5,839 |
|
|
$ |
358,108 |
|
|
$ |
(274,120 |
) |
|
$ |
|
|
|
$ |
89,827 |
|
Accounts receivable, net
|
|
|
87,435 |
|
|
|
(35,771 |
) |
|
|
2,226 |
|
|
|
|
|
|
|
53,890 |
|
Inventories
|
|
|
44,832 |
|
|
|
(17,852 |
) |
|
|
91 |
|
|
|
|
|
|
|
27,071 |
|
Prepaid expenses
|
|
|
6,658 |
|
|
|
(1,388 |
) |
|
|
|
|
|
|
80 |
|
|
|
5,350 |
|
Deferred tax asset
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,134 |
|
|
|
11,134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
144,764 |
|
|
|
303,097 |
|
|
|
(271,803 |
) |
|
|
11,214 |
|
|
|
187,272 |
|
Property, plant and equipment, net
|
|
|
253,875 |
|
|
|
(139,940 |
) |
|
|
|
|
|
|
173,257 |
|
|
|
287,192 |
|
Goodwill
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48,463 |
|
|
|
48,463 |
|
Other assets
|
|
|
45,212 |
|
|
|
(6,039 |
) |
|
|
(3,027 |
) |
|
|
(13,059 |
) |
|
|
23,087 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
443,851 |
|
|
$ |
157,118 |
|
|
$ |
(274,830 |
) |
|
$ |
219,875 |
|
|
$ |
546,014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
45,976 |
|
|
$ |
(16,684 |
) |
|
$ |
343 |
|
|
$ |
1,212 |
|
|
$ |
30,847 |
|
Accrued liabilities
|
|
|
31,860 |
|
|
|
(7,240 |
) |
|
|
791 |
|
|
|
(1,044 |
) |
|
|
24,367 |
|
Current portion of long-term debt
|
|
|
52,327 |
|
|
|
(10,127 |
) |
|
|
(42,200 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
130,163 |
|
|
|
(34,051 |
) |
|
|
(41,066 |
) |
|
|
168 |
|
|
|
55,214 |
|
Pre-petition liabilities subject to compromise
|
|
|
512,760 |
|
|
|
(2,159 |
) |
|
|
(510,601 |
) |
|
|
|
|
|
|
|
|
Pre-petition liabilities not subject to compromise
|
|
|
372,326 |
|
|
|
|
|
|
|
(372,326 |
) |
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
|
|
|
|
|
|
|
|
94,275 |
|
|
|
|
|
|
|
94,275 |
|
Deferred tax liability
|
|
|
13,835 |
|
|
|
(13,835 |
) |
|
|
|
|
|
|
60,802 |
|
|
|
60,802 |
|
Deferred credits and other liabilities
|
|
|
39,189 |
|
|
|
(15,011 |
) |
|
|
45,970 |
|
|
|
24,850 |
|
|
|
94,998 |
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable preferred stock
|
|
|
|
|
|
|
|
|
|
|
30,000 |
|
|
|
|
|
|
|
30,000 |
|
Stockholders equity (deficiency in assets):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, $.01 par value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28 |
|
|
|
28 |
|
Additional paid-in capital
|
|
|
(141,786 |
) |
|
|
|
|
|
|
30,000 |
|
|
|
322,483 |
|
|
|
210,697 |
|
Retained earnings (accumulated deficit)
|
|
|
(434,465 |
) |
|
|
188,891 |
|
|
|
448,918 |
|
|
|
(203,344 |
) |
|
|
|
|
Accumulated other comprehensive income
|
|
|
(48,171 |
) |
|
|
33,283 |
|
|
|
|
|
|
|
14,888 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity (deficiency in assets)
|
|
|
(624,422 |
) |
|
|
222,174 |
|
|
|
478,918 |
|
|
|
134,055 |
|
|
|
210,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity (deficiency in
assets)
|
|
$ |
443,851 |
|
|
$ |
157,118 |
|
|
$ |
(274,830 |
) |
|
$ |
219,875 |
|
|
$ |
546,014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganization adjustments reflect the forgiveness of debt,
including related accrued interest and certain pre-petition
liabilities, in consideration for new debt and new common stock,
resulting in a gain from debt restructuring of
$457.8 million, partially offset by an expense of
$8.9 million for professional fees incurred in connection
with the reorganization. Fresh-start adjustments primarily
reflect the recording of property, plant and equipment at fair
market value, the recording of a net deferred tax liability
arising out of the difference between the book and tax basis of
certain assets and liabilities and the recognition of previously
unrecognized pension and other post-employment benefits
liabilities.
55
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
4. DISCONTINUED OPERATIONS
For the period from October 1, 2002 through
December 19, 2002 and for fiscal 2002, the amount of
revenue and net income (loss) (including gains or losses
recorded on the sales) attributable to the discontinued
operations were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Sterling | |
|
|
| |
|
|
October 1 to | |
|
Fiscal Year Ended | |
|
|
December 19, 2002 | |
|
September 30, 2002 | |
|
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Revenues:
|
|
|
|
|
|
|
|
|
|
Pulp chemicals business
|
|
$ |
50,282 |
|
|
$ |
227,962 |
|
|
Acrylic fibers business
|
|
|
4,075 |
|
|
|
18,964 |
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
54,357 |
|
|
$ |
246,926 |
|
|
|
|
|
|
|
|
Net income (loss):
|
|
|
|
|
|
|
|
|
|
Pulp chemicals business
|
|
$ |
201,404 |
|
|
$ |
25,652 |
|
|
Acrylic fibers business
|
|
|
(6,767 |
) |
|
|
(9,022 |
) |
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
194,637 |
|
|
$ |
(16,630 |
) |
|
|
|
|
|
|
|
56
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
5. DETAIL OF CERTAIN BALANCE
SHEET ACCOUNTS
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
|
December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Inventories:
|
|
|
|
|
|
|
|
|
|
Finished products
|
|
$ |
63,841 |
|
|
$ |
37,944 |
|
|
Raw materials
|
|
|
18,682 |
|
|
|
16,480 |
|
|
|
|
|
|
|
|
Inventories at cost
|
|
|
82,523 |
|
|
|
54,424 |
|
|
Inventories under exchange agreements
|
|
|
330 |
|
|
|
1,325 |
|
|
Stores and supplies (net of obsolescence reserve of $1,938 and
$1,370, respectively)
|
|
|
5,127 |
|
|
|
5,834 |
|
|
|
|
|
|
|
|
|
|
$ |
87,980 |
|
|
$ |
61,583 |
|
|
|
|
|
|
|
|
Property, plant and equipment, net:
|
|
|
|
|
|
|
|
|
|
Land
|
|
$ |
7,149 |
|
|
$ |
7,149 |
|
|
Buildings
|
|
|
4,497 |
|
|
|
3,543 |
|
|
Plant and equipment
|
|
|
292,567 |
|
|
|
282,648 |
|
|
Construction in progress
|
|
|
14,915 |
|
|
|
10,097 |
|
|
Less: accumulated depreciation
|
|
|
(70,530 |
) |
|
|
(25,824 |
) |
|
|
|
|
|
|
|
|
|
$ |
248,598 |
|
|
$ |
277,613 |
|
|
|
|
|
|
|
|
Accrued liabilities:
|
|
|
|
|
|
|
|
|
|
Employee compensation and benefits
|
|
$ |
11,135 |
|
|
$ |
20,643 |
|
|
Property taxes
|
|
|
5,694 |
|
|
|
|
|
|
Other
|
|
|
6,958 |
|
|
|
3,402 |
|
|
|
|
|
|
|
|
|
|
$ |
23,787 |
|
|
$ |
24,045 |
|
|
|
|
|
|
|
|
Deferred credits and other liabilities:
|
|
|
|
|
|
|
|
|
|
Accrued postretirement, pension and post employment benefits
|
|
$ |
68,298 |
|
|
$ |
82,433 |
|
|
Other
|
|
|
6,166 |
|
|
|
3,974 |
|
|
|
|
|
|
|
|
|
|
$ |
74,464 |
|
|
$ |
86,407 |
|
|
|
|
|
|
|
|
Pursuant to our Plan of Reorganization, on December 19,
2002, we issued $94.3 million in original principal amount
of our 10% Senior Secured Notes due 2007 (our Secured
Notes) to the holders of Predecessor Sterlings
123/8% Senior
Secured Notes due 2006. Our Secured Notes are senior secured
obligations and rank equally in right of payment with all of our
other existing and future senior indebtedness, and senior in
right of payment to all of our existing and future subordinated
indebtedness. Our Secured Notes are guaranteed by Sterling
Chemicals Energy, Inc. (Sterling Energy), one of our
wholly-owned subsidiaries. Sterling Energys guaranty ranks
equally in right of payment with all of its existing and future
senior indebtedness, and senior in right of payment to all of
its existing and future subordinated indebtedness. Our Secured
Notes and Sterling Energys guaranty are secured by a first
priority lien on all of our production facilities and related
assets.
57
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Our Secured Notes bear interest at an annual rate of 10%,
payable semi-annually on June 15 and December 15 of each year.
Under certain circumstances, for any interest period ending on
or before December 19, 2004, we could elect to pay interest
on our Secured Notes through the issuance of additional Secured
Notes rather than the payment of cash. However, if we paid
interest through the issuance of additional Secured Notes rather
than the payment of cash, the interest rate for the relevant
period was increased to
133/8%.
In December 2003, we made an interest payment on our Secured
Notes at the higher rate through the issuance of
$6.3 million in original principal amount of additional
Secured Notes, increasing the aggregate principal amount of
outstanding Secured Notes to $100.6 million. We have made
all other interest payments on our Secured Notes in cash.
Subject to compliance with the terms of our Revolving Credit
Agreement dated December 19, 2002, with The CIT Group/
Business Credit, Inc., as administrative agent and a lender, and
certain other lenders (our Revolver), we may redeem
our Secured Notes at any time at a redemption price of 100% of
the outstanding principal amount thereof plus accrued and unpaid
interest. In addition, in the event of a specified change of
control or the sale of our facility in Texas City, Texas, we are
required to offer to repurchase our Secured Notes at 101% of the
outstanding principal amount thereof plus accrued and unpaid
interest. Under certain circumstances, we are also required to
use the proceeds of other asset sales to repurchase any of our
Secured Notes tendered by the holders of our Secured Notes at a
price equal to 100% of the outstanding principal amount thereof
plus accrued and unpaid interest.
The indenture governing our Secured Notes contains numerous
covenants and conditions, including, but not limited to,
restrictions on our ability to incur indebtedness, create liens,
sell assets, make investments, make capital expenditures, engage
in mergers and acquisitions and pay dividends. The indenture
also includes various circumstances and conditions that would,
upon their occurrence and subject in certain cases to notice and
grace periods, create an event of default thereunder. However,
the indenture does not require us to satisfy any financial
ratios or maintenance tests.
On December 19, 2002, we established the Revolver, which
provides up to $100 million in revolving credit loans. The
Revolver has an initial term ending on September 19, 2007.
Under the Revolver, we and Sterling Energy are co-borrowers and
are jointly and severally liable for any indebtedness
thereunder. The Revolver is secured by first priority liens on
all of our accounts receivable, inventory and other specified
assets, as well as all of the issued and outstanding capital
stock of Sterling Energy.
Borrowings under the Revolver bear interest, at our option, at
an annual rate of either the Alternate Base Rate plus 0.75% or
the LIBO Rate (as defined in the Revolver) plus
2.75%. The Alternate Base Rate is equal to the
greater of the Base Rate as announced from time to
time by JPMorgan Chase Bank in New York, New York or
0.50% per annum above the latest Federal Funds
Rate (as defined in the Revolver). The average borrowing
rate under the Revolver for the year ended December 31,
2004 was 5.8%. Under the Revolver, we are also required to pay
an aggregate commitment fee of 0.50% per year (payable
monthly) on any unused portion of the Revolver. Available credit
under the Revolver is subject to a monthly borrowing base of 85%
of eligible accounts receivable plus the lesser of
$50 million and 65% of eligible inventory. In addition, the
borrowing base for the Revolver must exceed outstanding
borrowings thereunder by $8 million at all times. As of
December 31, 2004, total credit available under the
Revolver was limited to $74 million due to these borrowing
base limitations. As of December 31, 2004, there was
$18 million in loans outstanding under the Revolver and we
had $2 million in outstanding letters of credit issued
pursuant to the Revolver. As required pursuant to EITF Issue
No. 95-22, Balance Sheet Classification of Borrowings
under Revolving Credit Agreements That Include both a Subjective
Acceleration Clause and a Lock-Box Arrangement, any
balances outstanding pursuant to our Revolver are classified as
current portion of long-term debt.
The Revolver contains numerous covenants and conditions,
including, but not limited to, restrictions on our ability to
incur indebtedness, create liens, sell assets, make investments,
make capital expenditures,
58
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
engage in mergers and acquisitions and pay dividends. The
Revolver also contains a covenant that requires us to earn a
specified amount of earnings before interest, income taxes,
depreciation and amortization (as defined in the Revolver) on a
monthly basis if, for 15 consecutive days, unused
availability under the Revolver plus cash on hand is less than
$20 million. The Revolver includes various circumstances
and conditions that would, upon their occurrence and subject in
certain cases to notice and grace periods, create an event of
default thereunder.
The Secured Notes, which had an aggregate principal balance of
$100.6 million outstanding as of December 31, 2004,
are due on December 19, 2007.
A reconciliation of federal statutory income taxes to our
effective tax provision (benefit) is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
Predecessor Sterling | |
|
|
| |
|
| |
|
|
|
|
|
|
|
|
Fiscal Year | |
|
|
|
|
December 20 to | |
|
October 1 to | |
|
Ended | |
|
|
December 31, | |
|
December 31, | |
|
December 31, | |
|
December 19, | |
|
September 30, | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Provision (benefit) for income taxes at statutory rates
|
|
$ |
(26,125 |
) |
|
$ |
(7,387 |
) |
|
$ |
(831 |
) |
|
$ |
78,391 |
|
|
$ |
(18,372 |
) |
Change in beginning of the year valuation allowance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(148,464 |
) |
|
|
18,371 |
|
Non-deductible expenses
|
|
|
26 |
|
|
|
65 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Non-deductible fresh-start adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,073 |
|
|
|
|
|
Non-deductible goodwill impairment
|
|
|
16,962 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State income taxes
|
|
|
(1,933 |
) |
|
|
(361 |
) |
|
|
26 |
|
|
|
8 |
|
|
|
125 |
|
Other
|
|
|
(930 |
) |
|
|
(201 |
) |
|
|
(23 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax provision
|
|
$ |
(12,000 |
) |
|
$ |
(7,884 |
) |
|
$ |
(828 |
) |
|
$ |
8 |
|
|
$ |
125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The provision (benefit) for income taxes is composed of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
Predecessor Sterling | |
|
|
| |
|
| |
|
|
|
|
|
|
|
|
Fiscal Year | |
|
|
Year Ended | |
|
Year Ended | |
|
December 20 to | |
|
October 1 to | |
|
Ended | |
|
|
December 31, | |
|
December 31, | |
|
December 31, | |
|
December 19, | |
|
September 30, | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Current federal
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Deferred federal
|
|
|
(10,105 |
) |
|
|
(7,323 |
) |
|
|
(854 |
) |
|
|
|
|
|
|
|
|
State income taxes
|
|
|
(1,895 |
) |
|
|
(561 |
) |
|
|
26 |
|
|
|
8 |
|
|
|
125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total tax provision (benefit)
|
|
$ |
(12,000 |
) |
|
$ |
(7,884 |
) |
|
$ |
(828 |
) |
|
$ |
8 |
|
|
$ |
125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
The components of our deferred income tax assets and liabilities
are summarized below:
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
|
| |
|
|
December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Accrued liabilities
|
|
$ |
3,737 |
|
|
$ |
7,434 |
|
Accrued postretirement cost
|
|
|
13,916 |
|
|
|
15,004 |
|
Accrued pension cost
|
|
|
8,377 |
|
|
|
11,163 |
|
Tax loss and credit carry forwards
|
|
|
27,475 |
|
|
|
13,612 |
|
Allowance for doubtful accounts
|
|
|
1,082 |
|
|
|
2,401 |
|
Other
|
|
|
55 |
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets
|
|
$ |
54,642 |
|
|
$ |
49,614 |
|
|
|
|
|
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Property, plant and equipment
|
|
$ |
(70,680 |
) |
|
$ |
(81,764 |
) |
State deferred taxes
|
|
|
(2,166 |
) |
|
|
(2,291 |
) |
Other
|
|
|
|
|
|
|
(683 |
) |
|
|
|
|
|
|
|
Subtotal
|
|
|
(72,846 |
) |
|
|
(84,738 |
) |
Less: valuation allowance
|
|
|
(6,096 |
) |
|
|
(5,704 |
) |
|
|
|
|
|
|
|
Total deferred tax liabilities
|
|
|
(78,942 |
) |
|
|
(90,442 |
) |
|
|
|
|
|
|
|
Net deferred tax liabilities
|
|
$ |
(24,300 |
) |
|
$ |
(40,828 |
) |
|
|
|
|
|
|
|
As of December 31, 2004, we had an available
U.S. operating loss carryforward of approximately
$58 million, which expires during 2023 and 2024. Deferred
tax assets are regularly assessed for recoverability based on
both historical and anticipated earnings levels, and a valuation
allowance is recorded when it is more likely than not that these
amounts will not be recovered. A portion of our state operating
loss carry forwards originated prior to our emergence from
Chapter 11. Our valuation allowance at December 31,
2004 and 2003 reflects a 100% valuation taken against these
pre-Chapter 11 emergence state operating loss carry
forwards. Any future recognition of these operating loss carry
forwards would be recorded as an increase in our paid-in capital
rather than as a reduction in our provision for income taxes.
We have established the following benefit plans:
We have non-contributory pension plans which cover all salaried
and hourly wage employees. Under our hourly plan, the benefits
are based primarily on years of service and employees pay
near retirement. Under our salaried plan, which was recently
amended in the manner described below, the benefits are based
primarily on years of service and an employees pay as of
the earlier of the employees retirement or January 1,
2005. Our funding policy is consistent with the funding
requirements of federal law and regulations.
The expected long-term rate of return on pension plan assets is
a market-related value currently equal to 7.5%. Sterlings
actual annualized return for the past 10 years is
approximately 10.5%.
60
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Pension plan assets are invested in a balanced portfolio managed
by an outside investment manager. Within this balanced fund,
assets are invested 55% in equities, 40% in bonds and 5% in real
estate, with rebalancing on a continual basis. Our investment
policy is to generate a total return that, over the long term,
provides sufficient assets to fund its liabilities, reduces risk
through diversification of investments within asset classes and
complies with the Employee Retirement Income Security Act of
1974 (ERISA) by investing in a manner consistent
with ERISAs fiduciary standards.
Information concerning the pension obligation, plan assets,
amounts recognized in our financial statements and underlying
actuarial assumptions is stated below:
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
|
| |
|
|
December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Change in benefit obligation:
|
|
|
|
|
|
|
|
|
|
Benefit obligation at beginning of year
|
|
$ |
124,704 |
|
|
$ |
116,818 |
|
|
Service cost
|
|
|
3,466 |
|
|
|
3,312 |
|
|
Interest cost
|
|
|
7,561 |
|
|
|
7,634 |
|
|
Plan amendment/curtailment
|
|
|
(14,472 |
) |
|
|
|
|
|
Actuarial loss
|
|
|
5,600 |
|
|
|
4,179 |
|
|
Benefits paid
|
|
|
(7,177 |
) |
|
|
(7,239 |
) |
|
|
|
|
|
|
|
|
Benefit obligation at end of year
|
|
$ |
119,682 |
|
|
$ |
124,704 |
|
|
|
|
|
|
|
|
Change in plan assets:
|
|
|
|
|
|
|
|
|
|
Fair value at beginning of year
|
|
$ |
77,709 |
|
|
$ |
66,496 |
|
|
Actual return on plan assets
|
|
|
8,511 |
|
|
|
9,253 |
|
|
Employer contributions
|
|
|
10,207 |
|
|
|
9,199 |
|
|
Benefits paid
|
|
|
(7,177 |
) |
|
|
(7,239 |
) |
|
|
|
|
|
|
|
|
Fair value at end of year
|
|
$ |
89,250 |
|
|
$ |
77,709 |
|
|
|
|
|
|
|
|
Development of net amount recognized:
|
|
|
|
|
|
|
|
|
|
Funded status
|
|
$ |
(30,432 |
) |
|
$ |
(46,995 |
) |
|
Actuarial loss
|
|
|
1,626 |
|
|
|
130 |
|
|
|
|
|
|
|
|
|
Net amount recognized
|
|
$ |
(28,806 |
) |
|
$ |
(46,865 |
) |
|
|
|
|
|
|
|
Amounts recognized in the statement of financial position:
|
|
|
|
|
|
|
|
|
|
Accrued pension cost
|
|
$ |
(30,415 |
) |
|
$ |
(47,116 |
) |
|
Accumulated other comprehensive income (pre-tax)
|
|
|
1,609 |
|
|
|
251 |
|
|
|
|
|
|
|
|
|
Net amount recognized
|
|
$ |
(28,806 |
) |
|
$ |
(46,865 |
) |
|
|
|
|
|
|
|
Weighted-average assumptions:
|
|
|
|
|
|
|
|
|
|
Discount Rate
|
|
|
5.75 |
% |
|
|
6.25 |
% |
|
Rates of increase in salary compensation level
|
|
|
5.00 |
% |
|
|
5.00 |
% |
All plans have projected benefit obligations and accumulated
benefit obligation in excess of plan assets at December 31,
2004. The total accumulated benefit obligation was
$119.7 million as of November 30, 2004. Estimated
contributions for 2005 are expected to be approximately
$6 million, a portion of which are above the minimum
funding requirements.
61
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Effective as of January 1, 2005, we froze all accruals
under our defined benefit pension plan for our salaried
employees, which resulted in a plan curtailment under
FAS No. 88 Employers Accounting for
Settlement and Curtailments of Defined Benefit Pension Plans and
for Termination Benefits. As a result, we recorded a
pretax curtailment gain of $13 million in the fourth
quarter of 2004. At the time we froze accruals under our defined
benefit pension plan, we also increased the company match for
employee contributions under our 401(k) plan.
Net periodic pension costs consist of the following components:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor | |
|
|
Reorganized Sterling | |
|
Sterling | |
|
|
| |
|
| |
|
|
|
|
|
|
Fiscal Year | |
|
|
Year Ended | |
|
Year Ended | |
|
October 1 to | |
|
Ended | |
|
|
December 31, | |
|
December 31, | |
|
December 31, | |
|
September 30, | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Components of net pension costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost-benefits earned during the year
|
|
$ |
3,466 |
|
|
$ |
3,312 |
|
|
$ |
1,081 |
|
|
$ |
3,826 |
|
|
Interest on prior years projected benefit obligation
|
|
|
7,561 |
|
|
|
7,634 |
|
|
|
2,258 |
|
|
|
7,317 |
|
|
Expected return on plan assets
|
|
|
(5,934 |
) |
|
|
(5,205 |
) |
|
|
(1,602 |
) |
|
|
(6,536 |
) |
|
Net amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss (gain)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
152 |
|
|
|
Prior service cost
|
|
|
|
|
|
|
|
|
|
|
203 |
|
|
|
777 |
|
|
|
Transition liability
|
|
|
|
|
|
|
|
|
|
|
425 |
|
|
|
354 |
|
|
Discontinued operations (see Note 4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,255 |
|
|
Settlement/curtailment
|
|
|
(12,944 |
) |
|
|
|
|
|
|
63 |
|
|
|
22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net pension costs
|
|
$ |
(7,851 |
) |
|
$ |
5,741 |
|
|
$ |
2,428 |
|
|
$ |
7,167 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount Rate
|
|
|
6.25% |
|
|
|
6.75% |
|
|
|
6.75% |
|
|
|
6.75% |
|
|
Rates of increase in salary compensation level
|
|
|
5.00% |
|
|
|
5.00% |
|
|
|
4.92% |
|
|
|
4.92% |
|
|
Expected long-term rate of return on plan assets
|
|
|
7.50% |
|
|
|
8.00% |
|
|
|
8.72% |
|
|
|
8.72% |
|
The Transition Period is not presented separately for
Predecessor Sterling and Reorganized Sterling due to
immateriality.
|
|
|
Postretirement Benefits Other than Pensions |
We provide certain health care benefits and life insurance
benefits for retired employees. Substantially all of our
employees become eligible for these benefits at early retirement
age. We accrue the cost of these benefits during the period in
which the employee renders the necessary service.
Health care benefits are currently provided to employees hired
prior to June 7, 2004, who retire from us with ten or more
years of credited service. Some of our employees are eligible
for postretirement life insurance, depending on their hire date.
Postretirement health care benefits plans are contributory.
Benefit provisions for most hourly employees are subject to
collective bargaining. In general, retiree health care benefits
are paid as covered expenses are incurred.
62
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
In June 2004, we had a reduction in force at our Texas City
plant. This reduction in force led to a curtailment of our
postretirement benefit plan resulting in a $1.4 million
curtailment gain. The gain of $1.3 million is reflected in
cost of goods sold and $0.1 million is reflected in
selling, general and administrative expenses. In addition, our
plan was amended as of June 1, 2004 as follows: employees
hired after this date are not eligible for retiree medical
benefits, our contribution rates for retiree medical coverage
are frozen at the 2004 level and prescription drug co-pays were
increased. This amendment reduced the accumulated postretirement
benefit obligation by $9.2 million, which is being
amortized over the average remaining service period to full
eligibility of the active plan participants (which is
8.5 years).
Effective April 1, 2003, we amended our postretirement
medical plan to increase the contribution rates required for
coverage. The effect of the amendment as of that date was a
reduction in accumulated postretirement benefit obligations
(APBO) totaling $13 million. Because the
participants affected by the amendment were all retired, the
negative change to APBO is amortizable into expense over the
average remaining life expectancy of these retirees which is
20.6 years.
On December 8, 2003, the Medicare Prescription Drug
Improvement and Modernization Act of 2003 (the Act)
was passed. The Act introduces a prescription drug benefit under
Medicare (Medicare Part D), as well as a federal subsidy to
sponsors of retiree health care benefit plans that provide a
benefit that is at least actuarially equivalent to Medicare
Part D. In January 2004, FASB issued Staff Position
No. FAS 106-1, Accounting and Disclosure
Requirements Related to the Medicare Prescription Drug
Improvement and Modernization Act of 2003
(FAS 106-1), which is effective for interim or
annual financial statements of fiscal years ending after
December 7, 2003 and permits a one-time election to defer
accounting for the effects of the Act. In May 2004, the FASB
issued FASB Staff Position No. 106-2, Accounting and
Disclosure Requirements Related to the Medicare Prescription
Drug, Improvement and Modernization Act of 2003
(FAS 106-2), which supercedes FAS 106-1.
FAS 106-2 provides guidance on the accounting for the
effects of the Act for employers that sponsor postretirement
heath care plans that provide prescription drug benefits, and
requires those employers to provide certain disclosures
regarding the effect of the federal subsidy provided under the
Act. FAS 106-2 applies to us effective July 1, 2004.
We measured the effects of the Act on our accumulated
postretirement benefit obligation and determined that, based on
the regulatory guidance currently available, benefits provided
by our postretirement plan are at least actuarially equivalent
to Medicare Part D, and accordingly, we expect to be
entitled to the federal subsidy in the years 2006 through 2009.
We estimate that this subsidy will be approximately 20% of the
net benefits under our plan, or $0.2 million annually.
63
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Information concerning the plan obligation, the funded status,
amounts recognized in our financial statements and underlying
actuarial assumptions are stated below:
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
|
| |
|
|
December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Change in benefit obligation:
|
|
|
|
|
|
|
|
|
|
Benefit obligation at beginning of year
|
|
$ |
34,870 |
|
|
$ |
46,141 |
|
|
Service cost
|
|
|
310 |
|
|
|
460 |
|
|
Interest cost
|
|
|
1,864 |
|
|
|
2,336 |
|
|
Plan amendments
|
|
|
(9,541 |
) |
|
|
(13,070 |
) |
|
Actuarial loss (gain)
|
|
|
4,404 |
|
|
|
(220 |
) |
|
Benefits paid
|
|
|
(4,162 |
) |
|
|
(777 |
) |
|
|
|
|
|
|
|
|
Benefit obligation at end of year
|
|
$ |
27,745 |
|
|
$ |
34,870 |
|
|
|
|
|
|
|
|
Funded plan assets
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
Development of net amount recognized:
|
|
|
|
|
|
|
|
|
|
Funded status
|
|
$ |
(27,745 |
) |
|
$ |
(34,870 |
) |
|
Unrecognized cost:
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss
|
|
|
5,204 |
|
|
|
1,151 |
|
|
|
Plan amendment
|
|
|
(19,164 |
) |
|
|
(12,593 |
) |
|
|
|
|
|
|
|
|
Net amount recognized
|
|
$ |
(41,705 |
) |
|
$ |
(46,312 |
) |
|
|
|
|
|
|
|
|
Prepaid OPEB cost
|
|
$ |
|
|
|
$ |
|
|
|
Accrued OPEB liability
|
|
|
(41,705 |
) |
|
|
(46,312 |
) |
|
|
|
|
|
|
|
|
Net amount recognized
|
|
$ |
(41,705 |
) |
|
$ |
(46,312 |
) |
|
|
|
|
|
|
|
64
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Net periodic plan costs consist of the following components:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor | |
|
|
Reorganized Sterling | |
|
Sterling | |
|
|
| |
|
| |
|
|
|
|
|
|
Fiscal Year | |
|
|
Year Ended | |
|
Year Ended | |
|
October 1 to | |
|
Ended | |
|
|
December 31, | |
|
December 31, | |
|
December 31, | |
|
September 30, | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Components of net plan costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$ |
310 |
|
|
$ |
460 |
|
|
$ |
115 |
|
|
$ |
480 |
|
|
Interest cost
|
|
|
1,864 |
|
|
|
2,336 |
|
|
|
749 |
|
|
|
3,132 |
|
|
Net amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss
|
|
|
21 |
|
|
|
|
|
|
|
121 |
|
|
|
642 |
|
|
|
Prior service cost
|
|
|
|
|
|
|
|
|
|
|
(116 |
) |
|
|
(463 |
) |
|
|
Plan amendment
|
|
|
(1,223 |
) |
|
|
(477 |
) |
|
|
|
|
|
|
|
|
|
Discontinued operations (see Note 4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
151 |
|
|
Curtailment and special termination benefits
|
|
|
|
|
|
|
(1,418 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net plan costs
|
|
$ |
(446 |
) |
|
$ |
2,319 |
|
|
$ |
869 |
|
|
$ |
3,942 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
5.75% |
|
|
|
6.25% |
|
|
|
6.75% |
|
|
|
6.75% |
|
The Transition Period is not presented separately for
Predecessor Sterling and Reorganized Sterling due to
immateriality.
The weighted-average annual assumed health care trend rate is
assumed to be 10% for 2004. The rate is assumed to decrease
gradually to 4.5% in 2013 and remain level thereafter. Based on
plan changes enacted, assumed health care cost trend rates no
longer have a significant effect on the amounts reported for the
health care plans. A one percentage point change in assumed
health care trend rates would have the following effects:
|
|
|
|
|
|
|
|
|
|
|
1% Increase | |
|
1% Decrease | |
|
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Effect on total of service and interest cost components
|
|
$ |
114 |
|
|
$ |
(108 |
) |
Effect on post-retirement benefit obligation
|
|
|
1,123 |
|
|
|
(1,076 |
) |
|
|
|
Estimated Future Benefits Payable |
We estimate that the future benefits payable under our pension
and other post-retirement benefits as of December 31, 2004
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other | |
|
|
|
|
Pensions- | |
|
Pensions- | |
|
Postretirement | |
|
|
|
|
Hourly | |
|
Salaried | |
|
Benefits | |
|
Total | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in thousands) | |
2005
|
|
$ |
3,516 |
|
|
$ |
3,626 |
|
|
$ |
2,682 |
|
|
$ |
9,824 |
|
2006
|
|
|
3,381 |
|
|
|
3,734 |
|
|
|
2,640 |
|
|
|
9,755 |
|
2007
|
|
|
3,201 |
|
|
|
3,841 |
|
|
|
2,578 |
|
|
|
9,620 |
|
2008
|
|
|
3,048 |
|
|
|
3,953 |
|
|
|
2,528 |
|
|
|
9,529 |
|
2009
|
|
|
2,935 |
|
|
|
4,205 |
|
|
|
2,503 |
|
|
|
9,643 |
|
2010-2014
|
|
|
15,219 |
|
|
|
27,822 |
|
|
|
10,030 |
|
|
|
53,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
31,300 |
|
|
$ |
47,181 |
|
|
$ |
22,961 |
|
|
$ |
101,442 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
|
|
|
Savings and Investment Plan |
Our Sixth Amended and Restated Savings and Investment Plan
covers substantially all employees, including executive
officers. This Plan is qualified under Section 401(k) of
the Internal Revenue Code. Each participant has the option to
defer taxation of a portion of his or her earnings by directing
us to contribute a percentage of such earnings to the Plan. A
participant may direct up to a maximum of 20% of eligible
earnings to this Plan, subject to certain limitations set forth
in the Internal Revenue Code. A participants contributions
become distributable upon the termination of his or her
employment. Beginning October 1, 2000, we began matching
50% of a participants contributions, to the extent such
contributions do not exceed 7% of such participants base
compensation (excluding bonuses, profit sharing and similar
types of compensation). Such contributions amounted to
$0.8 million in 2004, $0.8 million in 2003 and
$0.9 million in fiscal 2002. Beginning January 1,
2005, we began matching 100% of salaried employees
contributions, to the extent such contributions do not exceed 6%
of such participants base compensation (excluding bonuses,
profit sharing and similar types of compensation).
|
|
|
Bonus Plan and Gain Sharing Plan |
In February 2002, our Board of Directors, upon recommendation of
its Compensation Committee, approved the establishment of a
Bonus Plan and a Gain Sharing Plan. The Bonus Plan is designed
to benefit all qualified salaried employees, while the Gain
Sharing Plan is designed to benefit all qualified hourly
employees. Both plans provide our qualified employees the
opportunity to earn bonuses depending on, among other things,
our annual financial performance. Although we did not meet the
minimum financial threshold of these plans for 2004, on
February 11, 2005, our Board authorized the payment of
$0.9 million under these plans related to our 2004
financial performance and we accrued that amount in 2004. There
was no expense incurred pursuant to these plans during 2003. No
expenses for our prior Profit Sharing Plan were incurred in
fiscal 2002.
|
|
|
Key Employee Protection Plan |
On January 26, 2000, we instituted our Key Employee
Protection Plan, which has subsequently been amended several
times. We established this Plan to help us retain certain of our
employees and motivate them to continue to exert their best
efforts on our behalf during periods when we may be susceptible
to a change of control, and to assure their continued dedication
and objectivity during those periods. Our Compensation Committee
has designated a select group of management or highly
compensated employees as participants under our Key Employee
Protection Plan, and has established their respective applicable
multipliers and other variables for determining benefits. Our
Compensation Committee is also authorized to designate
additional management or highly compensated employees as
participants under our Key Employee Protection Plan and set
their applicable multipliers. Our Compensation Committee may
also terminate any participants participation under this
Plan on 60 days notice if it determines that the
participant is no longer one of our key employees.
Under our Key Employee Protection Plan, any participant under
the Plan that terminates his or her employment for Good
Reason or is terminated by us for any reason other than
Misconduct or Disability within his or
her Protection Period is entitled to benefits under
the Plan. A participants Protection Period commences
180 days prior to the date on which a specified change of
control occurs and ends either two years or 18 months after
the date of that change of control, depending on the size of the
participants applicable multiplier. A participant may also
be entitled to receive payments under this Plan in the absence
of a change of control if he or she terminates his or her
employment for Good Reason or is terminated by us
for any reason other than Misconduct or
Disability, but in these circumstances his or her
applicable multiplier is reduced by 50%. If a participant
becomes entitled to benefits under our Key Employee Protection
Plan, we are required to provide the participant with a lump sum
cash payment that
66
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
is determined by multiplying the participants applicable
multiplier by the sum of the participants highest annual
base compensation during the last three years plus the
participants targeted bonus for the year of termination,
and then deducting the sum of any other separation, severance or
termination payments made by us to the participant under any
other plan or agreement or pursuant to law.
In addition to the lump sum payment, the participant is entitled
to receive any accrued but unpaid compensation, compensation for
unused vacation time and any unpaid vested benefits earned or
accrued under any of our benefit plans (other than qualified
plans). Also, for a period of 24 months (including
18 months of COBRA coverage), the participant will continue
to be covered by all of our life, health care, medical and
dental insurance plans and programs (other than disability), as
long as the participant makes a timely COBRA election and pays
the regular employee premiums required under our plans and
programs and by COBRA. In addition, our obligation to continue
to provide coverage under our plans and programs to any
participant ends if and when the participant becomes employed on
a full-time basis by a third party which provides the
participant with substantially similar benefits.
If any payment or distribution under our Key Employee Protection
Plan to any participant is subject to excise tax pursuant to
Section 4999 of the Internal Revenue Code, the participant
is entitled to receive a gross-up payment from us in an amount
such that, after payment by the participant of all taxes on the
gross-up payment, the amount of the gross-up payment remaining
is equal to the excise tax imposed under Section 4999 of
the Internal Revenue Code. However, the maximum amount of any
gross-up payment is 25% of the sum of the participants
highest annual base compensation during the last three years
plus the participants targeted bonus for the year of
payment.
We may terminate our Key Employee Protection Plan at any time
and for any reason but any termination does not become effective
as to any participant until 90 days after we give the
participant notice of the termination of the Plan. In addition,
we may amend our Key Employee Protection Plan at any time and
for any reason, but any amendment that reduces, alters,
suspends, impairs or prejudices the rights or benefits of any
participant in any material respect does not become effective as
to that participant until 90 days after we give him or her
notice of the amendment of the Plan. No termination of our Key
Employee Protection Plan, or any of these types of amendments to
the Plan, can be effective with respect to any participant if
the termination or amendment is related to, in anticipation of
or during the pendency of a change of control, is for the
purpose of encouraging or facilitating a change of control or is
made within 180 days prior to any change of control.
Finally, no termination or amendment of our Key Employee
Protection Plan can affect the rights or benefits of any
participant that are accrued under the Plan at the time of
termination or amendment or that accrue thereafter on account of
a change of control that occurred prior to the termination or
amendment or within 180 days after such termination or
amendment. In 2004, we expensed $0.3 million under this
Plan. There was no expense incurred pursuant to this Plan during
2003 or fiscal 2002.
On July 13, 2001, our Board of Directors approved our
Retention Bonus Plan, which was subsequently amended. This Plan
was established to help us retain our employees whose
resignations would cause significant disruption to our
operations and whose skills would be particularly difficult and
costly to replace, to improve their morale during the pendency
of our bankruptcy proceedings and to help provide incentive to
these employees to work diligently toward the resolution of our
bankruptcy proceedings. A select group of management or highly
compensated employees were designated as participants under the
plan and their respective benefits were established. Each
participant in the plan was entitled to payments under the plan
on specified dates, unless the participants employment
with us terminated prior to that payment date for any reason
other than a termination by the participant for Good
Reason or a termination by us for any reason other than
Misconduct or Disability. Payments under
the plan were based on specified
67
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
percentages of the participants annual compensation,
including payments under our Supplemental Pay Plan. Each
participant who became entitled to payments under the plan was
paid 25% of the total amount payable to that participant on
April 15, 2002, an additional 25% on October 15,
2002 and the final 50% was paid on November 20, 2002.
During the period from October 1, 2002 to December 19,
2002 and fiscal 2002, we expensed $3 million and
$2 million, respectively, in connection with this Plan.
On March 8, 2001, our Board of Directors approved our
Severance Pay Plan, which has subsequently been amended. This
Plan covers all of our non-unionized employees and was
established to help us retain these employees by assuring them
that they will receive some compensation in the event that their
employment is adversely affected in specified ways. Under our
Severance Pay Plan, any participant that terminates his or her
employment for Good Reason or is terminated by us
for any reason other than Misconduct or
Disability is entitled to benefits under our
Severance Pay Plan. If a participant becomes entitled to
benefits under our Severance Pay Plan, we are required to
provide the participant with a lump sum cash payment in an
amount equivalent to two weeks of such participants base
salary for each credited year of service, with a maximum payment
of one years base salary. The amount of this lump sum
payment is reduced, however, by the amount of any other
separation, severance or termination payments made by us to the
participant under any other plan or agreement, including our Key
Employee Protection Plan, or pursuant to law.
In addition to the lump sum payment, for a period of six months
after the participants termination date, the COBRA premium
required to be paid by such participant for coverage under our
medical and dental plans may not be increased beyond that
required to be paid by active employees for similar coverage
under those plans, as long as the participant makes a timely
COBRA election and pays the regular employee premiums required
under those plans and otherwise continues to be eligible for
coverage under those plans.
We may terminate or amend our Severance Pay Plan at any time and
for any reason but no termination or amendment of our Severance
Pay Plan can affect the rights or benefits of any participant
that are accrued under the plan at the time of termination or
amendment. In 2004, we expensed $2.4 million under this
Plan, of which $0.7 million was paid in 2004, with the
balance paid in 2005.
On July 13, 2001, our Board of Directors approved our
Supplemental Bonus Plan, which was subsequently amended. This
Plan was designed to help us retain certain of our employees
during the pendency of our bankruptcy proceedings and provide us
with the ability to reward our employees who made extraordinary
contributions and personal sacrifices in connection with our
bankruptcy proceedings. Under our Supplemental Bonus Plan, our
Board had the ability to designate employees as participants
under the plan and determine the amount payable to those
participants, subject to an overall limit of $1.4 million
in payments. No amounts were expensed under this plan during
2004 or 2003. Approximately $0.8 million was expensed
during fiscal 2002 and paid on November 20, 2002.
On March 8, 2001, our Board of Directors approved our
Supplemental Pay Plan. Historically, we have paid our senior
level employees below-market salaries with the opportunity to
earn above-market compensation through stock based incentives
and significant bonuses in years when we achieve targeted levels
of financial performance. Due to our financial difficulties at
that time, the opportunity to earn additional compensation
through these programs was significantly reduced, if not
entirely eliminated. As a result, we established this plan to
address the concern that the overall compensation provided to
our senior
68
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
level employees would always be below-market and, consequently,
not adequate to retain these employees or attract new
highly-qualified employees. A select group of management or
highly compensated employees was designated as participants
under this Plan and their respective benefits were established.
Each payment under this Plan was a specified percentage of the
participants annual base salary for fiscal 2001, and
payments were made on or before the tenth day after the last day
of each calendar quarter. Payments of $2 million were made
pursuant to this Plan before the Plan was terminated effective
June 30, 2003.
|
|
|
Outstanding Stock Options |
A summary of our stock option activity for the years ended
December 31, 2004 and 2003 are presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted- | |
|
|
|
|
average | |
|
|
|
|
exercise | |
As of December 31, 2004: |
|
Shares | |
|
price | |
|
|
| |
|
| |
Outstanding at beginning of year
|
|
|
326,000 |
|
|
$ |
31.60 |
|
Granted
|
|
|
27,500 |
|
|
|
31.60 |
|
Forfeited
|
|
|
(59,166 |
) |
|
|
31.60 |
|
|
|
|
|
|
|
|
Outstanding at end of year
|
|
|
294,334 |
|
|
$ |
31.60 |
|
|
|
|
|
|
|
|
|
Options exercisable at end of year
|
|
|
99,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted- | |
|
|
|
|
average | |
|
|
|
|
exercise | |
As of December 31, 2003: |
|
Shares | |
|
price | |
|
|
| |
|
| |
Outstanding at beginning of year
|
|
|
|
|
|
$ |
|
|
Granted
|
|
|
326,000 |
|
|
|
31.60 |
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of year
|
|
|
326,000 |
|
|
$ |
31.60 |
|
|
|
|
|
|
|
|
|
Options exercisable at end of year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All outstanding options at December 31, 2004 and
December 31, 2003 have an exercise price of $31.60.
There were 27,500 options granted during 2004. We account
for our stock-based compensation arrangements using the
intrinsic value method in accordance with the provisions of
APB 25, and related interpretations. All stock options
issued under our 2002 Stock Plan were granted with exercise
prices at estimated fair value at the time of the grant.
Therefore no compensation expense has been recognized under
APB 25.
Prior to December 6, 2002, all issued and outstanding
shares of Predecessor Sterlings capital stock were held by
Holdings and, accordingly, prior periods are not presented.
|
|
9. |
COMMITMENTS AND CONTINGENCIES |
We have certain long-term agreements, which provide for the
dedication of 100% of our production of acetic acid,
plasticizers, sodium cyanide and DSIDA, each to one customer. We
also have various sales
69
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
and conversion agreements, which dedicate significant portions
of our production of styrene and acrylonitrile to various
customers. Some of these agreements generally provide for cost
recovery plus an agreed margin or element of profit based upon
market price.
We have entered into various non-cancelable long-term operating
leases. Future minimum lease commitments at December 31,
2004, are as follows: 2005 $0.3 million;
2006 $0.3 million; 2007
$0.3 million, 2008 $0.3 million;
2009 $0.3 million and thereafter
$1.1 million.
Our operations involve the handling, production, transportation,
treatment and disposal of materials that are classified as
hazardous or toxic waste and that are extensively regulated by
environmental and health and safety laws, regulations and permit
requirements. Environmental permits required for our operations
are subject to periodic renewal and can be revoked or modified
for cause or when new or revised environmental requirements are
implemented. Changing and increasingly strict environmental
requirements can affect the manufacture, handling, processing,
distribution and use of our chemical products and, if so
affected, our business and operations may be materially and
adversely affected. In addition, changes in environmental
requirements can cause us to incur substantial costs in
upgrading or redesigning our facilities and processes, including
our waste treatment, storage, disposal and other waste handling
practices and equipment.
We conduct environmental management programs designed to
maintain compliance with applicable environmental requirements
at all of our facilities. We routinely conduct inspection and
surveillance programs designed to detect and respond to leaks or
spills of regulated hazardous substances and to correct
identified regulatory deficiencies. We believe that our
procedures for waste handling are consistent with industry
standards and applicable requirements. In addition, we believe
that our operations are consistent with good industry practice.
We continue to participate in Responsible Care® initiatives
as a part of our membership in several trade groups, which are
partner associations in the American Chemistry Council in the
United States. Notwithstanding our efforts and beliefs, a
business risk inherent in chemical operations is the potential
for personal injury and property damage claims from employees,
contractors and their employees and nearby landowners and
occupants. While we believe our business operations and
facilities generally are operated in compliance with all
applicable environmental and health and safety requirements in
all material respects, we cannot be sure that past practices or
future operations will not result in material claims or
regulatory action, require material environmental expenditures
or result in exposure or injury claims by employees, contractors
and their employees and the public. Some risk of environmental
costs and liabilities is inherent in our operations and
products, as it is with other companies engaged in similar
businesses.
Our operating expenditures for environmental matters, mostly
waste management and compliance of our continuing operations,
were $26 million in both 2004 and in 2003. We also spent
$8 million for environmentally related capital projects in
2004 and $3 million for these types of capital projects
in 2003.
Air emissions from our Texas City facility are subject to
certain permit requirements and self-implementing emission
limitations and standards under state and federal laws. Our
Texas City facility is located in an area that the Environmental
Protection Agency (EPA) has classified as not having
attained the ambient air quality standards for ozone, which is
controlled by direct regulation of volatile organic compounds
and nitrogen oxide. The Texas Commission for Environmental
Quality ( the TCEQ) has imposed strict requirements
on regulated facilities, including our Texas City facility, to
ensure that the air quality control region will achieve the
ambient air quality standards for ozone. Our Texas City facility
is subject to the federal governments June 1997 National
Ambient Air Quality Standards, which lower
70
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
the ozone and particulate matter threshold for attainment. Local
authorities also may impose new ozone and particulate matter
standards. Compliance with these stricter standards may
substantially increase our future nitrogen oxide, volatile
organic compounds and particulate matter control costs, the
amount and full impact of which cannot be determined at this
time. On December 13, 2002, the TCEQ adopted a revised
State Implementation Plan (SIP) for compliance with
the ozone provisions of the Clean Air Act. The SIP is currently
being reviewed by the EPA, which is expected to make further
revisions to these rules. Under the current SIP, we would be
required to reduce emissions of nitrogen oxide at our Texas City
facility by approximately 80% by the end of 2007. The current
rule also requires monitoring of emissions of highly reactive
volatile organic carbons (HRVOCs), such as ethylene
and propylene, by the end of 2005, and may impose a site-wide
cap on emissions of HRVOCs in 2006. At the conclusion of its
review of the SIP, the EPA may require further control measures,
including possibly increasing the total amount of reductions of
nitrogen oxide emissions required from 80% to 90%. Based on the
SIP as adopted by the TCEQ, we believe that the total cost of
the capital improvements required to comply with all of these
new regulations will be between $22 million and
$24 million, of which $6.0 million, $0.8 million
and zero were expended in 2004, 2003 and fiscal 2002,
respectively. We anticipate that the balance of these capital
expenditures and other expenses would need to be incurred
between 2005 and 2008. Under certain of our production
agreements, we will be able to recover a small portion of these
costs from the other parties to these agreements. We are
currently evaluating several alternative methods of reducing
nitrogen oxide emissions at our Texas City facility that would
either require less capital expenditures or result in energy
savings that would, over a period of years, more than offset the
initial capital expenditures. However, alternative methods may
not be available to us or, even if available, such alternative
methods may not reduce the net amount of our required capital
expenditures by a meaningful amount.
To reduce the risk of offsite consequences from unanticipated
events, we acquired a greenbelt buffer zone adjacent to our
Texas City facility in 1991. We also participate in a regional
air monitoring network to monitor ambient air quality in the
Texas City community.
As previously discussed, the Debtors filed voluntary petitions
for reorganization under Chapter 11 on July 16, 2001.
As a result of the commencement of the Chapter 11 cases, an
automatic stay was imposed against the commencement or
continuation of legal proceedings against the Debtors outside of
the Bankruptcy Court. Claimants with alleged claims against the
Debtors were required to assert their claims in the
Chapter 11 cases by timely filing a proof of claim, to
which the Debtors were allowed to file an objection and seek a
determination from the Bankruptcy Court as to whether such
claims were allowable. Claimants who desired to liquidate their
claims in legal proceedings outside of the Bankruptcy Court were
required to obtain relief from the automatic stay by order of
the Bankruptcy Court before doing so. If such relief was
granted, the automatic stay remained in effect with respect to
the collection of liquidated claim amounts. As a general rule,
all claims against the Debtors that sought a recovery from
assets of the Debtors estates have been addressed in the
Chapter 11 cases and have been or will be paid only
pursuant to the terms of our Plan of Reorganization or
negotiated settlements.
A few issues remain outstanding before the Bankruptcy Court
related to the allowability and classification of certain
claims. We do not believe that the outcome of any of these
issues will have a material adverse effect on our business,
financial position, results of operations or cash flows, but we
cannot guarantee that result.
We are subject to various other claims and legal actions that
arise in the ordinary course of our business. Claims and legal
actions against the Debtors that existed as of the
Chapter 11 filing date are subject to the discharge
injunction provided for in our Plan of Reorganization, and
recoveries sought thereon from assets of the Debtors are subject
to the terms of our Plan of Reorganization.
71
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Sales to major customers constituting 10% or more of total
revenues and export sales from continuing operations were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reorganized Sterling | |
|
Predecessor Sterling | |
|
|
| |
|
| |
|
|
|
|
December 20 | |
|
|
|
Fiscal Year | |
|
|
Year Ended | |
|
Year Ended | |
|
to | |
|
October 1 to | |
|
Ended | |
|
|
December 31, | |
|
December 31, | |
|
December 31, | |
|
December 19, | |
|
September 30, | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2002 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands) | |
Major customers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BP p.l.c. and subsidiaries
|
|
$ |
119,008 |
|
|
$ |
93,061 |
|
|
$ |
3,595 |
|
|
$ |
14,049 |
|
|
$ |
60,095 |
|
|
Customer B
|
|
|
127,956 |
|
|
|
69,533 |
|
|
|
* |
|
|
|
* |
|
|
|
* |
|
|
Customer C
|
|
|
116,912 |
|
|
|
* |
|
|
|
* |
|
|
|
* |
|
|
|
* |
|
Export sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Export revenues
|
|
$ |
317,104 |
|
|
$ |
224,595 |
|
|
$ |
3,715 |
|
|
$ |
15,996 |
|
|
$ |
131,701 |
|
|
Percentage of total revenues
|
|
|
37 |
% |
|
|
38 |
% |
|
|
30 |
% |
|
|
16% |
|
|
|
34% |
|
|
|
* |
Does not comprise more than 10% of total revenue for the periods
indicated, therefore not presented. |
|
|
11. |
FINANCIAL INSTRUMENTS |
We sell our products primarily to companies involved in the
petrochemicals industry. We perform ongoing credit evaluations
of our customers and generally do not require collateral for
accounts receivable. However, letters of credit are required by
us on many of our export sales. Historically, our credit losses
have been minimal.
We maintain cash deposits with major banks, which from time to
time may exceed federally insured limits. We periodically assess
the financial condition of these institutions and believe that
the likelihood of any possible loss is minimal.
|
|
|
Fair Value of Financial Instruments |
The carrying amounts reflected in the consolidated balance
sheets for cash and cash equivalents, accounts receivable,
accounts payable, certain accrued liabilities and amounts due
under our Revolver approximate fair value due to the short
maturities of these instruments. As of December 31, 2004,
the fair value of our Senior Notes was $99.7 million based
on its quoted price.
Under our Certificate of Incorporation, we are authorized to
issue 10,125,000 shares of capital stock, consisting of
10,000,000 shares of common stock, par value $0.01 per
share, and 125,000 shares of preferred stock, par value
$0.01 per share. In connection with our Plan of
Reorganization and the merger of Holdings into Predecessor
Sterling, we issued a total of 2,825,000 shares of common
stock. Subject to applicable law and the provisions of our
Certificate of Incorporation, the indenture governing our
Secured Notes and the Revolver, dividends may be declared on our
shares of capital stock at the discretion of our Board of
Directors and may be paid in cash, in property or in shares of
our capital stock.
Upon the effective date of our Plan of Reorganization, we
authorized 25,000 shares and issued 2,175 shares of
our Series A Convertible Preferred Stock
(Series A Preferred Stock). Each share of
72
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
Series A Preferred Stock is convertible at the option of
the holder thereof at any time into 1,000 shares of our
common stock, subject to adjustments. The Series A
Preferred Stock has a cumulative dividend rate of 4% per
quarter, payable in additional shares of Series A Preferred
Stock in arrears on the first Business Day of each calendar
quarter. As our shares of Series A Preferred Stock are
convertible into shares of our Common Stock (currently on a one
to 1,000 share basis), each dividend paid in additional
shares of our Series A Preferred Stock has a dilutive
effect on our shares of common stock. Since the initial issuance
of Series A Preferred Stock, we have issued an additional
818.464 shares of our Series A Preferred Stock
(convertible into 818,464 shares of our common stock) in
dividends.
Our Series A Preferred Stock carries a liquidation
preference of $13,793.11 per share, subject to adjustments.
We may redeem all or any number of our shares of Series A
Preferred Stock at any time after December 19, 2005, at a
redemption price determined in accordance with Certificate of
Designations, Preferences, Rights and Limitations of our
Series A Preferred Stock, provided that the current equity
value of our capital stock issued on the effective date of our
Plan of Reorganization exceeds specified levels. The holders of
our Series A Preferred Stock may elect to have us redeem
all or any of their shares of Series A Preferred Stock
following a specified change of control at a redemption price
equal to the greater of:
|
|
|
|
|
the liquidation preference for such shares (plus accrued and
unpaid dividends); |
|
|
|
in the event of a merger or consolidation, the fair market value
of the consideration that would have been received in such
merger or consolidation in respect of the shares of our common
stock into which such shares of Series A Preferred Stock
were convertible immediately prior to such merger or
consolidation had such shares of Series A Preferred Stock
been converted prior thereto; or |
|
|
|
in the event of some other specified change of control, the
current market value of the shares of our common stock into
which such shares of Series A Preferred Stock were
convertible immediately prior to such change of control had such
shares of Series A Preferred Stock been converted prior
thereto (plus accrued and unpaid dividends). |
Upon the effective date of our Plan of Reorganization, we also
issued warrants (the Warrants) to purchase, in the
aggregate, 949,367 shares of common stock. Each Warrant
represents the right, at any time on or before December 19,
2008, to purchase one share of our common stock at an exercise
price of $52 per share (subject to adjustments).
|
|
13. |
RELATED PARTY TRANSACTIONS |
Resurgence Asset Management, L.L.C. (Resurgence) has
beneficial ownership of a substantial majority of the voting
power of our equity securities due to its investment and
disposition authority over securities owned by its and its
affiliates managed funds and accounts. Currently,
Resurgence has beneficial ownership of over 98% of our
Series A Preferred Stock and over 63% of our common stock,
representing ownership of over 80% of the total voting power of
our equity. Each share of our Series A Preferred Stock is
convertible at the option of the holder thereof at any time into
1,000 shares of our common stock, subject to adjustments.
The holders of our Series A Preferred Stock are entitled to
designate a number of our directors roughly proportionate to
their overall equity ownership, but in any event not less than a
majority of our directors as long as they hold in the aggregate
at least 35% of the total voting power of our equity. As a
result, these holders have the ability to control our
management, policies and financing decisions, elect a majority
of our Board and control the vote on all matters presented to a
vote of our stockholders. In addition, our shares of
Series A Preferred Stock, almost all of which are
beneficially owned by Resurgence, carry a cumulative dividend
rate of 4% per quarter, payable in additional shares of
Series A Preferred Stock. Each dividend paid in additional
shares of our Series A Preferred Stock has a
73
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
dilutive effect on our shares of common stock and increases the
percentage of the total voting power of our equity beneficially
owned by Resurgence. Series A Preferred Stock dividends
were 434.638 shares and 371.530 shares during 2004 and
2003, respectively. Five of our directors, Messrs. Byron J.
Haney, Marc S. Kirschner, Philip M. Sivin, Robert T. Symington
and Keith R. Whittaker, are employed by Resurgence. Our former
Chairman of the Board, Mr. James B. Rubin, was also
employed by Resurgence during the first half of the year.
Pursuant to established policies of Resurgence, all director
compensation earned by Messrs Rubin, Haney, Kirschner, Sivin,
Symington and Whittaker was paid to Resurgence. During 2004, we
paid Resurgence an aggregate amount equal to $190,750 related to
director compensation along with reimbursement of an immaterial
amount of direct, out-of-pocket expenses incurred in connection
with services as directors. During the period October 1 to
December 19, 2002, with the approval of the Bankruptcy
Court, we made payments totaling approximately $1 million
to Resurgence in reimbursement of certain expenses incurred by
Resurgence in its role as the Investor in our Plan of
Reorganization and in accordance with our contractual
obligations.
We have significant transactions with ANEXCO, LLC
(ANEXCO), a 50/50 joint venture agreement with BP
Amoco Chemical Company. ANEXCO markets all of the parties
respective sales of acrylonitrile everywhere in the world other
than the United States, Canada, Mexico, Turkey and the European
Union. Revenues earned during 2004 and 2003 pursuant to this
joint venture agreement were $142 million and
$33 million, respectively. There were no revenues earned
pursuant to this joint venture agreement during the three-months
ended December 31, 2002 or fiscal 2002. At
December 31, 2004 and 2003, we had $35.6 million and
$8.3 million, respectively, recorded in accounts receivable
related to sales of our acrylonitrile to ANEXCO. At
December 31, 2004 and 2003, we also had $0.8 million
and $2.7 million, respectively, recorded in accounts
payable related to fixed costs reimbursements to ANEXCO.
|
|
14. |
NEW ACCOUNTING STANDARDS |
On December 8, 2003, the Medicare Prescription Drug
Improvement and Modernization Act of 2003 (the Act)
was passed. The Act introduces a prescription drug benefit under
Medicare (Medicare Part D), as well as a federal subsidy to
sponsors of retiree health care benefit plans that provide a
benefit that is at least actuarially equivalent to Medicare
Part D. In January 2004, the Financial Accounting Standards
Board (the FASB) issued FASB Staff Position
No. FAS 106-1, Accounting and Disclosure
Requirements Related to the Medicare Prescription Drug
Improvement and Modernization Act of 2003
(FAS 106-1), which is effective for interim or
annual financial statements of fiscal years ending after
December 7, 2003 and permits a one-time election to defer
accounting for the effects of the Act. In May 2004, the FASB
issued FASB Staff Position No. 106-2, Accounting and
Disclosure Requirements Related to the Medicare Prescription
Drug, Improvement and Modernization Act of 2003
(FAS 106-2), which supercedes FAS 106-1.
FAS 106-2 provides guidance on the accounting for the
effects of the Act for employers that sponsor postretirement
heath care plans that provide prescription drug benefits, and
requires those employers to provide certain disclosures
regarding the effect of the federal subsidy provided under the
Act. FAS 106-2 applies to us effective July 1, 2004.
We measured the effects of the Act on our accumulated
postretirement benefit obligation and determined that, based on
the regulatory guidance currently available, benefits provided
by our postretirement plan are at least actuarially equivalent
to Medicare Part D, and accordingly, we expect to be
entitled to the federal subsidy in the years 2006 through 2009.
We estimate that this subsidy will be approximately 20% of the
net benefits under our plan, or $0.2 million annually.
In November 2004, the FASB issued SFAS No. 151,
Inventory Costs an amendment of ARB
No. 43, Chapter 4, (SFAS 151)
in an effort to conform U.S. accounting standards for
inventories to International Accounting Standards. SFAS 151
requires idle facility expenses, freight, handling costs and
wasted material (spoilage) costs to be recognized as
current-period charges. It also requires that the
74
STERLING CHEMICALS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Continued)
allocation of fixed production overheads to the costs of
conversion be based on the normal capacity of the relevant
production facilities. SFAS 151 will be effective for
inventory costs incurred during fiscal years beginning after
June 15, 2005. We are currently evaluating the impact of
this standard on our consolidated financial statements.
In December 2004, the FASB issued SFAS No. 123-Revised
2004 (SFAS 123®), Share-Based
Payment. This is a revision of SFAS No. 123,
Accounting for Stock-Based Compensation, and supersedes APB
No. 25, Accounting for Stock Issued to Employees. As noted
in the notes to financial statements, we do not record
compensation expense for stock-based compensation. Under
SFAS 123®, we will be required to measure the cost of
employee services received in exchange for stock based on the
grant-date fair value (with limited exceptions). That cost will
be recognized over the period during which an employee is
required to provide service in exchange for the award (usually
the vesting period). The fair value will be estimated using an
option-pricing model. Excess tax benefits, as defined in
SFAS 123®, will be recognized as an addition to
paid-in capital. This is effective as of the beginning of the
first interim or annual reporting period that begins after
June 15, 2005. We are currently in the process of
evaluating the impact of SFAS 123® on our financial
statements, including different option-pricing models. The pro
forma table in Note 2 of the Notes to the Consolidated
Financial Statements illustrates the effect on net income and
earnings per share if we had applied the fair value recognition
provisions of SFAS 123.
In December 2003, the FASB issued FASB Statement
No. 132-Revised 2003 (SFAS 132R),
Employers Disclosures about Pensions and Other
Postretirement Benefits. This standard increases the
existing disclosure requirements by requiring more details about
pension plan assets, benefit obligations, cash flows, benefit
costs and related information. Companies are required to
segregate plan assets by category, such as debt, equity and real
estate, and to provide certain expected rates of return and
other informational disclosures. SFAS 132R also requires
companies to disclose various elements of pension and
postretirement benefit costs in interim-period financial
statements for quarters beginning after December 15, 2003
(see Note 8 of the Notes to the Consolidated Financial
Statements). We have complied with the disclosure requirements
of SFAS 132R.
75
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Sterling Chemicals, Inc.:
We have audited the accompanying consolidated balance sheets of
Sterling Chemicals, Inc. and subsidiaries (the
Company) as of December 31, 2004 and 2003
(Successor Company balance sheets) and the related consolidated
statements of operations, changes in stockholders equity
(deficiency in assets) and cash flows for the years ended
December 31, 2004 and 2003 and the period from
December 20, 2002 to December 31, 2002 (Successor
Company operations) and for the period from October 1, 2002
to December 19, 2002 and the fiscal year ended
September 30, 2002 (Predecessor Company operations). These
financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes consideration
of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion
on the effectiveness of the Companys internal control over
financial reporting. Accordingly, we express no such opinion. An
audit also includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as
well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our
opinion.
As discussed in Note 1 to the financial statements, on
November 20, 2002, the Bankruptcy Court entered an order
confirming the plan of reorganization which became effective
after the close of business on December 19, 2002.
Accordingly, the accompanying financial statements have been
prepared in conformity with AICPA Statement of
Position 90-7, Financial Reporting for Entities in
Reorganization Under the Bankruptcy Code, for the
Successor Company as a new entity with assets, liabilities and a
capital structure having carrying values not comparable with
prior periods as described in Notes 1 and 3.
In our opinion, the Successor Company financial statements
present fairly, in all material respects, the financial position
of the Company as of December 31, 2004 and 2003, and the
results of its operations and its cash flows for the years ended
December 31, 2004 and 2003 and the period from
December 20, 2002 to December 31, 2002 in conformity
with accounting principles generally accepted in the United
States of America. Further, in our opinion, the Predecessor
Company financial statements referred to above present fairly,
in all material respects, the results of its operations and its
cash flows for the period from October 1, 2002 to
December 19, 2002 and the fiscal year ended
September 30, 2002 in conformity with accounting principles
generally accepted in the United States of America.
As disclosed in Note 1 to the financial statements, in
December 2002, the Company changed its fiscal year-end from
September 30 to December 31.
Houston, Texas
February 15, 2005
76
STERLING CHEMICALS, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
QUARTERLY FINANCIAL DATA (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First | |
|
Second | |
|
Third | |
|
Fourth | |
|
|
Year | |
|
Quarter | |
|
Quarter | |
|
Quarter | |
|
Quarter | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(Dollars in Thousands, Except Per Share Data) | |
Revenues
|
|
|
2004 |
|
|
$ |
146,101 |
|
|
$ |
184,905 |
|
|
$ |
251,839 |
|
|
$ |
268,817 |
|
|
|
|
2003 |
|
|
|
121,849 |
|
|
|
120,121 |
|
|
|
160,210 |
|
|
|
190,611 |
|
|
Gross profit (loss)
|
|
|
2004 |
|
|
|
(11,600 |
) |
|
|
3,135 |
|
|
|
15,293 |
|
|
|
(4,260 |
) |
|
|
|
2003 |
|
|
|
(2,644 |
) |
|
|
(9,788 |
) |
|
|
7,160 |
|
|
|
8,323 |
|
|
Net income (loss) from continuing operations
(1)
|
|
|
2004 |
|
|
|
(9,860 |
) |
|
|
(50,584 |
) |
|
|
5,529 |
|
|
|
(7,729 |
) |
|
|
|
2003 |
|
|
|
(3,540 |
) |
|
|
(9,775 |
) |
|
|
1,535 |
|
|
|
(1,443 |
) |
|
Income (loss) from discontinued operations
|
|
|
2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2003 |
|
|
|
(634 |
) |
|
|
(342 |
) |
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to common stockholders
|
|
|
2004 |
|
|
|
(11,272 |
) |
|
|
(52,052 |
) |
|
|
4,002 |
|
|
|
(9,316 |
) |
|
|
|
2003 |
|
|
|
(5,381 |
) |
|
|
(11,372 |
) |
|
|
230 |
|
|
|
(2,801 |
) |
|
Net income (loss) per share of common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
2004 |
|
|
|
(3.99 |
) |
|
|
(18.43 |
) |
|
|
1.42 |
|
|
|
(3.30 |
) |
|
|
|
2003 |
|
|
|
(1.90 |
) |
|
|
(4.03 |
) |
|
|
0.08 |
|
|
|
(0.99 |
) |
|
|
Diluted
|
|
|
2004 |
|
|
|
(3.99 |
) |
|
|
(18.43 |
) |
|
|
0.99 |
|
|
|
(3.30 |
) |
|
|
|
2003 |
|
|
|
(1.90 |
) |
|
|
(4.03 |
) |
|
|
0.08 |
|
|
|
(0.99 |
) |
|
|
(1) |
In the second quarter of 2004, we recorded a $48.5 million
non-cash goodwill impairment charge. In the fourth quarter of
2004, we recorded a $22 million non-cash impairment charge
related to our acrylonitrile long-lived assets and a pension
curtailment gain of $13 million. We incurred
$17.0 million in reorganization items in fiscal 2002 as a
result of our Chapter 11 proceedings. Contractual interest
expense not paid or accrued was $49 million in fiscal 2002. |
|
|
Item 9. |
Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure |
None.
|
|
Item 9A. |
Controls and Procedures |
We maintain disclosure controls and procedures that are designed
to ensure that information required to be disclosed in our
Exchange Act reports is recorded, processed, summarized and
reported within the time periods specified in the rules and
forms of the Securities and Exchange Commission, and that such
information is accumulated and communicated to our management,
including our Chief Executive Officer and Chief Financial
Officer, as appropriate, to allow timely decisions regarding
required disclosure. Management necessarily applied its judgment
in assessing the costs and benefits of such controls and
procedures which, by their nature, can provide only reasonable
assurance regarding managements control objectives.
We carried out an evaluation, under the supervision and with the
participation of our management, including our Chief Executive
Officer and Chief Financial Officer, of the effectiveness of the
design and operation of our disclosure controls and procedures
pursuant to Exchange Act Rule 13a-15, as of the end of the
fiscal period covered by this report on Form 10-K. Based
upon that evaluation, each of our Chief Executive Officer and
our Chief Financial Officer concluded that our disclosure
controls and procedures are effective in timely alerting them to
material information relating to us (including our consolidated
subsidiaries) required to be disclosed in our Exchange Act
reports. In connection with our evaluation, no
77
change was identified in our internal controls over financial
reporting that occurred during the fourth quarter of 2004 that
has materially affected, or is reasonably likely to materially
affect, our internal controls over financial reporting.
Beginning with our annual report on Form 10-K for 2005, we
will be subject to the provisions of Section 404 of the
Sarbanes-Oxley Act that require an annual management assessment
of our internal control over financial reporting and related
attestation by our independent registered public accounting firm.
|
|
Item 9B. |
Other Information |
None.
PART III
|
|
Item 10. |
Directors and Executive Officers of the Registrant |
Reference is made to the information responsive to Item 10
of this Part III contained in our definitive proxy
statement for our 2005 Annual Meeting of Stockholders which is
hereby incorporated herein by reference in response to this item.
|
|
Item 11. |
Executive Compensation |
Reference is made to the information responsive to Item 11
of this Part III contained in our definitive proxy
statement for our 2005 Annual Meeting of Stockholders which is
hereby incorporated herein by reference in response to this item.
|
|
Item 12. |
Security Ownership of Certain Beneficial Owners and
Management |
Reference is made to the information responsive to Item 12
of this Part III contained in our definitive proxy
statement for our 2005 Annual Meeting of Stockholders which is
hereby incorporated herein by reference in response to this item.
|
|
Item 13. |
Certain Relationships and Related Transactions |
Reference is made to the information responsive to Item 13
of this Part III contained in our definitive proxy
statement for our 2005 Annual Meeting of Stockholders which is
hereby incorporated herein by reference in response to this item.
|
|
Item 14. |
Principal Accountant Fees and Services |
Reference is made to the information responsive to Item 14
of this Part III contained in our definitive proxy
statement for our 2005 Annual Meeting of Stockholders which is
hereby incorporated herein by reference in response to this item.
PART IV
|
|
Item 15. |
Exhibits and Consolidated Financial Statement
Schedules. |
(a) Financial Statements, Financial Statement Schedules and
Exhibits.
|
|
|
1. Consolidated Financial Statements. See
Item 8. Financial Statements and Supplementary
Data Index to Financial Statements. |
|
|
2. Consolidated Financial Statement Schedules. All
schedules for which provision is made in Regulation S-X
either are not required under the related instruction or are
inapplicable and, therefore, have been omitted. |
78
|
|
|
3. Exhibits. See the Exhibit Index for a list of those
exhibits filed herewith, which index also includes and
identifies management contracts or compensatory plans or
arrangements required to be filed as exhibits to this
Form 10-K by Item 601(b)(10)(iii) of
Regulation S-K. |
(b) Exhibit index.
|
|
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibit |
|
|
|
|
|
|
2.1 |
|
|
|
|
Certificate of Ownership and Merger merging Sterling Chemicals
Holdings, Inc. into Sterling Chemicals, Inc. (incorporated
herein by reference from Exhibit 2.1 to our Annual Report
on Form 10-K for the fiscal year ended September 30, 2002). |
|
2.2 |
|
|
|
|
Joint Plan of Reorganization of Sterling Chemicals Holdings,
Inc., et. al., Debtors, dated October 14, 2002
(incorporated herein by reference from Exhibit 2.1 to our
Form 8-K filed on November 26, 2002). |
|
2.3 |
|
|
|
|
First Modification to Joint Plan of Reorganization of Sterling
Chemicals Holdings, Inc., et. al., Debtors, dated
November 18, 2002 (incorporated herein by reference from
Exhibit 2.2 to our Form 8-K filed on November 26,
2002). |
|
3.1 |
|
|
|
|
Amended and Restated Certificate of Incorporation of Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 3.1 to our Annual Report on Form 10-K for the
fiscal year ended September 30, 2002). |
|
3.2 |
|
|
|
|
Restated Certificate of Designations, Preferences, Rights and
Limitations of Series A Convertible Preferred Stock of
Sterling Chemicals, Inc. (incorporated herein by reference from
Exhibit 3.2 to our Annual Report on Form 10-K for the
fiscal year ended December 31, 2003). |
|
3.3 |
|
|
|
|
Restated Bylaws of Sterling Chemicals, Inc. (conformed copy)
(incorporated herein by reference from Exhibit 3.3 to our
Quarterly Report on Form 10-Q for the quarterly period ended
June 30, 2003). |
|
4.1 |
|
|
|
|
Warrant Agreement dated as of December 19, 2002 by and
between Sterling Chemicals, Inc., and Wells Fargo Bank
Minnesota, N.A., as warrant agent (incorporated herein by
reference from Exhibit 5 to our Form 8-A filed on
December 19, 2002). |
|
4.2 |
|
|
|
|
Registration Rights Agreement dated as of December 19, 2002
by and between Sterling Chemicals, Inc. and Resurgence Asset
Management, L.L.C. (incorporated herein by reference from
Exhibit 7 to our Form 8-A filed on December 19,
2002). |
|
4.3 |
|
|
|
|
Tag Along Agreement dated as of December 19, 2002 by and
among Sterling Chemicals, Inc., Resurgence Asset Management,
L.L.C. and the Official Committee of the Unsecured Creditors
(incorporated herein by reference from Exhibit 8 to our
Form 8-A filed on December 19, 2002). |
|
4.4 |
|
|
|
|
Indenture dated December 19, 2002 by and among Sterling
Chemicals, Inc., as Issuer, Sterling Chemicals Energy, Inc., as
Guarantor, and National City Bank, as Trustee, governing the
10% Senior Secured Notes due 2007 of Sterling Chemicals,
Inc. (incorporated herein by reference from Exhibit T3-C to
Amendment No. 3 to our Form T-3 filed on
December 19, 2002). |
|
4.5 |
|
|
|
|
Deed of Trust, Assignment of Leases and Rents, Security
Agreement and Fixture Filing dated December 19, 2002 made
by Sterling Chemicals, Inc., as Trustor, to Thomas S. Henderson,
as Individual Trustee for the benefit of National City Bank, in
its capacity as described therein, as Beneficiary (incorporated
herein by reference from Exhibit 4.2 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
4.6 |
|
|
|
|
Security Agreement dated as of December 19, 2002 by and
among Sterling Chemicals, Inc. and Sterling Chemicals Energy,
Inc., as Assignors, National City Bank, as Collateral Agent, and
National City Bank, as Indenture Trustee for the benefit of the
holders the 10% Senior Secured Notes due 2007 of Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 4.3 to our Transition Report on Form 10-Q for
the transition period ended December 31, 2002). |
79
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.1 |
|
|
|
|
Revolving Credit Agreement dated as of December 19, 2002 by
and among Sterling Chemicals, Inc. and Sterling Chemicals
Energy, Inc., as Borrowers, the various financial institutions
as are or may become parties thereto from time to time, as the
Lenders, and The CIT Group/Business Credit, Inc., as the
Administrative Agent for the Lenders (incorporated herein by
reference from Exhibit 4.4 to our Transition Report on Form
10-Q for the transition period ended December 31, 2002). |
|
10.1(a) |
|
|
|
|
First Amendment to Revolving Credit Agreement dated as of
February 12, 2003 by and among Sterling Chemicals, Inc. and
Sterling Chemicals Energy, Inc., as Borrowers, the various
financial institutions party thereto, as the Lenders, and The
CIT Group/Business Credit, Inc., as the Administrative Agent for
the Lenders (incorporated herein by reference from
Exhibit 4.8 to our Transition Report on Form 10-Q for
the transition period ended December 31, 2002). |
|
10.2 |
|
|
|
|
Security Agreement dated as of December 19, 2002 made by
Sterling Chemicals, Inc. and Sterling Chemicals Energy, Inc., as
Grantors, in favor of The CIT Group/Business Credit, Inc., as
Administrative Agent for the Secured Parties (incorporated
herein by reference from Exhibit 4.5 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.3 |
|
|
|
|
Pledge Agreement dated as of December 19, 2002 made by
Sterling Chemicals, Inc. and Sterling Chemicals Energy, Inc., as
Pledgors, in favor of The CIT Group/Business Credit, Inc., as
Administrative Agent for the Secured Parties (incorporated
herein by reference from Exhibit 4.6 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.4* |
|
|
|
|
Sterling Chemicals, Inc. 2002 Stock Plan (incorporated herein by
reference to Exhibit 6 to our Form 8-A filed on
December 19, 2002). |
|
10.5* |
|
|
|
|
Fourth Amended and Restated Key Employee Protection Plan
(incorporated herein by reference from Exhibit 10.1 to our
Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2004). |
|
10.6* |
|
|
|
|
Amended and Restated Supplemental Pay Plan (incorporated herein
by reference from Exhibit 10.1 to our Quarterly Report on
Form 10-Q for the quarterly period ended June 30, 2001). |
|
10.6(a)* |
|
|
|
|
First Amendment to Amended and Restated Supplemental Pay Plan
(incorporated herein by reference from Exhibit 10.2(a) to
our Annual Report on Form 10-K for the fiscal year ended
September 30, 2002). |
|
10.7* |
|
|
|
|
Third Amended and Restated Severance Pay Plan (incorporated
herein by reference from Exhibit 10.7 to our Annual Report
on Form 10-K for the fiscal year ended December 31, 2003). |
|
10.8* |
|
|
|
|
Sterling Chemicals, Inc. Amended and Restated Salaried
Employees Pension Plan (Effective as of May 1, 1996)
(incorporated herein by reference from Exhibit 10.4 to our
Annual Report on Form 10-K for the fiscal year ended
September 30, 2000). |
|
10.8(a)* |
|
|
|
|
First Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
January 31, 1997) (incorporated herein by reference from
Exhibit 10.4(a) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2000). |
|
10.8(b)* |
|
|
|
|
Second Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
January 1, 1997) (incorporated herein by reference from
Exhibit 10.4(b) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2000). |
|
10.8(c)* |
|
|
|
|
Third Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
November 1, 1998) (incorporated herein by reference from
Exhibit 10.4(c) to our Annual Report on Form 10-K for the
fiscal year ended September 30, 2000). |
80
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.8(d)* |
|
|
|
|
Fourth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
December 31, 1998) (incorporated herein by reference from
Exhibit 10.4(d) to our Annual Report on Form 10-K for the
fiscal year ended September 30, 2000). |
|
10.8(e)* |
|
|
|
|
Fifth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
April 1, 1999) (incorporated herein by reference from
Exhibit 10.4(e) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2000). |
|
10.8(f)* |
|
|
|
|
Sixth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
May 14, 1999) (incorporated herein by reference from
Exhibit 10.4(f) to our Annual Report on Form 10-K for the
fiscal year ended September 30, 2000). |
|
10.8(g)* |
|
|
|
|
Seventh Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.1 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.8(h)* |
|
|
|
|
Eighth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.2 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.8(i)* |
|
|
|
|
Ninth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.3 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.8(j)* |
|
|
|
|
Tenth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.2 to our Quarterly
Report on Form 10-Q for the quarterly period ended
June 30, 2003). |
|
10.8(k)* |
|
|
|
|
Eleventh Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.8(k) to our Annual
Report on Form 10-K for the fiscal year ended December 31,
2003). |
|
10.8(l)* |
|
|
|
|
Twelfth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.1 to our Quarterly
Report on Form 10-Q for the quarterly period ended
June 30, 2004). |
|
10.8(m)* |
|
|
|
|
Thirteenth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.2 to our Quarterly
Report on Form 10-Q for the quarterly period ended
June 30, 2004). |
|
**10.8(n)* |
|
|
|
|
Fourteenth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan. |
|
10.9* |
|
|
|
|
Sterling Chemicals, Inc. Pension Benefit Equalization Plan
(incorporated herein by reference from Exhibit 10.10 to our
Registration Statement on Form S-1 (Registration
No. 33-24020)). |
|
**10.9(a)* |
|
|
|
|
First Amendment to Sterling Chemicals, Inc. Pension Benefit
Equalization Plan. |
|
10.10* |
|
|
|
|
Sterling Chemicals, Inc. Amended and Restated Supplemental
Employee Retirement Plan (incorporated herein by reference from
Exhibit 10.34 to our Annual Report on Form 10-K for
the fiscal year ended September 30, 1989 (SEC File
Number 1-10059)). |
|
**10.10(a) |
* |
|
|
|
First Amendment to Sterling Chemicals, Inc. Amended and Restated
Supplemental Employee Retirement Plan. |
81
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.11 |
|
|
|
|
Sterling Chemicals, Inc. Amended and Restated Hourly Paid
Employees Pension Plan (Effective as of May 1, 1996)
(incorporated herein by reference from Exhibit 10.3(c) to
our Annual Report on Form 10-K for the fiscal year ended
September 30, 1996 (SEC File Number 333-04343-01)). |
|
10.11(a) |
|
|
|
|
First Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (Effective as
of December 31, 1998) (incorporated herein by reference
from Exhibit 10.7(a) to our Annual Report on Form 10-K
for the fiscal year ended September 30, 2000). |
|
10.11(b) |
|
|
|
|
Second Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (Effective as
of December 17, 1998) (incorporated herein by reference
from Exhibit 10.7(b) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2000). |
|
10.11(c) |
|
|
|
|
Third Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (Effective as
of September 20, 1999) (incorporated herein by reference
from Exhibit 10.7(c) to our Annual Report on Form 10-K
for the fiscal year ended September 30, 2000). |
|
10.11(d) |
|
|
|
|
Fourth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (incorporated
herein by reference from Exhibit 10.4 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.11(e) |
|
|
|
|
Fifth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (incorporated
herein by reference from Exhibit 10.5 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.11(f) |
|
|
|
|
Sixth Amendment to the Sterling Chemicals, Inc. Hourly Paid
Employees Pension Plan (incorporated herein by reference
from Exhibit 10.3 to our Quarterly Report on Form 10-Q
for the quarterly period ended June 30, 2003). |
|
10.11(g) |
|
|
|
|
Seventh Amendment to the Sterling Chemicals, Inc. Hourly Paid
Employees Pension Plan (incorporated herein by reference
from Exhibit 10.11(g) to our Annual Report on
Form 10-K for the fiscal year ended December 31, 2003). |
|
10.11(h) |
|
|
|
|
Eighth Amendment to the Sterling Chemicals, Inc. Hourly Paid
Employees Pension Plan (incorporated herein by reference
from Exhibit 10.3 to our Quarterly Report on Form 10-Q
for the quarterly period ended June 30, 2004). |
|
10.12* |
|
|
|
|
Sterling Chemicals, Inc. Sixth Amended and Restated Savings and
Investment Plan dated as of October 1, 2000 (incorporated
herein by reference from Exhibit 10.8 to our Annual Report
on Form 10-K for the fiscal year ended September 30,
2000). |
|
10.12(a) |
* |
|
|
|
First Amendment to the Sixth Amended and Restated Savings and
Investment Plan dated as of October 1, 2000 (incorporated
herein by reference from Exhibit 10.1 to our Quarterly
Report on Form 10-Q for the quarterly period ended
December 31, 2001). |
|
10.12(b) |
* |
|
|
|
Second Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.6 to our Transition Report on Form 10-Q for
the transition period ended December 31, 2002). |
|
10.12(c) |
* |
|
|
|
Third Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.7 to our Transition Report on Form 10-Q for
the transition period ended December 31, 2002). |
|
10.12(d) |
* |
|
|
|
Fourth Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.4 to our Quarterly Report on Form 10-Q for
the quarterly period ended June 30, 2003). |
|
10.12(e) |
* |
|
|
|
Fifth Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.4 to our Quarterly Report on Form 10-Q for
the quarterly period ended June 30, 2004). |
82
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.12(f) |
* |
|
|
|
Sixth Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.1 to our Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2004). |
|
**10.12(g) |
* |
|
|
|
Seventh Amendment to the Sixth Amended and Restated Savings and
Investment Plan. |
|
10.13 |
|
|
|
|
Articles of Agreement between Sterling Chemicals, Inc., its
successors and assigns, and Texas City, Texas Metal Trades
Council, AFL-CIO Texas City, Texas, May 27, 2004 to
May 1, 2007 (incorporated herein by reference from
Exhibit 10.5 to our Quarterly Report on Form 10-Q for
the quarterly period ended June 30, 2004). |
|
10.14* |
|
|
|
|
Form of Indemnity Agreement with each of its officers and
directors (incorporated herein by reference from
Exhibit 10.17 to our Annual Report on Form 10-K for
the fiscal year ended September 30, 1996 (SEC File
Number 333-04343-01)). |
|
10.15* |
|
|
|
|
Employment Agreement dated as of January 23, 2001 among
David G. Elkins, Sterling Chemicals Holdings, Inc. and Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.16 to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2002). |
|
10.16* |
|
|
|
|
Severance Agreement dated effective as of January 2, 2003
between David G. Elkins and Sterling Chemicals, Inc.
(incorporated herein by reference from Exhibit 10.10 to our
Transition Report on Form 10-Q for the transition period
ended December 31, 2002). |
|
10.17* |
|
|
|
|
Settlement Agreement, Waiver and General Release dated
March 17, 2003 between Frank P. Diassi and Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.1 to our Quarterly Report on Form 10-Q for
the transition period ended March 31, 2003). |
|
+10.18 |
|
|
|
|
Amended and Restated Production Agreement dated March 31,
1998 between BP Chemicals, Inc. (predecessor in interest to
BP Amoco Chemical Company) and Sterling Chemicals, Inc.
(incorporated herein by reference from Exhibit 10.2 to our
Quarterly Report on Form 10-Q for the quarterly period
ended March 31, 1998 (SEC File Number 333-04343-01)). |
|
+10.19 |
|
|
|
|
Joint Venture Agreement dated March 31, 1998 between
BP Chemicals Inc. (predecessor in interest to BP Amoco
Chemical Company) and Sterling Chemicals, Inc. (incorporated
herein by reference from Exhibit 10.4 to our Quarterly
Report on Form 10-Q for the quarterly period ended
March 31, 1998 (SEC File Number 333-04343-01)). |
|
+10.19(a) |
|
|
|
|
First Amendment to Joint Venture Agreement dated effective as of
March 31, 1998 between BP Chemicals Inc. (predecessor in
interest to BP Amoco Chemical Company) and Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.26(a) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 1998 (SEC File
Number 333-04343-01)). |
|
+10.20 |
|
|
|
|
Acrylonitrile Expanded Relationship and Master Modification
Agreement dated June 19, 2003 between BP Chemicals
Inc. (predecessor in interest to BP Amoco Chemical Company)
and Sterling Chemicals, Inc. (incorporated herein by reference
from Exhibit 10.1 to our Quarterly Report on Form 10-Q
for the quarterly period ended June 30, 2003). |
|
+10.21 |
|
|
|
|
Second Amended and Restated Production Agreement dated effective
as of August 1, 1996 between BP Chemicals Inc.
(predecessor in interest to BP Amoco Chemical Company) and
Sterling Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.3 to our Quarterly Report on Form 10-Q for
the quarterly period ended March 31, 1998 (SEC File
Number 333-04343-01)). |
|
+10.21(a) |
|
|
|
|
Amendment to Second Amended and Restated Production Agreement
dated as of March 1, 2001 between BP Chemicals Inc.
(predecessor in interest to BP Amoco Chemical Company) and
Sterling Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.1 to our Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2001). |
83
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
+10.22 |
|
|
|
|
Amended and Restated Product Sales Agreement dated effective as
of January 1, 1998 between BASF Corporation and Sterling
Chemicals, Inc. (incorporated herein by referenced from
Exhibit 10.11 to our Annual Report on Form 10-K for
the fiscal year ended September 30, 1997 (SEC File
Number 333-04343-01)). |
|
10.23 |
|
|
|
|
License Agreement dated August 1, 1986 between Monsanto
Company and Sterling Chemicals, Inc. (incorporated herein by
reference from Exhibit 10.25 to our Registration Statement
on Form S-1 (Registration No. 33-24020)). |
|
10.24 |
|
|
|
|
Asset and Stock Purchase Agreement dated as of November 13,
2002 among Sterling Chemicals, Inc. and Sterling Canada, Inc.,
Sterling Pulp Chemicals US Inc., Sterling Pulp Chemicals,
Inc. and Sterling Chemicals Acquisitions, Inc., as Sellers, and
Superior Propane Inc., as Purchaser (incorporated herein by
reference from Exhibit 10.23 to our Annual Report on
Form 10-K for the fiscal year ended September 30,
2002). |
|
10.25 |
|
|
|
|
Investment Agreement dated as of October 11, 2002 among
Sterling Chemicals Holdings, Inc., Sterling Chemicals, Inc. and
Resurgence Asset Management, L.L.C. (incorporated herein by
reference from Exhibit 2.1 to our Annual Report on
Form 10-K for the fiscal year ended September 30,
2002). |
|
14.1 |
|
|
|
|
Sterling Chemicals, Inc. Code of Ethics for the Chief Executive
Officer and Senior Financial Officers (incorporated herein by
reference from Exhibit 14.1 to our Quarterly Report on Form
10-Q for the quarterly period ended June 30, 2003). |
|
**21.1 |
|
|
|
|
Subsidiaries of Sterling Chemicals, Inc. |
|
**23.1 |
|
|
|
|
Consent of Deloitte & Touche LLP. |
|
**31.1 |
|
|
|
|
Rule 13a-14(a) Certification of the Chief Executive Officer |
|
**31.2 |
|
|
|
|
Rule 13a-14(a) Certification of the Chief Financial Officer |
|
**32.1 |
|
|
|
|
Section 1350 Certification of the Chief Executive Officer |
|
**32.2 |
|
|
|
|
Section 1350 Certification of the Chief Financial Officer |
|
99.1 |
|
|
|
|
Amended and Restated Audit Committee Charter of Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 99.1 to our Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2003). |
|
99.2 |
|
|
|
|
Amended and Restated Corporate Governance Committee Charter of
Sterling Chemicals, Inc. (incorporated herein by reference from
Exhibit 99.2 to our Annual Report on Form 10-K for the
fiscal year ended December 31, 2003). |
|
|
* |
Management contracts or compensatory plans or arrangements. |
|
|
** |
Filed or furnished herewith. |
|
|
+ |
Portions of the exhibit have been omitted and filed separately
with the Securities and Exchange Commission pursuant to a
request for confidential treatment. |
84
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
Sterling Chemicals, Inc.
|
|
(Registrant) |
|
|
|
|
|
Richard K. Crump |
|
President, Chief Executive Officer and Director |
|
|
|
|
By: |
/s/ Paul G. Vanderhoven
|
|
|
|
|
|
Paul G. Vanderhoven |
|
Senior Vice President-Finance and |
|
Chief Financial Officer |
Date: February 15, 2005
Pursuant to the requirements of the Securities and Exchange Act
of 1934, this report has been signed below by the following
persons on behalf of the registrant and in the capacities and on
the dates indicated.
|
|
|
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
|
Principal Executive Officer: |
|
|
|
|
|
/s/ Richard K. Crump
Richard
K. Crump |
|
President, Chief Executive Officer and Director |
|
February 15, 2005 |
|
Principal Financial Officer: |
|
|
|
|
|
/s/ Paul G. Vanderhoven
Paul
G. Vanderhoven |
|
Senior Vice President-Finance and
Chief Financial Officer |
|
February 15, 2005 |
|
Principal Accounting Officer: |
|
|
|
|
|
/s/ John R. Beaver
John
R. Beaver |
|
Vice President,
Corporate Controller |
|
February 15, 2005 |
|
/s/ Byron J. Haney
Byron
J. Haney |
|
Director |
|
February 15, 2005 |
|
/s/ Marc S. Kirschner
Marc
S. Kirschner |
|
Director |
|
February 15, 2005 |
|
/s/ Robert T. Symington
Robert
T. Symington |
|
Director |
|
February 15, 2005 |
|
/s/ Keith R. Whittaker
Keith
R. Whittaker |
|
Director |
|
February 15, 2005 |
|
/s/ John W. Gildea
John
W. Gildea |
|
Director |
|
February 15, 2005 |
|
/s/ Thomas P. Krasner
Thomas
P. Krasner |
|
Director |
|
February 15, 2005 |
|
/s/ Dr. Peter Ting Kai
Wu
Dr.
Peter Ting Kai Wu |
|
Director |
|
February 15, 2005 |
|
/s/ Philip M. Sivin
Philip
M. Sivin |
|
Director |
|
February 15, 2005 |
85
|
|
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibit |
|
|
|
|
|
|
2.1 |
|
|
|
|
Certificate of Ownership and Merger merging Sterling Chemicals
Holdings, Inc. into Sterling Chemicals, Inc. (incorporated
herein by reference from Exhibit 2.1 to our Annual Report
on Form 10-K for the fiscal year ended September 30, 2002). |
|
2.2 |
|
|
|
|
Joint Plan of Reorganization of Sterling Chemicals Holdings,
Inc., et. al., Debtors, dated October 14, 2002
(incorporated herein by reference from Exhibit 2.1 to our
Form 8-K filed on November 26, 2002). |
|
2.3 |
|
|
|
|
First Modification to Joint Plan of Reorganization of Sterling
Chemicals Holdings, Inc., et. al., Debtors, dated
November 18, 2002 (incorporated herein by reference from
Exhibit 2.2 to our Form 8-K filed on November 26,
2002). |
|
3.1 |
|
|
|
|
Amended and Restated Certificate of Incorporation of Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 3.1 to our Annual Report on Form 10-K for the
fiscal year ended September 30, 2002). |
|
3.2 |
|
|
|
|
Restated Certificate of Designations, Preferences, Rights and
Limitations of Series A Convertible Preferred Stock of
Sterling Chemicals, Inc. (incorporated herein by reference from
Exhibit 3.2 to our Annual Report on Form 10-K for the
fiscal year ended December 31, 2003). |
|
3.3 |
|
|
|
|
Restated Bylaws of Sterling Chemicals, Inc. (conformed copy)
(incorporated herein by reference from Exhibit 3.3 to our
Quarterly Report on Form 10-Q for the quarterly period ended
June 30, 2003). |
|
4.1 |
|
|
|
|
Warrant Agreement dated as of December 19, 2002 by and
between Sterling Chemicals, Inc., and Wells Fargo Bank
Minnesota, N.A., as warrant agent (incorporated herein by
reference from Exhibit 5 to our Form 8-A filed on
December 19, 2002). |
|
4.2 |
|
|
|
|
Registration Rights Agreement dated as of December 19, 2002
by and between Sterling Chemicals, Inc. and Resurgence Asset
Management, L.L.C. (incorporated herein by reference from
Exhibit 7 to our Form 8-A filed on December 19,
2002). |
|
4.3 |
|
|
|
|
Tag Along Agreement dated as of December 19, 2002 by and
among Sterling Chemicals, Inc., Resurgence Asset Management,
L.L.C. and the Official Committee of the Unsecured Creditors
(incorporated herein by reference from Exhibit 8 to our
Form 8-A filed on December 19, 2002). |
|
4.4 |
|
|
|
|
Indenture dated December 19, 2002 by and among Sterling
Chemicals, Inc., as Issuer, Sterling Chemicals Energy, Inc., as
Guarantor, and National City Bank, as Trustee, governing the
10% Senior Secured Notes due 2007 of Sterling Chemicals,
Inc. (incorporated herein by reference from Exhibit T3-C to
Amendment No. 3 to our Form T-3 filed on
December 19, 2002). |
|
4.5 |
|
|
|
|
Deed of Trust, Assignment of Leases and Rents, Security
Agreement and Fixture Filing dated December 19, 2002 made
by Sterling Chemicals, Inc., as Trustor, to Thomas S. Henderson,
as Individual Trustee for the benefit of National City Bank, in
its capacity as described therein, as Beneficiary (incorporated
herein by reference from Exhibit 4.2 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
4.6 |
|
|
|
|
Security Agreement dated as of December 19, 2002 by and
among Sterling Chemicals, Inc. and Sterling Chemicals Energy,
Inc., as Assignors, National City Bank, as Collateral Agent, and
National City Bank, as Indenture Trustee for the benefit of the
holders the 10% Senior Secured Notes due 2007 of Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 4.3 to our Transition Report on Form 10-Q for
the transition period ended December 31, 2002). |
|
10.1 |
|
|
|
|
Revolving Credit Agreement dated as of December 19, 2002 by
and among Sterling Chemicals, Inc. and Sterling Chemicals
Energy, Inc., as Borrowers, the various financial institutions
as are or may become parties thereto from time to time, as the
Lenders, and The CIT Group/Business Credit, Inc., as the
Administrative Agent for the Lenders (incorporated herein by
reference from Exhibit 4.4 to our Transition Report on Form
10-Q for the transition period ended December 31, 2002). |
86
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.1(a) |
|
|
|
|
First Amendment to Revolving Credit Agreement dated as of
February 12, 2003 by and among Sterling Chemicals, Inc. and
Sterling Chemicals Energy, Inc., as Borrowers, the various
financial institutions party thereto, as the Lenders, and The
CIT Group/Business Credit, Inc., as the Administrative Agent for
the Lenders (incorporated herein by reference from
Exhibit 4.8 to our Transition Report on Form 10-Q for
the transition period ended December 31, 2002). |
|
10.2 |
|
|
|
|
Security Agreement dated as of December 19, 2002 made by
Sterling Chemicals, Inc. and Sterling Chemicals Energy, Inc., as
Grantors, in favor of The CIT Group/Business Credit, Inc., as
Administrative Agent for the Secured Parties (incorporated
herein by reference from Exhibit 4.5 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.3 |
|
|
|
|
Pledge Agreement dated as of December 19, 2002 made by
Sterling Chemicals, Inc. and Sterling Chemicals Energy, Inc., as
Pledgors, in favor of The CIT Group/Business Credit, Inc., as
Administrative Agent for the Secured Parties (incorporated
herein by reference from Exhibit 4.6 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.4* |
|
|
|
|
Sterling Chemicals, Inc. 2002 Stock Plan (incorporated herein by
reference to Exhibit 6 to our Form 8-A filed on
December 19, 2002). |
|
10.5* |
|
|
|
|
Fourth Amended and Restated Key Employee Protection Plan
(incorporated herein by reference from Exhibit 10.1 to our
Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2004). |
|
10.6* |
|
|
|
|
Amended and Restated Supplemental Pay Plan (incorporated herein
by reference from Exhibit 10.1 to our Quarterly Report on
Form 10-Q for the quarterly period ended June 30, 2001). |
|
10.6(a)* |
|
|
|
|
First Amendment to Amended and Restated Supplemental Pay Plan
(incorporated herein by reference from Exhibit 10.2(a) to
our Annual Report on Form 10-K for the fiscal year ended
September 30, 2002). |
|
10.7* |
|
|
|
|
Third Amended and Restated Severance Pay Plan (incorporated
herein by reference from Exhibit 10.7 to our Annual Report
on Form 10-K for the fiscal year ended December 31, 2003). |
|
10.8* |
|
|
|
|
Sterling Chemicals, Inc. Amended and Restated Salaried
Employees Pension Plan (Effective as of May 1, 1996)
(incorporated herein by reference from Exhibit 10.4 to our
Annual Report on Form 10-K for the fiscal year ended
September 30, 2000). |
|
10.8(a)* |
|
|
|
|
First Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
January 31, 1997) (incorporated herein by reference from
Exhibit 10.4(a) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2000). |
|
10.8(b)* |
|
|
|
|
Second Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
January 1, 1997) (incorporated herein by reference from
Exhibit 10.4(b) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2000). |
|
10.8(c)* |
|
|
|
|
Third Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
November 1, 1998) (incorporated herein by reference from
Exhibit 10.4(c) to our Annual Report on Form 10-K for the
fiscal year ended September 30, 2000). |
|
10.8(d)* |
|
|
|
|
Fourth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
December 31, 1998) (incorporated herein by reference from
Exhibit 10.4(d) to our Annual Report on Form 10-K for the
fiscal year ended September 30, 2000). |
87
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.8(e)* |
|
|
|
|
Fifth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
April 1, 1999) (incorporated herein by reference from
Exhibit 10.4(e) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2000). |
|
10.8(f)* |
|
|
|
|
Sixth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (Effective as of
May 14, 1999) (incorporated herein by reference from
Exhibit 10.4(f) to our Annual Report on Form 10-K for the
fiscal year ended September 30, 2000). |
|
10.8(g)* |
|
|
|
|
Seventh Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.1 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.8(h)* |
|
|
|
|
Eighth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.2 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.8(i)* |
|
|
|
|
Ninth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.3 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.8(j)* |
|
|
|
|
Tenth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.2 to our Quarterly
Report on Form 10-Q for the quarterly period ended
June 30, 2003). |
|
10.8(k)* |
|
|
|
|
Eleventh Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.8(k) to our Annual
Report on Form 10-K for the fiscal year ended December 31,
2003). |
|
10.8(l)* |
|
|
|
|
Twelfth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.1 to our Quarterly
Report on Form 10-Q for the quarterly period ended
June 30, 2004). |
|
10.8(m)* |
|
|
|
|
Thirteenth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan (incorporated
herein by reference from Exhibit 10.2 to our Quarterly
Report on Form 10-Q for the quarterly period ended
June 30, 2004). |
|
**10.8(n)* |
|
|
|
|
Fourteenth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Salaried Employees Pension Plan. |
|
10.9* |
|
|
|
|
Sterling Chemicals, Inc. Pension Benefit Equalization Plan
(incorporated herein by reference from Exhibit 10.10 to our
Registration Statement on Form S-1 (Registration
No. 33-24020)). |
|
**10.9(a)* |
|
|
|
|
First Amendment to Sterling Chemicals, Inc. Pension Benefit
Equalization Plan. |
|
10.10* |
|
|
|
|
Sterling Chemicals, Inc. Amended and Restated Supplemental
Employee Retirement Plan (incorporated herein by reference from
Exhibit 10.34 to our Annual Report on Form 10-K for
the fiscal year ended September 30, 1989 (SEC File
Number 1-10059)). |
|
**10.10(a) |
* |
|
|
|
First Amendment to Sterling Chemicals, Inc. Amended and Restated
Supplemental Employee Retirement Plan. |
|
10.11 |
|
|
|
|
Sterling Chemicals, Inc. Amended and Restated Hourly Paid
Employees Pension Plan (Effective as of May 1, 1996)
(incorporated herein by reference from Exhibit 10.3(c) to
our Annual Report on Form 10-K for the fiscal year ended
September 30, 1996 (SEC File Number 333-04343-01)). |
|
10.11(a) |
|
|
|
|
First Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (Effective as
of December 31, 1998) (incorporated herein by reference
from Exhibit 10.7(a) to our Annual Report on Form 10-K
for the fiscal year ended September 30, 2000). |
88
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.11(b) |
|
|
|
|
Second Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (Effective as
of December 17, 1998) (incorporated herein by reference
from Exhibit 10.7(b) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2000). |
|
10.11(c) |
|
|
|
|
Third Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (Effective as
of September 20, 1999) (incorporated herein by reference
from Exhibit 10.7(c) to our Annual Report on Form 10-K
for the fiscal year ended September 30, 2000). |
|
10.11(d) |
|
|
|
|
Fourth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (incorporated
herein by reference from Exhibit 10.4 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.11(e) |
|
|
|
|
Fifth Amendment to the Sterling Chemicals, Inc. Amended and
Restated Hourly Paid Employees Pension Plan (incorporated
herein by reference from Exhibit 10.5 to our Transition
Report on Form 10-Q for the transition period ended
December 31, 2002). |
|
10.11(f) |
|
|
|
|
Sixth Amendment to the Sterling Chemicals, Inc. Hourly Paid
Employees Pension Plan (incorporated herein by reference
from Exhibit 10.3 to our Quarterly Report on Form 10-Q
for the quarterly period ended June 30, 2003). |
|
10.11(g) |
|
|
|
|
Seventh Amendment to the Sterling Chemicals, Inc. Hourly Paid
Employees Pension Plan (incorporated herein by reference
from Exhibit 10.11(g) to our Annual Report on
Form 10-K for the fiscal year ended December 31, 2003). |
|
10.11(h) |
|
|
|
|
Eighth Amendment to the Sterling Chemicals, Inc. Hourly Paid
Employees Pension Plan (incorporated herein by reference
from Exhibit 10.3 to our Quarterly Report on Form 10-Q
for the quarterly period ended June 30, 2004). |
|
10.12* |
|
|
|
|
Sterling Chemicals, Inc. Sixth Amended and Restated Savings and
Investment Plan dated as of October 1, 2000 (incorporated
herein by reference from Exhibit 10.8 to our Annual Report
on Form 10-K for the fiscal year ended September 30,
2000). |
|
10.12(a) |
* |
|
|
|
First Amendment to the Sixth Amended and Restated Savings and
Investment Plan dated as of October 1, 2000 (incorporated
herein by reference from Exhibit 10.1 to our Quarterly
Report on Form 10-Q for the quarterly period ended
December 31, 2001). |
|
10.12(b) |
* |
|
|
|
Second Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.6 to our Transition Report on Form 10-Q for
the transition period ended December 31, 2002). |
|
10.12(c) |
* |
|
|
|
Third Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.7 to our Transition Report on Form 10-Q for
the transition period ended December 31, 2002). |
|
10.12(d) |
* |
|
|
|
Fourth Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.4 to our Quarterly Report on Form 10-Q for
the quarterly period ended June 30, 2003). |
|
10.12(e) |
* |
|
|
|
Fifth Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.4 to our Quarterly Report on Form 10-Q for
the quarterly period ended June 30, 2004). |
|
10.12(f) |
* |
|
|
|
Sixth Amendment to the Sixth Amended and Restated Savings and
Investment Plan (incorporated herein by reference from
Exhibit 10.1 to our Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2004). |
|
**10.12(g) |
* |
|
|
|
Seventh Amendment to the Sixth Amended and Restated Savings and
Investment Plan. |
|
10.13 |
|
|
|
|
Articles of Agreement between Sterling Chemicals, Inc., its
successors and assigns, and Texas City, Texas Metal Trades
Council, AFL-CIO Texas City, Texas, May 27, 2004 to
May 1, 2007 (incorporated herein by reference from
Exhibit 10.5 to our Quarterly Report on Form 10-Q for
the quarterly period ended June 30, 2004). |
89
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.14* |
|
|
|
|
Form of Indemnity Agreement with each of its officers and
directors (incorporated herein by reference from
Exhibit 10.17 to our Annual Report on Form 10-K for
the fiscal year ended September 30, 1996 (SEC File
Number 333-04343-01)). |
|
10.15* |
|
|
|
|
Employment Agreement dated as of January 23, 2001 among
David G. Elkins, Sterling Chemicals Holdings, Inc. and Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.16 to our Annual Report on Form 10-K for
the fiscal year ended September 30, 2002). |
|
10.16* |
|
|
|
|
Severance Agreement dated effective as of January 2, 2003
between David G. Elkins and Sterling Chemicals, Inc.
(incorporated herein by reference from Exhibit 10.10 to our
Transition Report on Form 10-Q for the transition period
ended December 31, 2002). |
|
10.17* |
|
|
|
|
Settlement Agreement, Waiver and General Release dated
March 17, 2003 between Frank P. Diassi and Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.1 to our Quarterly Report on Form 10-Q for
the transition period ended March 31, 2003). |
|
+10.18 |
|
|
|
|
Amended and Restated Production Agreement dated March 31,
1998 between BP Chemicals, Inc. (predecessor in interest to
BP Amoco Chemical Company) and Sterling Chemicals, Inc.
(incorporated herein by reference from Exhibit 10.2 to our
Quarterly Report on Form 10-Q for the quarterly period
ended March 31, 1998 (SEC File Number 333-04343-01)). |
|
+10.19 |
|
|
|
|
Joint Venture Agreement dated March 31, 1998 between
BP Chemicals Inc. (predecessor in interest to BP Amoco
Chemical Company) and Sterling Chemicals, Inc. (incorporated
herein by reference from Exhibit 10.4 to our Quarterly
Report on Form 10-Q for the quarterly period ended
March 31, 1998 (SEC File Number 333-04343-01)). |
|
+10.19(a) |
|
|
|
|
First Amendment to Joint Venture Agreement dated effective as of
March 31, 1998 between BP Chemicals Inc. (predecessor in
interest to BP Amoco Chemical Company) and Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.26(a) to our Annual Report on Form 10-K for
the fiscal year ended September 30, 1998 (SEC File
Number 333-04343-01)). |
|
+10.20 |
|
|
|
|
Acrylonitrile Expanded Relationship and Master Modification
Agreement dated June 19, 2003 between BP Chemicals
Inc. (predecessor in interest to BP Amoco Chemical Company)
and Sterling Chemicals, Inc. (incorporated herein by reference
from Exhibit 10.1 to our Quarterly Report on Form 10-Q
for the quarterly period ended June 30, 2003). |
|
+10.21 |
|
|
|
|
Second Amended and Restated Production Agreement dated effective
as of August 1, 1996 between BP Chemicals Inc.
(predecessor in interest to BP Amoco Chemical Company) and
Sterling Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.3 to our Quarterly Report on Form 10-Q for
the quarterly period ended March 31, 1998 (SEC File
Number 333-04343-01)). |
|
+10.21(a) |
|
|
|
|
Amendment to Second Amended and Restated Production Agreement
dated as of March 1, 2001 between BP Chemicals Inc.
(predecessor in interest to BP Amoco Chemical Company) and
Sterling Chemicals, Inc. (incorporated herein by reference from
Exhibit 10.1 to our Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2001). |
|
+10.22 |
|
|
|
|
Amended and Restated Product Sales Agreement dated effective as
of January 1, 1998 between BASF Corporation and Sterling
Chemicals, Inc. (incorporated herein by referenced from
Exhibit 10.11 to our Annual Report on Form 10-K for
the fiscal year ended September 30, 1997 (SEC File
Number 333-04343-01)). |
|
10.23 |
|
|
|
|
License Agreement dated August 1, 1986 between Monsanto
Company and Sterling Chemicals, Inc. (incorporated herein by
reference from Exhibit 10.25 to our Registration Statement
on Form S-1 (Registration No. 33-24020)). |
90
|
|
|
|
|
|
|
Exhibit | |
|
|
|
|
Number | |
|
|
|
Description of Exhibit |
| |
|
|
|
|
|
10.24 |
|
|
|
|
Asset and Stock Purchase Agreement dated as of November 13,
2002 among Sterling Chemicals, Inc. and Sterling Canada, Inc.,
Sterling Pulp Chemicals US Inc., Sterling Pulp Chemicals,
Inc. and Sterling Chemicals Acquisitions, Inc., as Sellers, and
Superior Propane Inc., as Purchaser (incorporated herein by
reference from Exhibit 10.23 to our Annual Report on
Form 10-K for the fiscal year ended September 30,
2002). |
|
10.25 |
|
|
|
|
Investment Agreement dated as of October 11, 2002 among
Sterling Chemicals Holdings, Inc., Sterling Chemicals, Inc. and
Resurgence Asset Management, L.L.C. (incorporated herein by
reference from Exhibit 2.1 to our Annual Report on
Form 10-K for the fiscal year ended September 30,
2002). |
|
14.1 |
|
|
|
|
Sterling Chemicals, Inc. Code of Ethics for the Chief Executive
Officer and Senior Financial Officers (incorporated herein by
reference from Exhibit 14.1 to our Quarterly Report on Form
10-Q for the quarterly period ended June 30, 2003). |
|
**21.1 |
|
|
|
|
Subsidiaries of Sterling Chemicals, Inc. |
|
**23.1 |
|
|
|
|
Consent of Deloitte & Touche LLP. |
|
**31.1 |
|
|
|
|
Rule 13a-14(a) Certification of the Chief Executive Officer |
|
**31.2 |
|
|
|
|
Rule 13a-14(a) Certification of the Chief Financial Officer |
|
**32.1 |
|
|
|
|
Section 1350 Certification of the Chief Executive Officer |
|
**32.2 |
|
|
|
|
Section 1350 Certification of the Chief Financial Officer |
|
99.1 |
|
|
|
|
Amended and Restated Audit Committee Charter of Sterling
Chemicals, Inc. (incorporated herein by reference from
Exhibit 99.1 to our Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2003). |
|
99.2 |
|
|
|
|
Amended and Restated Corporate Governance Committee Charter of
Sterling Chemicals, Inc. (incorporated herein by reference from
Exhibit 99.2 to our Annual Report on Form 10-K for the
fiscal year ended December 31, 2003). |
|
|
* |
Management contracts or compensatory plans or arrangements. |
|
|
** |
Filed or furnished herewith. |
|
|
+ |
Portions of the exhibit have been omitted and filed separately
with the Securities and Exchange Commission pursuant to a
request for confidential treatment. |
91